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ABSTRACT
ABSTRACT
Recent legislation has accentuated the importance of developing novel in vitro 
toxicology testing strategies which avoid the use of animals. The focus of this 
study was to use in vitro epithelial models to characterize the point of change 
between protective and deleterious responses in the lung following exposure 
to well-characterized commercial polymers. The first step was to develop and 
characterize the Normal Human Bronchial Epithelial (NHBE) primary cell 
model, which resulted in an organotypic, multi-differentiated bronchial model 
which was then used to elucidate the phenotypic and genotypic responses to 
polymers. The NHBE model exhibited evidence of ciliogenesis and mucus 
production comparable to native human bronchial epithelium. Conventional 
toxicology techniques were utilized to establish the doses required to induce 
sub-toxic responses in the model; a lower (TD05) dose to induce a protective 
response and a higher (TD20) dose to induce a more injurious response. 
Transmission (TEM) and Scanning Electron Microscopy (SEM) were 
employed to examine changes in the inter-cellular morphology and revealed 
the TD05 dose led to regional hypertrophy but that the TD20 dose resulted in 
cellular degradation and general degeneration of tissue integrity. 
Transcriptomic tools (GeneSpring, Metacore™) were applied to microarray 
data to compare gene expression profiles across NHBE cultures (multiple 
donors) and with a commercial tracheal model (EpiAirway™, single donor), as 
well as to characterize the molecular pathways implicated in response to each 
dose. This demonstrated that the TD05 dose induced alterations of genes 
and pathways representative of protective and inflammatory responses but 
the TD20 dose induced airway injury, wounding and remodeling. It was also 
found that although the nature of responses were similar, the EpiAirway™ 
tissues were over-sensitive and presented a shorter viable experimental 
window, therefore the NHBE was considered the optimal in vitro model to 
assess toxicological responses of the pulmonary epithelium.
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1.0 S tu d y  In tr o d u c tio n
The human respiratory tract is a vulnerable area of the body, regularly subjected 
to the exposure of potentially harmful ‘foreign’ particulates in the air. There is an 
increasing need to find alternatives to the use of animals in the study of the 
effects of these xenobiotic particles. Polymers represent a family of materials 
used in the production of personal care products, which are inhaled by 
consumers. The overall aim of this project was composed of the following three 
parts.
1. To develop an effective protocol for the culturing of the NHBE primary cell 
model and to assess it’s comparability to human tissue (particularly the 
bronchial epithelium in vivo) and it’s viability as part of a battery of in vitro 
tests designed to replace inhalation toxicology testing in vivo.
2. To utilize conventional toxicology techniques (e.g. MTT) to establish two 
sub-toxic concentration levels of commercial polymers, a lower (TD05) 
concentration, in order to characterize a possible protective or reversible 
response and a higher (TD20) concentration, in order to characterize a 
more injurious and damaging response.
3. The ultimate aim was to explore and compare the phenotypic and 
genotypic responses imposed by the polymers. Transmission electron 
microscopy (TEM) and Scanning electron microscopy (SEM) were 
employed to examine concomitant changes in the overall as well as the 
intercellular morphology. Transcriptomic analysis tools were also applied to 
microarray data to examine and compare the observed changes at a 
molecular level in terms of affected mechanisms and pathways of stress. 
The application of online database tools allowed the probing of gene 
expression profiles in order to uncover biological pathways and 
biochemical networks which characterized the different dose responses.
1.1 G e n er a l  O v e r v ie w  o f  t h e  H u m an  R espira to r y  System
Breathing is the primary function of the respiratory system and necessary for life. 
Respiration can be sub-divided into mechanical respiration, the physical 
mechanism of conducting air into and out of the body, and cellular respiration, the 
oxidative metabolism at the cellular and biochemical level. Humans on average, 
take about 12 breaths a minute, with an approximate tidal volume of 500 ml of air 
per breath (Phalen et a!., 2006). Once the air is inside the lungs, the essential
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diffusion of oxygen (O2) into the body, and carbon dioxide (CO2) out of the body 
takes place. Oxygen is necessary for cellular respiration and CO2 is a by-product 
of this process. Cellular respiration entails the breakdown of glucose in the 
presence of O2 to release energy (ATP) for metabolism. The human body must 
obtain a constant supply of 02, while removing CO2 . A dense network of 
capillaries carry blood to and from the lung. Haemoglobin, found in the red blood 
cells, is a complex molecule made up four polypeptide chains, each with an iron- 
containing haem group. The haem group acts as a carrier for either carbon 
dioxide (C 02) or oxygen (0 2) (Hlastala, 2001). The C 02 and 0 2 gases diffuse into 
and out of the red blood cells through the capillaries surrounding the alveoli or air 
sacs in the lung. The CO2 is carried out of the body via exhalation through the 
respiratory tract, while 0 2 is carried through the body via the capillary network.
During inhalation, the lungs take in with the air any suspended xenobiotics (i.e. 
solid and gaseous) that are 10 micrometres or less in aerodynamic diameter 
(Levisky, 1995). The surface epithelium of the respiratory system (RS) is 
considered a local exposure area, as it is in direct contact with the external 
environment. It is therefore vulnerable to any of the potentially harmful effects 
posed by incoming airborne foreign particulates. Consequently, the human RS 
has a number of morphological and biochemical methods that it uses to protect 
itself from such a potential attack. Depending on the level of toxicity of an inhaled 
xenobiotic, the concentration of the particulate in the air, the length of time of 
exposure to the surface epithelia, as well as the ability of the respiratory tract to 
respond to toxicant challenge, the outcomes (e.g. injury/disease) for any given 
exposure can be wide ranging. Inhaled toxicants can induce a variety of 
responses including allergic reactions, exacerbation of airway disease symptoms, 
the development of lung cancer and possibly death.
1.1.1 Structures of the Human Respiratory  System
The structure of the human RS (Figure 1.1) is divided into three main regions: (1) 
the nasopharyngeal (NR) or extra-thoracic region, which includes the nose, 
mouth, pharynx and larynx. This region is sometimes referred to as anatomical 
dead space, as there is no gas exchange occurring in this zone; the volume of the 
conducting airways is approximately 150 ml per breath; (2) The transitional,
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tracheobronchial (TB) tree or lower region, which includes the trachea (or 
windpipe), the two major bronchi and the succeeding smaller bronchioles; (3) the 
pulmonary (PR) or distal region, where O2 and CO2 gas exchange takes place. 
The latter zone consists of the terminal bronchioles, respiratory bronchioles and 
budding off at the end of these are the alveolar ducts and alveoli. The alveoli 
(Figure 1.2) are surrounded by the pulmonary capillaries that form a network of 
tiny vessels through which the red blood cells travel. The gas exchange occurs 
here between the air and red blood cells of the pulmonary capillaries. The PR 
(Figure 1.2) has the greatest volume, being approximately 2.5 to 3 litres (West, 
1995). All of these three zones of the RS are lined with epithelial tissue, the 
cellular compositions of which vary as one travels from the upper to the distal 
regions.
U pper RT
(NR)
Nasal Cavity
Pharynx
Larynx
Low er RT
(TB)
Trachea
Bronchu
Bronchiole
ZTtespiralory" 
bronchiole 
* (alveolar unit)
D istal RT
(PR)
Figure 1.1 An overview of the key structures in the human respiratory system depicting the upper, 
lower and distal respiratory tract (RT) regions (courtesy of Dr. K. B6ruB6, Cardiff University, 
2009); NR = Nasopharyngeal Region, TB = Tracheobronchial, and PR = pulmonary region.
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Figure 1.2 The pulmonary region, denoting the respiratory bronchioles and alveoli (adapted from 
Prince George’s Community College, http://academic.pgcc.edu, 2005).
1.1.1.1 T he R e s p ir a to r y  E p ith e lial  T issue
In general epithelial tissue acts to cover and line other tissues, and forms a 
protective layer or barrier between tissues and the outside environment. It may 
also provide a semi-permeable surface allowing for the exchange and 
transportation of materials. The respiratory epithelium (RE) is an example of a 
pseudo-stratified epithelium. It consists of one layer of columnar or rectangular 
shaped cells of different phenotypes, which are attached to a flat (squamous) 
layer of basal cells below, which in turn is connected to the basal lamina (Table 
1.1). As one travels down the RS, from the upper respiratory tract, to the lower or 
distal parts of the tract, the cellular characteristics of the respiratory epithelium 
change in both structure and function (Table 1.1).
1.1.1.1.1 In te r c e llu la r  J u n c tio n s
A number of important intercellular junctions act to hold together adjacent cells in 
the respiratory epithelial tissue, provide intracellular connections between the 
cellular membrane and the actin cytoskeleton, and play a role in both inter- and 
intracellular communication. The junctions between adjacent cells in the tissue 
are crucial to the integrity of the tissue. These intercellular junctions are also 
important in a number of signalling pathways and gene transcription (Hartsock 
and Nelson, 2008). The main differences between the types of intercellular
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REGION MORPHOLOGY
Upper Respiratory Epithelium
Goblet cell
*  fm
- V
• Pseudo-stratified tissue
• Tall columnar cells
• Large numbers of goblet cells
• Ciliated cells
Bronchial Epithelium
t
Ai .Cilia
. -■
' »  •  •
i  t*, * ,w ? ...
• Pseudo-stratified tissue
• Short columnar cells
• Few goblet cells
• Ciliated cells
Bronchiole Epithelium
•  SSCi
i  A , * * -  ^  ~
• Simple cuboidal tissue
• No goblet cells
• Clara cells
• Ciliated cells
Alveolar Epithelia
Endothelial cell
Type 2
Type 2
M acrophage
Simple squamous tissue 
No cilia
No goblet or Clara cells 
Alveolar Type I cells 
Alveolar Type 2 cells 
Macrophages
Table 1.1 The morphological organization of the respiratory epithelium according to the 
respiratory, bronchial, bronchiole and alveolar regions of the human respiratory system. Light 
Microscopy (LM) images courtesy of Dr. K. B6ruB6, Cardiff University, 2009.
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junctions include; their locations in the tissue, constituent adhesion proteins, and 
their resulting structure and function.
One characteristic of all epithelial tissue is the impermeable junctions that form 
between cells, and their location near the apical surface of the tissue. These 
junctions are referred to as tight junctions or zonulae occludins (Lodish, 1999). 
These junctions are comprised of primarily the transmembrane proteins occuldin 
and claudin, as well as the ZO-1, 2 and 3 proteins (Hartsock and Nelson, 2008). 
The first two of these, occuldin and claudin, mainly act to bind adjacent cells, 
whereas the ZO-1, 2 and 3 proteins may act to “form scaffolds and/or connections 
to the actin cytoskeleton" (Hatsock and Nelson, 2008). The tight junctions act to 
prevent the movement of materials from the external apical space into the tissue, 
and consist of rows or strands of proteins which form a barrier to seal off the 
space between the cells. Just below the tight junctions, are the adherens 
junctions. These types of junctions are also associated with the actin cytoskeleton 
of the cell (Hartsock and Nelson, 2008). Adherens junctions consist of dense 
plaques. The plaques of adjacent cells are then connected by E-cadherin cell 
adhesion proteins, as well as a number of forms of the intracellular molecule 
catenin (Hartsock and Nelson, 2008). Some authors refer to adherens junctions
Tight junctions 
(zonula ocludins)cV  Membrane protein 
Plasma membrane
TMicrofilament Adhering ,— s 
junction (^Adhesion belt 
(zonula
adherens) Intercellular space 
Adjacent plasma membranes Gap
junction
Pore
Connexon
Desmosome (macula 
adherens)
Protein plaque 
Protein filaments 
Plasma membraneIntercellular space
Figure 1.3 A diagram depicting the four main types of inter-cellular junctions found in epithelial 
tissue. These junction types include: tight junctions, adhering junctions, desmosomes and gap 
junctions. Adapted from McGraw-Hill, courtesy of Dr. K. B6ruB6, Cardiff University, 2009.
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as a form of desmosome or a ‘belt desmosome’ (Lodish et a!., 1995), whereas 
others distinguish a desmosome as a different junction, or as a mascula 
adherens, as shown in Figure 1.3. The broad term ‘desmosome’ refers to a 
thickened region of plasma, which acts both to hold adjacent cells together and to 
add strength and rigidity to the cell membrane (Lodish et a/., 1995). The macula 
adherens or desmosomes, also contain the cadherin adhesion proteins, 
desmoglin and desmocolin. In the desmosomes, keratin filaments form the 
connection between the cell adhesion proteins and the cytoskeleton (Presland 
and Jurevic, 2002). The desmosomes act to strengthen the connections between 
cells and act to anchor adjacent cells to the cytoskeletal filament network. In the 
case of mechanical stress to tissue, these bonds can be destroyed. Other 
junctions between cells, such as gap junctions act as channels or tubes for the 
movement of dissolved materials (such as ions and glucose), from one cell to 
another. Hemidesmosomes, another form of intercellular junction, act to attach or 
anchor cells in the basal region of the tissue to the basal lamina. They are made 
of different types of proteins (i.e. Laminin 5 and Plectin; Presland and Jurevic, 
2002).
1.2 C ells  o f  th e  R e s p ir a to r y  T r a c t
There are more then forty different cell types that comprise the human respiratory 
epithelium (Castell et al., 2005). Within the three main regions of the RS, specific 
groups of cell types work in unison to maintain the functional integrity of each 
region (Table 1.1). For example, in the NP region, (the lower portion of which 
includes the respiratory epithelium), principle cell types include the basal, ciliated 
and secretory cells. These cells are used to filter the air and debris and keep the 
epithelium humidified (Table 1.1, Table 1.2). The TB region, (includes the 
respiratory, bronchial and bronchiole epithelium), contains a similar set of cells 
but there is an increase in the number of goblet cells and the appearance of Clara 
cells (Breeze, 1997). One key feature of this region is the mucociliary escalator 
(Table 1.1) (Levitzky, 1995). All of these cells are referred to as being polarised; 
one side of the cell has a different structure and function than the other side of the 
cell (Alberts, 1998). In the case of the cells that line the respiratory tract, the 
apical side (top) of the cell is exposed to the incoming air while the basal side 
(bottom) of the cell is not. The basal side of the cell is attached to the basal
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UPPER AND LOWER AIRWAYS
CELL TYPE PHYSICAL CHARACTERISTICS FUNCTION
Basal Cells •  Flat or triangular cells with a large 
nucleus
•  Act as an anchor or base of the 
tissue
•  Act as progenitor or precursor 
cells, which go on to form 
differentiated cells
Secretory Cells 
Mucus,
Goblet cells
s m d m M
Clara Cells
•  Mucus cells contain secretory 
mucin granules, that are expelled 
from the apical surface of the cell
•  Goblet cells are dense as they 
contain many mucin granules and 
ribosomes and are located mainly 
in the upper respiratory tract
•  Clara cells have fewer and smaller 
secretory granules, large numbers 
of granular endoplasmic reticulum, 
do not have cilia, and appear dome 
shaped. They are mainly found in 
the lower respiratory tract
•  Secrete mucus, that warms air, 
keeps the epithelium from drying 
out and traps particles.
•  Metabolise xenobiotics
Ciliated Cells
' $>' .* 1
•  Columnar in shape and taper as 
they move down to the base, where 
they are attached to the basal cells
•  Are covered with approximately 
250 cilia per cell and therefore 
have a much greater surface area 
(Mathias etal., 1996)
•  The cilia are interspersed with 
about half as many microvilli and 
cytoplasmic processes, these are 
anchored in a basal body high in 
mitochondria to provide needed 
energy for movement (Breeze and 
Wheeldon, 1997)
•  Beat together to form a current 
which propels the mucus layer
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UPPER AND LOWER AIRWAYS
CELL TYPE PHYSICAL CHARACTERISTICS FUNCTION
B ru sh  c e lls •  Tall cells anchored to the basement 
membrane and are covered on the 
apical surface with a group or tuft of 
microvilli
•  Scattered in the trachea, bronchi and 
bronchioles
•  They are taller and wider and have 
more uniform microvilli then other 
cells
•  Evidence of nerves in the cells 
suggest a role as a type of 
receptor cell
•  Studies of the uptake of certain 
substances have pointed to a 
possible absorptive function 
(Breeze and Wheeldon, 1997)
•  Metabolize xenobiotics
DISTAL AIRWAYS
CELL TYPE PHYSICAL CHARACTERISTICS FUNCTION
Alveolar Type I 
1
^ ' ^ T y p e  1
•  Squamous attenuated cytoplasm
•  Described as having a ‘fried egg 
morphology’ with the nucleus of the 
cell appearing like the yolk in the 
fried egg (Steimer et al., 2005)
•  Cover approximately 96% of 
the surface of the alveolar sac
•  Form air-blood barrier with the 
capillaries
Alveolar Type II 
Type II
•  Round small cells, cuboidal in shape
•  These cells are in much greater 
numbers then the Type 1 cells
•  Produce and store surfactant, 
a phospholipids which acts to 
reduce surface tension and 
prevent alveolar collapse
•  Act as progenitor or precursor 
cells, as they can develop into 
Alveolar type I cells in certain 
circumstances
•  Exhibit endocytic properties
•  Produce and release 
antioxidants
Alveolar Macrophages •  Amoeboid shaped cells with a large 
single nucleus
•  Found in varying numbers of 
the surface of the alveoli
•  Free moving cells which roam 
and act to phagocytize 
xenobiotic particles and 
destroy them enzymatically 
within their lysosomes
Table 1.2 The respiratory cell types found in the upper, lower and distal airways of the respiratory 
tract (Breeze and Wheeldon, 1997; Thomassen and Nettesheim, 1990, B6ruB6 et al., 2009).
Tracy Hughes
CHAPTER ONE GENERAL INTRODUCTION
lamina. There are a number of other cells types which appear in much smaller 
populations.
As one travels down the TB pathway, the composition of the airway cell types 
changes. In the upper airways, (the upper respiratory and upper portion of the 
bronchial epithelium), the surface is made up of ciliated cells with the secretory 
goblet cells being distributed throughout, but in smaller numbers (Table 1.1,Table 
1.2). In the lower airways, (the bronchiole epithelium), ciliated cells are also 
found, but the secretory cells are now the Clara cells (Table 1.1, Table 1.2). In the 
distal region, (the alveolar epithelia), there are no Clara cells and the secretion is 
brought about via Alveolar Type II (ATII) cells (Table 1.1, Table 1.2). There are 
also a greater number of secretory cells in the NP and TB regions when 
compared to the PR; hypersecretion in the PR would occlude the airways. Also 
found on the surface of the mucosal layer of the respiratory tract are lymphocytes 
(nucleated white blood cells) and other leukocytes or white blood cells, such as 
eosinophils and neutrophils. These immune response cells are found in smaller 
numbers in the upper respiratory tract and in higher numbers in the lower 
respiratory tract. These will be discussed in more depth in Section 1.3.2.2 and on 
Table 1.4.
1.3 R e s p ir a to r y  Sy s te m  P r o te c tiv e  M echanism s
The protective mechanisms of the RS are varied. As xenobiotic particles and 
gases travel into and through the conducting airways, their aerodynamic 
properties (size, shape, etc.) determine their translocation route and deposition 
site. Aerial xenobiotics may enter the RS through the nose or the mouth. These 
entry points can influence their fate, or where there are eventually deposited in 
the RS. The three discrete regions of the RS are each supported by regional 
defence mechanisms (Table 1.3). In general, the NP region is devoted to filtering 
out particulate matter (>15pm diameter), absorbing and metabolising (e.g. 
olfactory epithelium) gaseous compounds and humidifying the nasal cavity 
(Levitzky, 1995). The TB region is characterised by the mucociliary escalator, 
which acts to maintain a sterile lung environment by trapping and removing debris 
upwards and limiting deposition of material in the PR. The ability to trap particles 
in the mucociliary escalator is a function of the physical characteristics of the 
epithelial lining fluid, including mucin molecules.
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1.3.1 M ucins
Mucus plays an important role in the protection of the respiratory tract. It acts to 
trap incoming particles which are then carried via the mucociliary escalator to be 
swallowed. When an excess amount of mucus is produced this can cause 
blockage of the respiratory tract. This is the problem in respiratory disorders such 
as cystic fibrosis (CF), chronic pulmonary obstruction disorder (COPD), and 
asthma. The overproduction of mucin is generally attributed to an increase in the 
numbers of secretory cells (Rogers, 2004). This may be due to a change in the 
morphology of existing cells or the production of new secretory cells, referred to 
as metaplasia and hyperplasia, respectively (Williams et al., 2006). The 
stimulation of new secretory cells and the upregulation of mucus or mucin gene 
expression does not only take place in the development of disease conditions, but 
also in allergic and injurious responses, i.e. inflammation in the airways of normal 
(atopic) healthy people. Mucus is a complex mixture of components including 
water, electrolytes, endogenous and exogenous proteins, lipids and 
carbohydrates (Rogers, 2004). The three main types of mucin or MUC genes 
found to be expressed in the human airways are the genes for gel forming mucin 
molecules referred to as MUC5B, MUB5AC and MUC2 (Thornton et al., 2000).
1.3.2 Fur th er  R e spir a to r y  S y s te m  R e spo n se  M echanism s
1.3.2.1 Physical Respo n ses
Protective mechanisms of the respiratory tract can be divided into a number of 
strategies. These may again be divided into physical and non-immunological 
(Tablel .3). Physical mechanisms are mainly denoted by the mucociliary 
escalator, (e.g. mucus trapping particles and the movement of the mucociliary 
transport system). The cilia are 5 to 7 pm long and beat between 1000 and 15000 
times per minute in a synchronized fashion (West, 2007). Other physical 
reactions include coughing, sneezing and the constriction of airways, preventing 
the movement of potentially toxic material deeper into the lung to the alveoli 
(Gerritsen, 2000). In the PR of the lung there are also alveolar macrophages (AM) 
to remove any debris deposited on the surface of the epithelium, through the 
process of exocytosis, (i.e. engulfing and physically breaking down the particles if 
possible). Other protective mechanisms include non specific secretions which are 
present in the bronchial fluids and produced locally in the mucous secreting cells,
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LOCATION DEFENCE MECHANISMS
Nasal vestibule •  Vibrissae or nasal hairs act to trap particles
Nasal Cavity 
(fossae)
•  Lined with tiny microvilli which act to trap particles
•  Mucus acts to trap particles
•  Olfactory epithelium contains secretory cells which release 
biotransforming enzyme P450 to detoxify xenobiotic compounds
•  Stimulation of nerve endings or receptors in the nasopharynx by 
certain ‘foreign bodies’ or xenobiotic material, induces a sneeze 
which forcefully expels materials
Buccal cavity and 
pharynx
•  Saliva and mucus line the walls and act to warm the air, trap 
particles and dissolve toxic gases
Trachea
•  Absorption of ions and liquids across the epithelium is needed to 
maintain the correct level of periciliary liquid (PCL) necessary for 
the active movement of the cilia
•  ‘Mucociliary escalator’ -  the cilia beat in a coordinated manner to 
transport the mucus layer above the cilia and PCL to be removed 
by swallowing, spitting, sneezing or lymphatic circulation
• Stimulation of receptors in the trachea by certain xenobiotics may 
result in a cough to expel these materials
Bronchi and 
Bronchioles
•  Migratory macrophages roam the epithelial and act to engulf and 
digest xenobitoic particles
• Cellular secretions contain enzymes which act to modify and 
detoxify toxic materials
• Recruitment of polymorphonuclear cells (PMN),white blood cells 
which include neutrophils and eosinophils. These act like 
macrophages to break down invaders. The PMN also release 
cytokines (e.g. Interleukin 6) which act to induce inflammation
Alveoli •  Alveolar macrophages act to engulf and digest xenobiotics as 
mentioned above
•  Type II cells secrete biotransforming enzyme Glutathione S- 
Tranferase (GST), surfactant, etc.
•  Type II cells are able to transform into type I cells in the event of 
damage
Table 1.3 The location of key defence mechanisms in the human respiratory system, according to 
the upper, lower and distal regions (Boyton and Openshaw, 2002; Castell et al., 2005; Levitsky, 
1995; Matsui eta!., 1998).
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such as lysozyme (lyses bacteria), lactoferrin (inhibits bacterial growth), and 
interferon (inhibits viral colonization) (Boyton and Openshaw, 2002). Collectins 
and defensins are proteins which bind to the surface of invading bacteria and 
viruses. These types of protective proteins stimulate further immune activity by 
activating other defence cells (e.g. macrophages, lymphocytes and natural killer 
cells).
1.3.2.2 Im m un olo gica l  R espo n ses
The epithelial cells play a primary role in responding to the stimulus of incoming 
irritants and particulates (e.g. synthetic commercial polymers, environmental 
pollutants and particles). This response involves the secretion of factors which 
recruit immune cells to the area to provide further defence. Phagocytic immune 
cells such as granulocytes (i.e. eosinophils and neutrophils) and macrophages, 
act to engulf and kill pathogens, as well as secreting further factors which include 
defensins, tumor necrosis factor alpha (TNF-a), interleukin-1 & (IL-1&) and 
interleukin 6 (IL-6) (Boyton and Openshaw, 2002). These factors, in turn, signal 
further immunological pathways. The main types of immune cells which play a 
secondary role in the respiratory defense are summarized in Table 1.4. These 
recruited immune cells include the lymphocytes, such as T and B cells. These 
cells act to recognize foreign bodies and in response they produce specialized 
antibodies, or high affinity binding molecules, which are tailored to adhere to 
these invading xenobiotics or antigens (Lodish et al., 1995). These antibodies can 
be used to label infected cells for destruction by macrophages, or to recognize 
and attack infected cells. Once activated, specialized antibodies and immune 
cells are then equipped to protect a person in the case of any future invasions by 
the antigen. Examples of the main types of secondary or immune cells recruited 
by the respiratory epithelial cells and their primary functions is shown on Table 
1.4. Also present in the respiratory epithelium are important components of the 
immune system known as immunoglobulins, abbreviated Ig and sometimes 
referred to as antibodies (Lodish etal., 1995). Primarily Immunoglobulin A (IgA) is 
found in the respiratory tract, but also in smaller quantities, IgG and IgE, which 
act to stop viral invaders from entering and infecting the body (Wood, 2006).
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Ph
ag
oc
yt
es
General cell type: White blood cells or leukocytes with cytoplasmic granules. Found 
in the blood and tissue and act to engulf and kill ‘invaders’.
G
ra
nu
lo
cy
te
s
SPECIFIC TYPE PRIMARY FUNCTION
Eosinophils
Express receptors for IgE. Phagocytes against 
antigen-antibody complexes and attack parasites. 
Release histamine and leukotrienes and are 
involved in mucosal inflammation in chronic 
allergic asthma.
Neutrophils
Phagocytes against bacteria, foreign particles, 
senescent self cells and dead tissue. Release 
defensins and Nitrogen Oxide (NO) and are 
attracted by chemokines.
Basophils
)
Bind to IgE via receptors. Are involved in allergic 
immune response by secreting substances such 
as histamines and serotonin, which act as 
anticoagulants and vasodilators. Release 
histamines.
O
th
er
s
Monocytes
Develop into macrophages (or dendritic cells), 
phagocytes of foreign particles, dead tissue and 
senescent cells. They are attracted by a wide 
range of interleukins, interferons, transforming 
growth factors, and tumour necrosis factors
Ly
m
ph
oc
yt
es
General Cell types: White blood cells or leukocytes found in the blood, lymph and 
lymphatic tissue. They have a very small amount of cytoplasm surrounding a large 
dense nucleus. They possess specific ‘recognition’ molecules and are involved in 
antibody production.
SPECIFIC TYPE PRIMARY FUNCTION
T cell Mature in thymus. Attach to antigens and have antigen 
receptors. Further subdivided into helper T cells (TH ), and 
cytotoxic T lymphocytes. The T helper cells are activated 
by antigen processing cells such as macrophages. Helper 
T cells release cytokines and direct B cells to kill infected 
and foreign cells, replicate and produce antibodies.
B cells o Characterized by isotypes of immunoglobulins on their surface or antigen receptors. Activated by either antigen or T cells and will replicate into many specific antibody 
producing clones and memory B cells for long- term 
immunity.
Natural Killer (NK) 
cells Attack cells infected with viruses and tumor cells. 
Release interferons.
Table 1.4 The principle types of ‘recruited’ or secondary immune cells (adapted from: Karp, 
(2005); Michal, (1999); Thompson e ta l ,  (1995); and Lodish et al., (1995)).
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Bronchial epithelial cells release mediating or cell signalling molecules (i.e. 
cytokines), which act to stimulate a number of actions involved in the 
inflammatory pathway. The principle cytokines released include IL-6 and IL-8, in 
response to inflammatory agents such as TNF or IL-1 (Alder et al., 1994). The 
expression of these pro-inflammatory cytokines is also dependent on the actions 
of transcription factors, such as nuclear factor -  kappa B (NFkB), which is now 
seen as a target in the search to control the pulmonary inflammatory hyper­
response, such as in the case of allergies and asthma (Newton et al., 2007).
1.3.2.3 S upplem ental  D efen c e  M echanisms
There are further supplemental defence mechanisms primarily located in the 
distal RS. The ATII cells secrete xenobiotic metabolising enzymes, (e.g. phase 1 
and phase 2 biotransformation). Phase 1 enzymes act to modify xenobiotics, via 
the cytochrome P450 (CYP-dependent mono-oxygenase) system, Phase 2 
enzymes act to further detoxify and eliminate molecules and metabolites of Phase 
1 enzyme activity, primarily by the actions of Glutathione S-Transferase (GST) 
(Castell et al., 2005). The ATII cells also secrete pulmonary surfactant, a lipid 
containing liquid which acts to reduce surface tension in the alveoli but also forms 
a protective coating. Furthermore, the ATII cells can differentiate into the ATI cell 
phenotype if the epithelium is damaged, in order to maintain alveolar structure 
and avoid compromise to gaseous exchange.
Overall, endogenous pulmonary protection is a multifaceted system that involves 
the physical actions of tissues, non-specific locally produced expressed factors, 
recruitment and migration of circulating factors and specific immune cells. The 
key to the success of endogenous protective mechanisms is in the level of the 
response and the clearance of the resulting products. If factors are over 
stimulated or over activated, this can lead to an inhibition of respiratory function, 
(e.g. reduction of gas exchange and tissue damage) (Gerritsen, 2000).
1.4 G en e r a l  Pa th w a y s  to  L un g  Inju r y
Despite the mechanisms which are employed to protect the RS, they can be 
overwhelmed and damage may result following exposure to bioreactive 
particulate matter (PM) and soluble or gaseous compounds (Table 1.5). With 
regard to PM, the size, aerodynamic properties and solubility of a particle will play
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an important role in determining where it will be deposited in the respiratory tract, 
and in turn, the potential to inflict injury (B6ruB6 et al., 2007). If particles are not 
carried via the mucociliary escalator up and out of the respiratory tract, then a 
number of responses may result (Table 1.3). Respiratory epithelial cell responses 
contribute to focal/system inflammation in the effected region in a number of 
manners as elemental as changes in ciliary beating and ion transport (Adler et al., 
1994). Aside from physical protective reflexes such as coughing and mucociliary 
transport, epithelial cells make an immediate response to a bioreactive material 
with an increase in locally produced antimicrobial agents. This immediate 
response may also include epithelial cell damage. There is then what may be 
referred to as a transient response in the form of mild inflammation, characterized 
by changes in the permeability of vascular membranes and the recruitment of 
phagocytic cells such as neutrophils. These act to destroy and contain the 
invasion (Gerritsen, 2000). Permeability changes or pulmonary oedema, allow for 
the increased movement of cells to the effected area, as well as causing swelling 
(Adler et al., 1994). Mild inflammation is a mechanism of repair and is necessary 
in order to regain normal functioning. In mild inflammation macrophages play an 
important role in resolving inflammation by engulfing neutrophils and eliminating 
them from the effected area, as well as sending out anti-inflammatory signals 
(Riches, 2004). In the normal lung and under most conditions, inflammation 
following acute PM exposures is most often transient and subsides in time 
(Riches, 2004). If inflammation is not resolved and the insult persists, it can lead 
to more severe or progressive damage states. The cells which have been 
recruited to engulf and to destroy pathogens must be cleared via the mucociliary 
elevator or cytotoxic consequences may result. In asthma, for example, the 
products of esinophils and mast cells cause epithelial cell damage (Holgate et al., 
2000). In severe or long term cases of PM exposures, especially with poorly- 
soluble materials such as coal dust particles, more persistent damage can occur 
that involves potentially irreversible alteration of the pulmonary architecture (i.e. 
pulmonary fibrosis). Fibrosis is the irreversible formation of scar tissue or the 
replacement of normal functioning parenchyma with connective tissue (Crouch, 
1990; Young and Adamson, 1993). This type of structural remodelling can lead to 
airspace fibrosis, alveolar collapse and to fibrous adhesion of collapsed septa 
(Crouch, 1990). Fibrosis involves the thickening of the alveolar walls due to the 
deposition of extracellular matrix proteins such as collagens, laminin and tenascin
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(Lloyd and Robinson, 2007). In conditions such as COPD, “airflow limitation is 
progressive and associated with abnormal inflammatory response of the lungs to 
noxious particles and gases” (Molfino and Jeffery, 2007). For most COPD 
patients, “prolonged exposure to cigarette smoke or other pollutants is the injury 
that initiates the pathologic process” (Molfino and Jeffery, 2007).
1.5 S u b s ta n c e s  K n o w n  to  Induce  Lung  Inju r y
Ambient air particles, which can be inhaled, are divided into a number of groups 
based on their size and the sources from which they were derived. The size or 
aerodynamic diameter of the particle determines if it is classified as ultra fine (£0 
.1 pm), fine (0.1 to 2.5 pm) or coarse (2.5 to 10 pm). Many ultra fine particles will 
aggregate to form fine particles. Those particles which are less then 10 pm in 
aerodynamic diameter are referred to as PM10 (B6ruB6 et al., 2007). The diameter 
of a particle will determine where it is most likely to be deposited in the respiratory 
tract. The clearance of the deposited particle depends not only on where in the 
respiratory it is deposited, but also on it’s physiochemical properties (e.g. 
solubility) and on the time since it’s deposition (Bogdanffy and Jarabek, 1995). 
However, due to the bifurcations in the respiratory system there are areas called 
hot spots, where high focal deposition, particularly in the TB region, causes 
disproportionately higher levels of exposure to particles in specific areas (Phalen 
et al., 2006). Interindividual variation also means that some humans will naturally 
be more sensitive to exposure and may respond differently (e.g. asthmatics). 
There are a number of classes of inhaled substances which have proven to 
cause lung injury and they can be divided into natural and man made ambient 
pollutants (Table 1.5). All of these substances interfere with host defence 
mechanisms, influencing the innate and immune mechanisms for clearance of 
bacteria and other materials in the lung (Diamond et al., 2000). They may 
influence the secretions of mucus secreting cells, or their actions may lead to the 
breakdown of the epithelium (Diamond etal., 2000).
Natural environmental air pollutants include those solid and gaseous substances 
released into the air as a result of forest and brush fires and volcanic eruptions 
(B6ruB6 et al., 2007). The natural source may also include biological components 
such as viruses, bacteria, yeast and moulds. The later includes 
lipopolysaccharide, an outer membrane component of gram negative bacteria,
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POLLUTANT SOURCE PROPERTIES DAMAGE CAUSED
Sulfur
Oxides
(SOx)
Fossil fuel 
combustion 
and smelting
Acidic
Sulphate
gases
• Airway hypersensitivity 
(Farley, 1992)
• Bronchitis and pulmonary 
edema (West, 2001)
Ozone
(0 3)
Generated by 
photochemical 
reactions of 
volatile 
organic 
compounds 
(VOCs) in the 
atmosphere
Odourless, 
colourless gas
• Destruction of epithelium 
(Bhalla, 1999, 2002; Farley, 
1992)
• Increased bronchial hyper­
responsiveness and 
inflammation (Koto et al., 
1997)
Particulate 
Matter 
10 microns 
PM10
Combustion, 
Construction, 
sea salt, soils 
and dusts
Particulate 
matter 
(mean 
diameter 
below 10 pm)
• Causes wide array of 
respiratory ailments 
(DEFRA, 2006)
• Pneumoconioses 
(West, 2001)
Nitrogen
Oxides
NOx
Combustion,
Nitrogen
gases
• Causes inflammatory 
response (Ayyagari et 
al.,2004)
Carbon
Oxides
Cox
Product of 
combustion
Odourless, 
colourless gas
• Inhibits oxygen absorption 
(West, 2007)
Volatile
Organic
Compounds
VOCs
Industrial 
solvents such 
as benzene, 
and products 
of petrol 
processing
Organic gases • Upper respiratory tract 
irritation and carcinogenic 
(EPA,2007)
Table 1.5 Major air pollutants: their sources, characteristics and damage caused to the 
human respiratory tract (DEFR = Department for Environment, Food and Rural Affairs, 
and EPA = Environmental Protection Agency).
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which induces airway hyper responsiveness (Liu, 2002; Reed and Milton, 2001). 
Anthropogenic or man made substances include PM10 mainly derived from 
vehicle exhaust and power generation stations. Some man made substances, 
such as cigarette smoke, are made up of a complex mixture of numerous toxic 
substances and cause a number of respiratory problems as a result, such as 
increases in alveolar permeability (Boucher et al., 1980; Jones et al., 1980), 
oxidative damage to cellular DNA and lung cancer (Hecht 1999).
Some pharmaceutical compounds such as bleomycin, a cancer treatment drug 
and amiodarone, an arrhythmia treatment drug, have proven to cause lung injury 
(Smith, 1985;Nicolescu et al., 2007;Brown et al., 1988; Young and Adamson, 
1993). Other inhaled man made particles include pesticides, such as paraquat, 
and commercial polymers.
1.5.1 Po o r ly  S o lu b le  Pa r tic les
A number of the above mentioned substances known to cause lung injury are 
examples of poorly soluble particles (PSP), and these include coal dust, carbon 
black, Titanium dioxide (Ti02), talc, and diesel exhaust particles. Due to the 
physical nature of these particles, i.e. the inability to dissolve, they tend to persist 
in the lower lung. If large enough quantities of PSP are deposited in the lung, a 
wide array of effects can occur if the lungs ability to clear the particles is 
overwhelmed or the lungs are overloaded. PSP are associated with the 
development of inflammation, fibrogenesis and carcinogensis in rats (Mossman, 
2000). PSP have also been shown to cause lung cancer in rodents (Borm et al., 
2004).
1.5.1.1 P o ly m e rs
The term polymer is a broad nomenclature that simply refers to a substance 
composed of molecules arranged in a long repeating chain. Polymers can be 
found in nature e.g. proteins, starches and DNA. Many polymers found in nature 
are used in the production of everyday consumable products. For example; 
casein, the protein found in milk, is used in the production of glues and artificial 
gems, and latex. A polymer found in the bark of trees is employed in the 
production of rubber products (National Geographical Society, 1997). Man made 
or synthetic polymers (SP) are a large group of molecules used in the production
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of a wide array of products and include acrylic, plastic, nylon, neoprene and vinyl 
(National Geographic Society, 1997). SPs are also used in the production of 
personal care products such as toothpastes, creams and sprayed items such as 
hairsprays and deodorants. An important category of SPs are those used as 
adhesives, such as polyvinyl methyl/maleic anhydride (PVM/MA) polymers. 
PVM/MA materials are copolymers with the two main polymer components being 
methyl vinyl ether and maleic anhydride. As with all polymers, depending on the 
size and chemistry conferred, they can be made with a range of physical 
properties. For example, there are a number of PVM/MA materials that are water- 
insoluble white powders that can be dispersed in water to produce a transparent 
solution (Figure 1.4). PVM/MA is an example of a co-polymer which when 
hydrated acts to increase adherence and viscosity. These polymers are used in a 
diverse range of products including toothpaste, denture adhesives, cleaning 
detergents, diaper rash creams, and trans-dermal patches (U.S. Department of 
Health and Human Services, 2009). When mixed with other chemical 
compounds, PVM/MA can act to bind to the compound and will release it slowly 
over time (Yoncheva et al., 2004). PVM/MA polymers are being explored as a 
component in drug delivery nanoparticles due to their ability to improve the 
bioavailability and activity of oral delivery (Yoncheva et al., 2004). Another family 
of copolymers are made up of the subunits of methyl methacrylate, ethyl 
methacrylate and butyl acrylate, (MM/EM/BA) which have found a common use 
as an adhesive. Polymers similar to these have been shown to induce pulmonary
Methyl methacrylate Ethyl methacrylate Butyl acrylate
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Figure 1.4 Diagrams of the chemical structures making up the subunits of the high molecular 
weight polymer (HMW) polymer (courtesy of Dr. Leona Merolla, Unilever, 2009).
injury in rats (Carthew et al., 2002; Carthew et al., 2006). Thirteen week 
instillation experiments showed that rats exposed to higher doses of polymers 
exhibited chronic inflammation and granuloma formation in the alveolar region of 
the lungs (Carthew et al., 2006). The Environmental Protection Agency (EPA) has
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expressed concern about the pulmonary effects of insoluble high molecular 
weight polymers, based on chronic inhalation exposure studies performed with 
rats using photocopy toner, in which irreversible lung damage resulted (EPA 
2009; Muhle, eta!., 1991; Bellman, etal., 1991; Morrow et al., 1991).
1.6 Expo sur e  M o d els  of Respiratory  T o xic ity
Historically, animals have been used to study the toxicology of substances in the 
area of respiratory toxicity. Researchers have used animals whose respiratory 
anatomy most closely reflects the human anatomy (i.e. dogs, pigs, monkeys and 
guinea pigs). The Organization for Economic Co-operation and Development 
(OECD) has established strict guidelines for the testing of chemicals using 
animals in the area of inhalation toxicology, using rodents. Short and long term 
toxicity testing, as well as genetic toxicity testing guidelines by the OECD, are 
currently under revision, in order to incorporate new alternatives to animal testing. 
The OECD guidelines for the testing of chemicals include; the draft proposal 436 
(November 2008), for acute inhalation toxicity studies, the draft proposal 413 
(March 2008), for sub-chronic toxicity studies and draft proposal 412 for repeat 
dose (sub-chronic) studies (March 2008). These guidelines outline a wide range 
of required conditions, from the room temperature for the test animals, to the test 
substance particle size distribution. Procedures for a typical study would involve a 
specific number of animals which are to receive the substance of research 
interest (typically either three animals per sex or six of the sex which has proven 
to be more sensitive to the substance being tested, and up to ten animals 
depending on the type of toxicity study [acute, sub-chronic, or repeat dose]). 
Substances are administered preferably by the nose only method, in a set 
number of prescribed doses or concentrations (generally three or four 
concentrations, dependening on whether the substance is in the gas, vapour or 
dust form). The need for a control group of animals is dependent on how the test 
substance is to be delivered or administered and if there is existing data about the 
vehicle for the substance. If the vehicle’s effects are unknown, or present a 
potential hazard, then control animals are used and administered with the vehicle. 
Animals are generally, continually exposed to the tested substance twice a day 
for 14 days in the acute studies, six hours a day, five days a week for ninety days 
in the sub-chronic studies and six hours a day, five days a week for 28 days in 
repeat dose toxicity studies. Detailed observations are continually made of the
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animals, in terms of any changes “in skin and fur, eyes and mucous membranes 
and also respiratory, circulatory, autonomic and central nervous systems and 
somato-motor activity and behavioural patterns” (OECD draft proposal 436, 
2008). Animals are humanely sacrificed following exposures in order to perform 
blood analysis, urinalysis and examination of bronchoalveolar fluid (BAL). Organs 
and tissues are further examined in terms of weight and histopathology. The goal 
is to establish a ‘no observed effect level’ (NOEL) or ‘no observed adverse effect 
level’ (NOAEL), for the substance being administered. This data is used to 
establish a “target concentration to provide ranking of test article toxicity” (OECD 
draft proposal 436, 2008). Data from such animal toxicity studies would then be 
extrapolated to predict human toxicity levels.
A wide range of animals continue to be used in a similar manner today in the 
area of respiratory toxicity, by many academic and private pulmonary research 
groups. However, in addition to such whole animal studies, many investigators 
now use perfused organs or tissues, cellular models and cell lines, especially in 
light of the 7th Amendment of the EU Cosmetic Directive (Section 1.7). 
Regardless of the animal system or model used, they all present problems when 
the toxicity data are required to be extrapolated for human outcomes.
1.6.1 A nimal Models
1.6.1.1 A n ato m ic al  D iffe r e n c e s
There are a number of logistical and scientific problems with using whole animal 
models for human respiratory studies, aside from the legislation and ethics. Since 
the mid-1980’s there has been a shift away from whole animal work due to 
differences in animal anatomy and physiology. The human respiratory tract is 
anatomically distinctive and broad morphological differences exist between 
humans and other animals. One example of such a difference is in the branching 
pattern of the tracheo-bronchial tree. The tree exhibits dichotomous bifurcations, 
where as the bronchi and bronchioles branch into two, these two are fairly equal 
in diameter. However, in animals, a mono-podial branching pattern is exhibited, 
where one branch is much smaller then the other (Schlesinger, 1985). 
Consequently, the deposition of inhaled aerosol particles will be different between 
humans and animals. Schlesinger (1985), found interspecies differences in the 
particle size deposition efficiency relationships in various regions of the
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respiratory system, due to a number of anatomical, physiological (i.e. breathing 
patterns) and experimental factors (e.g. techniques of instillation versus 
inhalation).
In addition to discrete anatomical differences, there are also differences in the 
types of cells that are found in the various regions of the RT and the percentage 
composition of these cell types. Thomassen and Nettesheim (1990), compiled the 
differences between the percentages of types of cells found in the trachea of 
commonly used laboratory mammal species, namely, the sheep, monkey, cat, 
rabbit and rodents (Table 1.6). Their work illustrated the variety and variation of 
cell types found in animals, which in turn may have a direct effect on the 
biological reactions to inhaled xenobiotics experienced by different animals.
1.6.1.2 P h ys io lo g ic a l  D iffe r e n c e s
There are a number of different physiological responses found in mammals, 
following exposure to inhaled toxicants. For example, humans respond to inhaled 
irritants with reflexive shifts in breathing patterns, whereas small mammals may 
experience hypothermia (Mautz, 2003). Small mammals are able to slow down 
their metabolic rate as a defence mechanism, which is not a human capability. 
The common laboratory rat has been found to employ strategies which make 
them less sensitive to inhaled toxicants and cigarette smoke. Costa et al., (1983), 
found that rats have a remarkable capacity to regenerate and compensate for lost 
pulmonary morphological and functional features. Slade et al., (1993) determined 
that rats have higher levels of antioxidants (AO) in their alveolar lining fluids than 
do humans. Researchers have also shown that there are variations between 
species in the release of biotransformation enzymes as a means of protection 
(Castell et al., 2005; Schlesinger, 1990).
The methods which must be employed when working with laboratory animals 
present issues and challenges. For example, many inhaled toxicants may be 
harmful at very low exposure levels over longer periods of time and most animal 
research models involve exposing animals for shorter periods of time at higher 
doses. This may not produce results that are reflective of the low dose response, 
as the higher dose may result in different types of reactions (Gerde, 2005). Often 
animal inhalation studies involve animals at rest, when in fact if they were
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Species n Total nuclei Basal cells Ciliated cells Clara
cells
Mucous 
goblet cells
Serous cells Other
cells
Unidentified
Sheep 5 414.3
(±33.2)
28.5% 30.6% 0 5.1% 0 35.9% 0
Bonnet
Monkey
3 266.0
(±12.0)
31% 41% 0 8% 0 16% 4%
Rhesus
Monkey
5 181.4
(±50.7)
42.0% 32.9% 0 16.8% 0 4.3% 4%
Cat 3 273.0
(±15.0)
37.3% 36.1% 0 20.2% 0 5.4% 1.1%
Rabbit 3 210.9
(±29.7)
28.2% 43.0% 17.6% 1.3% 0 0 9.4%
Rat 3 147.9
(±3.1)
13.4% 40.6% 0 0.5% 39.2% 0 6.2%
Hamster 3 151.4
(±11.2)
5.6% 47.5% 41.4% 0 O 0 5.3%
Mouse 7 228.6 7.7% 35.8% 52.1% 0 0 12% 0
Table 1.6.1 Comparison of abundance and percentage (%) of cell types in the distal third of the trachea of 8 mammalian species (mean ± 
S.D.) (adapted from Thomassen and Nuttesheim, 1990).
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exercising, the dose distribution would have much different effects (Mautz, 2003). 
Phimister et al., (2003), suggested the need to use new techniques to be assured 
of ‘pathogen free’ animals (Phimister et al., 2003). These researchers used a 
highly sensitive permeability assay using high resolution imaging and found that 
laboratory mice which had been purchased for respiratory toxicology studies did 
in fact have a viral infection. Therefore, a tremendous amount of physiological 
variation exists when using different animal exposure models.
1.6.2 P erfused  O rgans
In vitro scientific techniques involve the use of organs, tissues or cells outside the 
body, as a means to retain the ‘normal’ or ‘inside the body’ functional activity of 
the given organ, tissue or cells. One type of in vitro model for the RS is the use of 
whole respiratory organs that have been isolated (and perfused), from animals. 
Such studies have been performed using perfused lungs from lambs (Steinhom et 
al., 2000), mice (Parker et al., 1999), rabbits (Nakata and Dahms, 2000; Rimar 
and Gillis, 1995) and guinea pigs (Yamane and Kawata, 1999). The experiments 
were performed immediately after removal from the animal’s body. The perfusion 
systems involved the use of artificial ventilation and electrical stimulation, and the 
need for a constant flow rate of perfusion liquids.
Some of the uses of dissected organs, or segments of tissue taken from the 
respiratory tract, have involved growing them on substrates or in profusion 
chambers. This has been performed with both sheep and pig respiratory organs 
(Al-Bazzaz et al., 1991; Ballard and Taylor, 1994). Wang et al., (2005), used 
whole organ transfusion techniques when examining the electrolyte transport on 
the surface of the bronchiole airways (Wang et al., 2005). Great care had to be 
taken to keep the tissue moist, which involved the microperfusion of the 
bronchioles in order to minimize trauma to the delicate tissues of the small 
airways. These authors reported the complications brought about by small breaks 
and holes when attempting to dissect small airways. Models which involve the 
use of whole organs or tissue that have been dissected from an animal and then 
transplanted have been questioned, as the trauma of transplantation may have 
an effect on the ability of the tissue to perform normal transport functions.
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1.6.3 C ell C ulture  M odels
In addition to whole animal and perfused tissue models, cellular models can be 
used to study respiratory toxicity. Cellular models are less complex, and 
therefore, it is easier to control experimental conditions and variables. Working 
with cellular models also involves using much smaller quantities of the 
compounds to be tested. Epithelial cells from a plethora of laboratory animals 
have been used to study respiratory diseases. However, human derived cell lines 
have also been utilized (Table 1.7). Human cellular models can be divided into 
three main groups: (1) cells derived from carcinomas; (2) transformed cells and 
(3) primary cells.
The advantage of working with both carcinoma derived and transformed cells is 
that they are in fact immortalized cells and will have a theoretically limitless 
lifespan. Two examples of widely used carcinoma derived respiratory cell lines 
include the Calu-3 cells (a bronchial-adenocarcinoma derived cell line) and the 
A549 cells (an alveolar carcinoma derived cell line) (Table 1.7). The Calu-3 cell 
line is available from the American Tissue Culture Centre and has been used in a 
variety of research areas including drug absorption and metabolism (Forbes, 
2000). These cells express many metabolic transportation pathways known to 
occur in the human lung (Florea et al., 2003). The Calu-3 cells express mucin 
genes similar to those found in goblet or mucous cells (Gruenert et al., 1995). The 
A549 cells show characteristics similar to alveolar type II cells and have been 
used in the study of drug absorption and metabolism because of endocytotic 
properties. They have also been used in the study of cytotoxicity of PM by looking 
at the effects to their ‘plating efficiency’ (Hornberg et al., 1997). Transformed cells 
have been ‘transformed’ by the addition of a viral gene or vector. Two examples 
of widely used transformed respiratory cell lines include the HBE14o- cells (a 
bronchial surface epithelial cell line) and the BEAS-2B cells (a bronchial epithelial 
cell immortalized with a different type of viral vector) (Table 1.7). The HBE14o- 
cells have been used in drug absorption research (Forbes, 2000), as well as in 
allergen studies (Winton et al., 1998). The BEAS-2B cell line is more widely used 
in cytotoxic and genotoxic studies (Hornberg et al,. 1997), intercellular 
communication pathway research (Albright et al., 2002;Ulanova eta!., 2004), and 
in drug absorption studies (Forbes, 2000). Transformed cells and carcinoma 
derived cells have been shown to be useful tools in respiratory research.
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Cell Type Tight
Junction
Formation
Mucin
Secretion
Antioxidant
Expression
Cell Layer 
Formation
Cytokine
Expression
Ciliogensis References
Calu-3
+ / - + +
Mono-layers/
Multilayers
+ + / -
(Florea et al, 2003)
(Wan et al., 2000) 
(Witschi and Mrsy, 1999) 
(Shen etal, 1994)
A549
+ / - - -
Mono-layers
+ -
(Foster et al. 1998) 
(Forbes, 2000) 
(Larsson etal, 1999() 
(Castell et al, 2005)
HBE14o- + - Nl Mono-layers/
Multilayers
Nl + / -
(Wan etal, 2000)
(Ehrardtetal., 2002) 
(Westmoreland etal, 1999) 
(Steimer et al 2005)
BEAS-2B
- - + Mono-layers + -
(Mace etal., 1998) 
(Veronesi etal, 1999) 
(Tao et al 2003)
NHBE
+ + +
Mono-layers/
Multilayers
+ + / -
(Mace etal., 1998) 
(Lechner et al, 1984) 
(Wiley etal, 1996) 
(Gray et al, 2004)
Table 1.7 The principle characteristics of human-derived cell lines for respiratory toxicological applications. + denotes the presence of a structure 
or action and -  denotes the absence of a structure or action, Nl refers to 'no information’ available on that topic. These characteristics are often 
dependent on cell culture conditions.
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However, the question of the interactions of cancerous and transformed genes 
effecting outcomes can not be ignored. Indeed, such cells have been found to 
respond differently then their ‘normal’ counterparts (Albright et at, 2002).
Primary cells are cells that have been removed from human subjects, generally 
during a surgical procedure such as a heart-lung transplant, or immediately after 
death. The cells are then immediately separated from other cell types through a 
series of enzyme digests and grown up in culture before being cryostored in liquid 
nitrogen for further use. Primary cells generally have a limited number of 
passages (splitting) which they can undergo before they lose their viable 
characteristics (Table 1.7). They are therefore said to have a limited life span 
when compared with carcinoma derived or transformed cell lines. A number of 
primary respiratory cells have been derived, HAEpC primary alveolar epithelial 
cells, derived from the lung and normal human bronchial epithelial cells (NHBE) 
derived from the bronchial region. The NHBE model has been most widely used 
in the areas of inflammatory mediators (Hill et al., 1998), and mucin gene 
expression (Gray etai., 2001; Thornton etai., 2000).
1.7 H uman  T issue  Eq u iv a le n t  M o dels  of the  Respiratory
T ract
1.7.1 3D Models
There are a number of commercially available cell and cellular models that 
researchers may purchase. Currently, the industry leaders are the EpiAirway™ 
system by the MatTek Corporation (USA) and the Lonza (UK) NHBE primary 
cells. Both systems mimic the in vivo characteristics in the human lung but they 
also exhibit innate disadvantages.
1.7.1.1 E piA ir w a y ™
The EpiAirway™ system is a primary human tracheal/bronchial cell system 
(NHTBE), currently available from the MatTek Corporation (Asland, MA, USA). 
The system consists of primary human tracheal/bronchial cells grown on 
membranous inserts in an air/liquid interface (ALI) (Figure 1.5). The cells are 
differentiated, mixed mucociliary phenotype; some are able to secrete mucus, as 
well as expressing human cytokines. The drawbacks of the system are its great
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expense and small window of viability during which time the cultures can used 
experimentally. They arrive to the purchaser, they then must be equilibrated for
M atTek’s EpiAirway™ Tissue model
Tissue Culture Well
Culture Insert
ALI Tissue
Membrane
Medium
cilia
apical surface 
nucleus
basal surface 
membrane
Figure 1.5 EpiAirway™ Model. A) A diagrammatic representation of the insert system used to 
grow the cells in the air-liquid interface. B) A light microscope image of the MatTek EpiAirway ™ 
cell cultures (B6ruBe e ta i,  2009).
twenty-four hours and used within the next forty eight. Furthermore, the number 
of inserts per standard purchase price is limited to 24.
1.7.1.2 Lonza  NHBE C ells
The Lonza Company (Wokingham, UK) provide primary NHBE cells at a third of 
the price of the MatTek EpiAirway™ system. However, researchers are required 
to undertake laborious cell culture routines to obtain a working system (i.e. 5 
weeks from defrosted cryovial to cell culture) (Figure 1.6).
1 .8  E .U . C o s m e t ic s  D ir e c t iv e  ( 7 th A m e n d m e n t )
There is a long history in Britain of concern over animal cruelty and mistreatment, 
from the establishment of the Royal Society for the Prevention of Cruelty to
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0  0
Cryovial of NHBE G rown -  up in traditional Passage One and Tw o cells Passage Three cells
cells cell cu lture flasks grown in flasks grown in inserts
Untreated Controls Experimental Polymers
Treatment o f NHBE cells w ith polymers
Figure 1.6 A basic outline of the operational procedures of cell culture manipulations using the 
NHBE model system; (1) cells thawed from cryovial, (2) passage three seeding into Transwell® 
Inserts, (3) cells treated with xenobiotic.
Animals (RSPCA) in 1824, to the first “Cruelty to Animal Act” in 1875. In 1959, 
Russel and Burch published a book called “The Principles of Humane 
Experimental Technique”, and proposed the three main concepts of replacement, 
reduction, and refinement (the 3 Rs). Replacement refers to finding alternatives to 
using animals in research, or the use of lower animals, whenever possible. Such 
alternatives might be the use of invertebrates, microbes or cell/tissue cultures; but 
would need to share characteristics with the human tissue or organ of interest. 
Reduction as the term suggests, is concerned with reducing the numbers of 
animals used in an experiment, while still retaining the required level for scientific 
legitimacy. The concept of refinement refers to the use of techniques which bring 
about the least amount of pain or discomfort to the research animals.
Since the 1950s, the general public have expressed concerns and objections to 
the use of animals in scientific research, and particularly in the area of testing 
cosmetics ingredients. Political pressures have given way to legislative 
measures. In 1976, the European Economic Community (EEC) adopted a piece 
of legislation entitled the Cosmetic Directive (76/768/EEC). The Cosmetic 
Directives’ main objective was the protection of human health. This directive 
contains a definition of what a cosmetic is and information about which 
substances can and cannot be used in the production of cosmetic products sold
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in the European Union (EU). It also discusses the need for cosmetic ingredients 
to be safety tested on animals until alternative methods of toxicity testing have 
been established. In 1986, the Council Directive 86/609/EEC, established 
common rules for the use of animals, especially, Article 7 of the Directive, which 
requires that “animal experiments be replaced by alternative methods, when such 
methods exist and are scientifically satisfactory.” In that same year, the United 
Kingdom (U.K.) established “The Animals (Scientific Procedures) Act”. This act 
makes provision for the protection of animals used in experimental and other 
scientific purposes in the U.K. It replaced the Cruelty to Animals Act (1876) and 
implemented the requirement of the European Directive 86/609/EEC on the 
approximation of laws, regulations and administrative provisions of the Member 
States regarding the protection of animals used for experimental or other 
scientific purposes.
In 2003, the 7th Amendment to the Directive was adopted which now states that in 
accordance with Directive 86/609/EEC and with Directive 93/35/EEC, “it is 
essential that the aim of abolishing animal experiments for testing cosmetic 
products be pursued and that the prohibition of such experiments becomes 
effective in the territory of the Member States.” This piece of legislation also 
applied the deadline of March 2009 for acute endpoints (including dermal 
corrosivity, dermal irritancy etc.) and March 2013 for repeat-dose endpoints, after 
which if any cosmetic ingredient is tested on animals, the resultant product will be 
banned from market in the EU member states. This has served to both highlight 
and impel the development of novel test systems in the area of ‘alternatives to 
animal testing’.
1.9 Using  H um an  T issue  Eq u iva len t  M odels  of the Lung
1.9.1 C o n v e n tio n a l T o x ic o lo g y
The human respiratory system does not act alone in the human response to 
inhaled debris (e.g. particulates) and any cellular model will only provide a small 
component of the response experienced in vivo. Conventional in vitro toxicology, 
using human tissue equivalents of respiratory epithelia has proven to be both 
ethically (Section 1.8) and technically (Section 1.7) a better option than using the 
traditional “rat lung model” for inhalation toxicological experiments. Conventional 
toxicological methods involves measuring acute and chronic biochemical and
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histological responses in a test system (e.g. cell culture) to a toxicant challenge 
but can not inform about the responses that may or may not occur at the gene 
and protein levels. However, with the advent of toxicogenomics, or 
transcriptomics, it is now possible to extend the conventional toxicology findings 
beyond the biochemical level, i.e. relate it directly to the transcriptomic responses 
(Section 1.9.2).
1.9.2 T ranscripto m ics
The genome is the complete set of genetic information from a given organism. 
Each cell contains a complete copy of the genome of the organism. Modern 
techniques such as microarray technologies can be used to examine the 
‘expression’ or ‘transcription’ of all known genes, as well as particular groups or 
types of genes, using specially designed gene chips.
The DNA of all cells includes genes which encode amino acid sequences for the 
production of proteins. Complimentary mRNA is transcribed from these genes for 
protein production at the ribosome. By examining which mRNA is present in the 
cell, researchers obtain a ‘snapshot’ of which genes have been expressed or 
transcribed at that moment in time, and are now being put into the action of 
protein production.
1.9.3 M icroarray  T echnology
A microarray consists of a small sized piece or square of solid substrate (either 
silicon, nylon or glass), onto which a very large number of genes or nucleic acid 
sequences have been attached or ‘spotted’ in very specific locations on the chip 
(Cold Springs Harbor Laboratory, 2007). These genes or nucleic acid sequences 
are also called the ‘immobilized target DNA’. RNA is extracted from cells or 
tissue and cDNA copies are made. These cDNA copies of the RNA are then 
fluorescently labelled or tagged and applied to the microarray, where they will 
then attach or hybridize to complimentary sequences of the target DNA on the 
microarray. The hybridized cDNA can then be detected and quantified by 
‘scanning’ the chip with a laser. The data generated by the scanner relates to the 
‘signal’ or level of fluorescence released by each ‘spot’ or gene on the chip. This 
signal relates to the quantity of mRNA of the gene or it’s level of ‘expression’. The 
greater the number of genes being surveyed the greater the quantity of data
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generated by a microarray. In the case of the Whole Human Genome Array by 
Agilent, for example, the expression levels of as many as 44,000 genes may be 
examined or compared. This is an overwhelming quantity of data, and 
researchers must employ a number of methods to ‘weed through’ or extrapolate 
meaningful information. As microarray technology has evolved, so to have the 
types of arrays which exist, and the tools utilized to analyze the data they 
generate.
1.10 A im s  a nd  O bjectives  of T he Project
The overall aims of this project were presented in Section 1.0. In order to achieve 
these aims there were a number of technical objectives.
1.10.1 T e c h n ic a l  O b je c tiv e s
The technical objectives of this project are as follows (Figure 1.7):
• Establish and characterise the NHBE cell culture model
• Characterise the toxicological dose response of the NHBE cell culture 
model following treatment with polymers.
• Utilize the dose response data to investigate the transition point between 
protective or reversible changes and adaptive or irreversible changes
• Determine the transcriptomic profiles of adaptive and irreversible lung 
injury
• Identify early biochemical pathways of protective and adaptive lung injury 
as well as harm in the respiratory epithelium in response to polymers.
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Optim ization o f NHBE primary 
cell model system
M orphological and Biochemical 
Characterization o f the NHBE 
primary cell model system
P o l y m e r  Ex p o s u r e :
Normal, human-derived 
Tracheal/bronchial epithelia
Apical surface
NHBE Cell 
Tissue Model
Basal surface
T r an s c r ip to m ic s H istolo gy
Figure 1.7 The general research project aims. Flowchart of the project aims involved in 
optimization, characterization and exposure of the NHBE primary tissue model. Following 
exposure, the histological and transcriptomic analysis will explore alterations in the morphology, 
gene transcription and biological activity of the respiratory epithelia in response to commercial 
polymers.
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C hapter  2 
Developm ent of T he NHBE Cell 
C ulture  Protocol
2.0 Introduction
2.0.1 H istorical  D evelopment of the NHBE Model
A number of research groups working in the 1980’s examined optimum conditions 
under which to grow primary human bronchial epithelial (BE) cells. They were 
trying to achieve a three dimensional (3D), differentiated culture which mimicked 
the human tracheobronchial (TB) tissue in vivo. They began by specifying key 
factors for growth media requirements (Lechner et ai., 1981; Lechner et al., 1983;
Wu etai., 1990; Wu etai., 1986). Factors included lower then normal quantities of
Ca2+, growth media supplementation with insulin (ISN), hydrocortisone (HC), 
epidermal growth factor (EGF), bovine pituitary extract (BPE), epinephrine, 
transferrin, triodothronin (T3) and retinoic acid (RA). Later, other groups found 
more success with cells grown in serum-free medium (Chevillard et al., 1991; 
Gray et al., 1996). It became apparent that the presence of a collagen gel 
substrate was essential for successful cell adherence and differentiation 
(Chevillard et al., 1991; Lechner et al., 1981; Wu et al., 1990). Another important 
factor was the density at which the cells were seeded (Ke et al., 1990). Most 
researchers discovered that the ability of primary cells to respond and 
differentiate decreased after passage three (Gray et al., 1996; Wu et al., 1990).
In 1978, Whitcutt developed a chamber on which a nitrocellulose membrane was 
glued and cross linked with gelatine, on top of which a collagen gel substratum 
was formed (Whitcutt et al., 1988). Spacers were used to raise the chamber 
inside the culture dish. The chamber allowed cells to obtain nutrients from the 
bottom of the collagen gel (Whitcutt et al., 1988). This culture system 
demonstrated a polarity (i.e. apical and basal regions) in the differentiation of the 
cultured cells. Cilia development and mucus secretion existed in the apical region 
of the culture. Furthermore, the columnar appearance of some cells could be 
demonstrated (Wu et al., 1986). A number of groups followed with successful 
development of multiple cell layer thick (e.g. 3-6 layers), differentiated animal and 
human epithelial cells (Adler et al., 1987; Bernacki et al., 1999b; de Jong et al., 
1994; Gray et al., 1996; Kaartinen et al., 1993; Kondo etai., 1993; Yamaya etai., 
1992). Since the development of Whitcutt’s chamber, a number of such cell 
culture systems have been manufactured for the growth of cells in an air-liquid 
interface (ALI) (i.e. Coming’s Transwells® inserts, Millipore’s Millicells® inserts, 
Greiner Bio One’s ThinCerts™ inserts, etc.) The technique of developing an ALI
has now become standard procedure in the growth of these cells. However, after 
over twenty years of research, this system still has a number of optimization 
issues which must be solved when working with each individual cell type (e.g. 
consistent membrane quality, confluence of cell growth, cell feeding regimes, 
vulnerability to contamination, etc.)
In order to attain a cell culture of normal human bronchial epithelial cells (NHBE) 
which mimics the well differentiated airway epithelial cells in vivo, a number of 
factors must be taken into consideration. Cells will lose their differentiated 
appearance and function if grown under traditional cell culture conditions (i.e. 
submerged in culture medium) (de Jong et al., 1994). Over the years a number of 
researchers have discovered that under specific conditions (e.g. ALI, media 
supplementation), a well differentiated culture that exhibits many desired in vivo 
characteristics can be engineered (Chevillard et al., 1991; Lechner and LaVeck, 
1985; Wu et al., 1986; Yamaya et al., 1992). The development of the primary 
NHBE cell cultures for toxicological applications requires the following culturing 
considerations: (1) media and hormone supplementation; (2) basal growth 
substrates; (3) cell density and passage number; (4) ALI culturing; (5) 
ciliogenesis; and (6) secreted proteins. Each of these parameters must be 
implemented in order to develop a fully functional primary NHBE cell culture (i.e. 
active cilia, mucus secreting, cytokine expressing cells) for use in assessing the 
toxicity of xenobiotics. To fully characterize an NHBE model of respiratory 
epithelia, taking into consideration all of these parameters, growth experiments 
need to be performed over extended cell developmental periods with 
manipulation of essential culturing parameters, using conventional toxicological 
assays (e.g. trans-epithelial resistance, Bradford assay, cell metabolism assays, 
etc.).
2.0.2 Previous A pplications  of ALI culture  models
Since the development of the NHBE primary cell model, it has been used by a 
number of research groups, both in characterization experiments and to explore 
the responses of this human respiratory epithelial model to numerous growth 
factors, cell signalling molecules and xenobiotic particulates. Thornton et al. 
examined changes in the levels of expression of specific known human
respiratory mucin genes (MUC 5AC and MUC  2) over the development and 
differentiation of the culture (Thornton et al., 2000). This same group examined 
mucin gene expression of the NHBE model in response to the introduction of 
various supplementary growth hormones (Gray et al., 2001). Matsui et al. used 
fluorescent beads on the surface of the model to examine the movement of cilia, 
perciliary liquid and mucus (Matsui et al., 1998). Matsui et al., compared NHBE 
cells derived from healthy patients and from Cystic Fibrosis (CF) patients, in 
terms of perciliary liquid layer depletion and ion concentration (Matsui et al., 
1998). Researchers have exposed the NHBE model to various concentrations of 
exogenous retinoic acid (RA) and examined the resulting effects on eicosanoid, 
inflammatory or immune cell signalling molecule expression (Hill et al., 1998). 
Some research groups have investigated the model in terms of inflammatory 
cytokine expression in response to air pollution particles (Becker et al., 2005) and 
NO2 (Ayyagari et al., 2004), as well as the expression of xenobiotic metabolizing 
enzymes (Mace et al., 1998). These groups have all found the NHBE primary cell 
model was an effective tool in addressing questions and providing data 
particularly relevant to the human respiratory epithelial response.
2.1 A ims of the  C hapter
This chapter will explain and discuss the experiments performed in order to 
establish an effective ‘in-house’ protocol for the sub-culturing, growth and 
engineering of a robust and well differentiated, 3D, NHBE cell culture. The aim of 
these experiments was also to develop a ‘system’ which was reliable and 
reproducible as well as showing a greater cost efficiency then commercially 
available models (i.e. the greatest number of fully differentiated cell culture inserts 
per cryovial of cells). These experiments investigated the following parameters of 
cell sub-culturing:
• The effect of a donor’s percentage seeding efficiency on the resulting optimal 
growth conditions
• The maximum passage number at which the NHBE cells were able to form 
fully-differentiated cultures
• The most effective reagents for use in the process of removing adherent cells 
between passages or trypsinisation
• The most effective insert membrane on which to grow NHBE cells, as 
measured by trans-epithelial resistance (TEER; a measure of effective inter­
cellular tight junction formation) and MTT (MTT; a measure of cell culture 
metabolic activity)
This Chapter elaborates on a number of ‘challenges’ encountered in the protocol 
establishment process and the outcomes of investigations taken to resolve these 
‘challenges’. These ‘challenges’ included:
• Filamentous structures in submerged cultures
• Unusual growth patterns in cultures developing inside the inserts
2.2 M a te r ia ls , S to c k  S o lu tio n s  and  Equipm ent
2.2.1 Materials  an d  S tock  Solutions
BD Biosciences Oxford, UK
BD Falcon™ Individual Cell Inserts, 0.4pm pore size (353095)
Corning Life Sciences Schipol-Rijk, Netherlands
6.5 mm (0.4 pm pore size) Costar® Transwell Cell Culture Inserts (3470)
Fisher Manchester, UK
T75 (TKT-130-210T)
T175 (TKT-130-220Q)
Greiner Bio-One Ltd. Gloucestershire, UK
96-Well Plates (650 161)
Thincerts™ Cell Culture Inserts (662641)
Invitrogen Ltd., Paisley, Scotland
Dulbecco’s Modified Eagles Medium (41965039)
RPMI-1640 Growth Medium (31870025)
Hank’s Balanced Salt Solution (14170)
Trypsin- Ethylenediaminetetracetic Acid (25300)
Penicillin-Streptomycin Liquid (1510-122)
Kansas, USA
Switzerland
JRH BioScience
Foetal Bovine Serum (12103500M)
Lonza Group Ltd.
NHBE Cells (CC-2540)
BEGM Growth Medium (CC-3170)
BEGM Bullet Kit (CC-3170)
Lonza Group Ltd.
Subculture Reagents Kit (CC-5034)
Millipore UK
Millicell® Cell Culture Inserts (PIHT 12R 48)
Nutacom BV,
Vitrogen-100 Solution (FX -019)
Promega Corporation 
CellTiter-Blue™ Cell Viability Assay Kit (G8080)
Raymond A Lamb East Sussex, UK
Toluidine Blue (S338-2)
Sigma
Dimethyl Sulfoxide (154938)
Retinoic Acid (R2625)
Dulbecco’s Phosphate Buffered Saline (D8662)
Molecular Biology Grade Water (W4502)
Switzerland
Watford, UK
Netherlands
Madison, USA
St. Louis, USA
2.2.2 Equipm ent  
Dynex Technologies
Opsys MR-Dynex Microplate Reader
Reichert-Jung
Ultra Cut -  E Microtone
Nikon
Diaphot Inverted Tissue Culture Microscope 
World Precision Instruments 
ENDOHM-6 EndOhm Chamber
Worthing, UK
Austria
UK
Stevenage, U.K.
2.3 M ethods
The NHBE cells were purchased from the Lonza Corporation. A frozen cryovial of 
the cells (-500,000 cells, passage 1) arrived at the laboratory and were stored in
liquid nitrogen until the time of use. Each cryovial was provided with biographical 
data concerning the individual donors from whom the cells were derived, (i.e. age, 
race, sex and smoker or non-smoker), as well as the results of quality control 
analysis testing (i.e. cell count, doubling time, percentage seeding efficiency, 
viability, etc). Experiments were performed to determine the best parameters to 
utilize for the routine sub-culturing techniques, i.e. seeding densities, feeding 
regimes and commercial growth and splitting reagents. In the first two passages, 
cells were grown in the traditional manner of adherent cell cultures, submerged in 
tissue culture flasks. Challenges or issues encountered during the sub-culturing 
of passages one and two included; (1) varying donor seeding efficiency, (2) 
freezing and thawing conditions, (3) growth supplement quality concerns, and (4) 
splitting reagent toxicity. At the third passage, cells were seeded into membrane 
inserts, and grown in an Air-Liquid Interface. A time line of this sub-culturing 
procedure is illustrated in Figure 2.2. The issues encountered at the third passage 
included; (1) passage numbers (2) contamination, (3) questions of membrane 
quality (e.g. resulting in less efficient and unusual growth patterns) and (4) 
varying success surrounding feeding regimes.
This chapter outlines the challenges (typical and unusual) and their solutions, 
which were encountered when working with this novel alternative model for 
animal inhalation toxicology. The methods and challenges at the first two 
passages or submerged cell cultures will be explored first. Then the methods and 
issues encountered at the third passage or with the cell growth in the membranes 
will be explored. Due to questions raised about the consistency in quality of the 
Transwell® Insert membranes, an experiment was performed to compare the 
growth and development of the NHBE cells on a number of commercially 
available membrane inserts, of the same size and membrane material (PET). 
Passage three cells from three different Lonza NHBE cell donors were grown on 
four different commercially available cell culture growth inserts (Millicells®, 
Transwells®, ThinCerts™ and BD Falcon™), under the same growth conditions. 
The cells were grown under the same conditions for the first two passages. The 
NHBE cell morphogenesis of the cells grown in the four different inserts was then 
characterized in terms of trans-epithelial resistance (TEER), metabolic activity 
(using the MTT assay) and histological observations, using fixed, embedded and 
semi-thin sectioned tissue.
2.3.1 Passage  O ne and  Tw o  C ell C ulture challenges
2.3.1.1 Initial D e fr o s t in g  of Frozen  NHBE C ells
A frozen cryovial of NHBE primary cells (~500,000 cells, passage 1) was taken 
from cryostorage and thawed in a T75 cell culture flask. The flask had been 
coated with a 1:100 volume to volume ratio, (v:v), vitrogen:sterilized water 
solution, for 2 hours and the excess water removed. Vitrogen is a commercially 
available purified collagen consisting of 97% Type I collagen, with the remainder 
being comprised of Type III collagen. The medium in which the cells were 
rehydrated was Bronchial Epithelial Growth Medium (BEGM), which had been 
prepared with a commercially purchased Bronchial Epithelial Basal Medium 
(BEBM) (Lonza) and adding to it fresh aliquots of growth supplements and 
antibiotics; also provided by Lonza. This medium was prepared using a protocol 
recommended by Lonza (Appendix 1).
2.3.1.2 C o n flu e n c e  in T75 to  T175
Following initial thawing of frozen NHBE cells, the cells were grown in T75 flasks 
until they had reached approximately 70% confluence (approximately 2 to 3 
days). Cells from one cryovial were first thawed in one T75 flask and later into 
two. Confluent cells were trypsinized, and pelleted. This was performed, by first 
removing the growth medium from the flasks and placing a 2 ml aliquot of 0.05% 
Trypsin solution to the surface of the cells. The flask was returned to the 
incubator for 2 to 3 minutes, and then examined under the microscope to observe 
cell detachment. If less then 80% of the cells were detached, then the flask was 
returned to the incubator for another minute. When greater then 80% of the cells 
were detached, then 30 ml of a 10% foetal calf serum (FCS) in RPMI growth 
medium (Roswell Park Memorial Institute), solution was used to deactivate the 
trypsin and collect the cells. The solution was spun down for 4 minutes at 800 
revolutions per minute (rpm). Then the cell pellet was resuspended in BEGM and 
transferred to three T175 flasks that had also been pre-treated with 1:100 v:v 
vitrogen:sterile water solution.
2.3.1.3 F r o zen  A r c h ive d  Sa m p le s
Flasks of cells obtained from the initial thawing (Section 2.3.1.1) that were in 
excess of that required were frozen down for future use. In this case, after the 
flask had been trypsinized for two to three minutes, and spun down in the
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centrifuge for four minutes at 800 rpm , the cell pellet was resuspended in 1 ml of 
10% Dimethyl Sulfoxide (DMSO) (a solvent which also acts as a cell and tissue 
preservative) in BEGM solution and placed in a cryovial. The cryovial was then 
placed in the -80°C freezer overnight, (approximately 12 hours), before being 
placed into liquid nitrogen until further use.
2.3.2 Pa ssa g e  T h r e e : T ransfer  to  T ransw ell®  Inserts
The cells in T175 flasks were given fresh medium every two days until they had 
reached 60-70% confluence, which was approximately 4 to 5 days. Once 
confluence was achieved, the cells were incubated with trypsin and pelleted. The 
cell suspension was then diluted to a 5 X 105 viable cells/ml BEGM mixture and 
150 pi of this solution was placed or ‘seeded’ into the apical region of each 
Transwell ® insert; then below the insert, 500 pi of the BEGM was placed in each 
well to feed the cultures basally (Figure 2.1). The cells were then incubated 
overnight (approximately 12 hours).
Transwell Insert 
Upper
Compartment
Microporous
Membrane
Lower
compartment
Figure 2.1 The Transwell® insert system. (A) A schematic diagram of an individual insert. (B) The 
12 insert culture plate. Liquid is removed from the upper compartment after 24 hours to establish 
the Air-liquid interface (ALI).
2.3.2.1 C o n f lu e n t  In s e r t  C u ltu re s
On the first day of confluence (day 1), the apical medium was carefully removed 
without disturbing the cells. The lower BEGM basal medium was then replaced 
with an ALI medium. The ALI medium was made up of a mixture of a 
commercially available DMEM growth medium with 1% penicillin:streptomycin 
(pen-strep) added to it, as well as RA. The RA was dissolved in DMSO. The 
concentration of the RA to DMEM + pen-strep was 20 pi of RA (5 X 10'5 M) per
Trac\ 4.
10 ml of DMEM + pen-strep, and this solution is mixed in a 1:1 ratio to the BEGM 
mixture to form the ALI medium (protocol from Richter, personal communication, 
2005).
Due to the light sensitivity of RA, it had to be prepared out of direct UV light. 
Consequently the DMEM + RA + pen-strep portion of the solution had to be made 
up fresh daily. Frozen aliquots of RA solution were defrosted daily and first added 
to the DMEM + pen-strep which were then added to the prepared BEGM portion. 
Once the cells were growing in the inserts, the basal ALI/DMEM solution was 
changed daily, with old medium removed and 300pl of fresh medium placed in 
each well. After the cells began to show mucin secretion, which would appear as 
a layer of clear viscous liquid on the apical surface of the cultures, it was carefully 
removed using a mini-pastette every second day to maintain the ALI.
2.3.3  P h a s e  C o n t r a s t  L ig h t  M ic r o s c o p y
Cell cultures at all stages of growth and development were visually monitored 
using phase contrast microscopy. In the T75 and T175, or initial cell cultures, the 
microscope (Nikon Diaphot at 40X magnification), was used to monitor the health 
and confluence of the cultures. The microscope provided visual confirmation of 
the adherence and confluence of cells. This was an important tool in the 
determination of when to split passage 1 and 2 cultures. In the passage 3 cells, or 
cell insert cultures, the visual assessment involved the confirmation of the 
establishment of the ‘cobblestone’ type appearance of the cells, as well as to 
observe any possible ciliary movement in the differentiated cultures. A light 
microscope timeline is depicted in Figure 2.2.
2.3.4  T r a n s -E p ith e l ia l  R e s is ta n c e
The Trans-epithelial resistance (TEER) values of each cell culture, or per 
Transwell® insert was evaluated using the Endohm chamber (Figure 2.3). The 
chamber was first filled with 1 ml of PBS solution to cover the bottom electrode. 
The cell insert was then placed inside the Endohm chamber and 150 pi of PBS 
solution was placed inside the top layer of the cell insert. The top electrode was 
then placed on top of the insert and the reading was taken by pressing down on 
the current release button on the voltohmeter (EVOM). The EVOM then receives 
input from the bottom electrode, and reads the resistance created by the insert.
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Figure 2.2 A light microscope (400X) time line depicting the cell culturing of the NHBE cells, from passage 1 in T75 tissue culture flasks, under
o>
growth medium, to passage 2 in T175 tissue culture flasks under growth medium, to passage 3 growing in the Transwell inserts in the ALI.
24 hours in insert 3 days in insert 16 days in insert 33 days in insert
Transwell Insert
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The current was first checked with an empty chamber. Prior to measuring the
resistance values for the inserts with the cell cultures, a ‘blank’ or empty insert
was read, and the value of resistance for the blank was later deducted from the 
resistance value of the cell culture inserts (Figure 2.4). The TEER values were 
reported as Ohms (Cl) per cm2 (surface area of tissue).
2.3.5 M etabolic  A ctivity  A ssays
2.3.5.1 C e l l T iter  Bl u e ™
The Cell Titer Blue™ reagent aliquot was removed from the freezer and defrosted 
in a 37°C water bath. In a 24-well culture plate 450 pi of fresh BEGM medium was 
mixed with 90 pi of Cell Titer Blue™ reagent. One hundred and fifty microlitres of 
the mix was then taken up into a pipette tip. A cell culture insert was placed into 
the well with the BEGM/Cell Titer Blue™ reagent mix and the 150 pi of mixture 
was placed on to the apical surface of the insert. The plate was set up with one 
blank (empty) insert and three cell culture inserts and was placed back into the 
37°C incubator for 4 hours. After 4 hours incubation, a 96-well plate was set up, 
and into the first well was placed the 150 pi of BEGM/Cell Titer-Blue™ Reagent 
from the blank insert, and in the second through to the fourth wells was placed 
the 150pl of reagent mix from the apical surface of the three cell culture inserts 
being tested. The 96-well plate was then placed in a plate reader, and readings 
were taken at both 540 and 620 nm wavelengths. The light absorbance and 
fluorescence properties of the Cell Titer Blue™ reagent were changed by the 
cellular reduction of the chemical compound resazurin to resorufin (Figure 2.5). 
The resazurin dye component of the Cell Titer Blue™ reagent renders it a blue 
colour. However, after incubation with actively metabolizing cells, it was taken up 
by the cells and reduced. The product, resorufin, can then diffuse out of the cells 
into the surrounding medium yielding a fluorescent pink colour. Resorufin has an 
absorption peak at 570 nm and resazurin has an absorption peak at 620 nm. By 
comparing absorption values, one may compare levels of cellular activity. The 
Cell Titer Blue™ Reagent is non-destructive and after measurements were made 
with the apical solution of the cell inserts, they were then placed back into fresh 
basal medium in a 12-well plate and placed back into the incubator for further 
growth and monitoring.
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Cap
Electrode
Endohm chamber
Electrode
Figure 2.3 The Endohm chamber. The cell insert was placed inside the Endohm chamber (as 
shown). The current travels from the EVOM (not shown), through the top electrode, then through 
the cell culture to the lower electrode and back to the EVOM. The reading is shown as a measure 
in Ohms on the EVOM. Diagram courtesy of Dr. Balharry, Natural Environmental Research 
Council, (NERC), Swindon, UK.
High Resistance Low Resistance
Cathode
PBS
Anode
Figure 2.4 A schematic diagram depicting the differences in TEER readings between a healthy 
confluent epithelial culture and a culture without tight junction formation. Diagram courtesy of Dr. 
Balharry, NERC, Swindon, UK.
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Figure 2.5 A diagram illustrating the changes which occurs to the reagent resazurin 
when it is taken in and metabolized by cells and converted to resorufin. RSZ = resazurin, 
RF = resorufin. Diagram courtesy of Dr. Balharry, NERC, Swindon, UK.
2 .3 .5 .2  MTT A ssay
The MTT assay operates on the same principles as the Cell Titer-Blue™ assay. 
The MTT assay measures the ability of cells to reduce the yellow tetrazolium salt 
(3-(4,5-Dimethvlthiazol-2-yl)-2,5-diphenvltetrazolium bromide or MTT), to form 
insoluble purple formazan crystals. A detergent solution is then added to lyse the 
cells and solubilize the crystals. MTT was dissolved into ALI growth medium to 
make a 1 mg/ml concentration solution. Three hundred microlitres of the MTT/ALI 
solution was placed into each well of the 12-well plate. Inserts were placed into 
the MTT/ALI solution and incubated at 37° C for 4 hours. After the incubation, the 
inserts were placed into a new 12-well plate with 400 pi of solubilization solution, 
and 150 pi of solubilization solution was placed on the apical surface. The 
samples were then wrapped in parafilm and placed in the dark overnight 
(approximately 12 hours). The following morning, the apical solutions for each 
insert were added to the basal solutions and mixed thoroughly. Three 200 pi 
aliquots from each sample were placed into a 96-well plate. Readings were then 
taken at 570nm using a plate reader.
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2.3.6 B r a d fo r d  (P ro te in )  A ssa y
A wash can be made by applying a volume of an isotonic (phosphate buffered 
saline) solution, to the apical surface of the cell culture and then collecting the 
buffer back. The collected buffer or ‘apical wash’ can be analyzed for any 
secretions which may lie on the surface of the cells. The Bradford assay was 
used to provide information about the presence of proteins; or indication of mucus 
glycoprotein secretion (Bradford, 1976). In order to measure accurately protein 
concentration using the Bradford reagent (colorimetric chemical agent), a number 
of standards must be run to establish a concentration curve. This was 
accomplished using an albumin protein standard (2 mg/ml), that was diluted into 
the following concentrations: 16 pg/ml, 14 pg/ml, 12 pg/ml, 10 pg/ml, 8 pg/ml, 6 
pg/ml, 4 pg/ml, and 2 pg/ml. An aliquot of Bradford reagent was added to all of 
these standards. These solutions were then placed in the plate reader and read 
at 590 nm wavelength. Using data from the standards, a curve was established 
from which unknown sample protein concentrations could be determined.
2.3.7 In s e r t  M em branes
Passage 3 cells from three different NHBE donors (Table 2.1), were split and 
seeded (following the protocol described in Section 2.3.2), onto four different 
types of cell culture inserts (Table 2.2). The cells were seeded at the same 
density (-75,000 cells or 150 pi of a 5 X 105 cells/ml concentration of BEGM 
solution) onto the four different cell culture insert types. The cells were then fed 
the same volume (300 pi) of fresh growth medium at the same regular time points 
(Monday through Friday) for a 30 day period. On Day 30, the cell culture inserts 
were then examined in terms of TEER values (Section 2.3.4), and MTT values 
(Section 2.3.5.1). The membrane inserts were fixed, resin embedded and 
sectioned (Chapter 3 Section 3.3.4.1 - 3.3.4.2).
Donor
Number Age Sex Race
Seeding
Efficiency Viability
Doubling
Time
(#1)
7F1169 28 F B 65 87 20
(#2)
6F4180 43 M C 23 96 25
(#3)
6F4181 19 M C 35 96 26
Table 2.1 The biographical and quality control information for the three NHBE donors used in the 
membrane comparison experiment (Data courtesy of Lonza).
Tracy Hughe 50
CHAPTER TWO: DEVELOPMENT OF THE NHBE CELL CULTURE PROTOCOL
Insert Type MembraneMaterial
Pore
Size
Pore 
Density in 
pores/cm2
Membrane
Thickness
Membrane
Area
Millicells® PET 0.4 pm 1 X 108 12 pm 33 mm2
Transwells® PET 0.4 pm 4 X 106 10 pm 33 mm2
ThinCerts™ PET 0.4 pm 2 X 106 N.A. 33.6 mm2
BD Falcon™ PET 0.4 pm 1.6 X 106 N.A. 33 mm2
Table 2.2 A number of physical characteristics of 4 types of commercially available cell 
culture insert membranes (Data provided by commercial suppliers).
2.3.9 Sta tis t ic a l  A nalysis
Data handling and graphical representation was performed in Microsoft Excel 
2003. Statistical analysis utilized Microsoft and Excel, and included the derivation 
of p-values using the t-test. The Minitab program was used for deriving R-squared 
values and for linear regression analysis in the calculations of unknown protein 
concentration values in the Bradford assay. Minitab was also used to perform 
Anderson Darling analysis for normality of data sets, analysis of variance or 
ANOVA analysis and the non-parametric Mann-Whitney Test.
2 .4  R e s u l t s
2.4.1 Passage  O ne and  Tw o  C ell C ulture  cha lleng es
2.4.1.1 O ptim al G row th  Pattern
NHBE passage 1 cells grown in tissue culture flasks were adherent within 24 
hours of their seeding into the flasks and exhibited a slightly oblong shape (Figure
2.6). They took on a more flattened appearance over time as they grew closer to 
confluence. Cells were generally confluent within 3 days from being seeded into 
the T75 from the cryovial. Passage 2 cells were seeded into T175 flasks and 3 
days after being in the T175, the cells reached ~70% confluence, at which time 
they would be seeded into the inserts.
The cell culture methods presented were derived as a result of numerous 
optimization experiments surrounding a number of cell culture parameters. The 
preliminary cell culture work involved testing different seeding densities, freezing 
and thawing regimes, passage numbers and different splitting reagents.
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2.4.1.1.1 S eed in g  E ffic ie n c y
In the case of most donors, thawing of the primary cell cryovial into two T75 flasks 
was successful. A number of ‘batches’ of cells from 2 different donors (donor 
7F1169 and donor 7F3000) had been successfully grown in two T75 flasks, after 
reaching approximately 75% confluence, and then each T75 was split into three 
separate T175 flasks. However, when donor 6F4181 (in October 2007), was split 
from two T75 flasks and seeded into three T175 flasks, they did not continue to 
grow successfully in the second passage. This donor (6F4181) had a seeding 
efficiency of 35%, versus the previous two donors which both had seeding 
efficiency values of 65%. Another cryovial of donor 6F4181 was grown 
successfully by seeding the cells from the two confluent T75 flasks into two, 
rather then three T175 flasks each. In subsequent experiments the value of the 
donors’ seeding efficiency would determine the number of T175 flasks the cells 
would be split into. Donors were also chosen based on higher seeding efficiency 
values to assure that greater numbers of cell inserts could be derived.
2.4.1.1.2 F r eezin g  a n d  T h a w in g  o f  C u ltu r es
It was determined that cells could be frozen down after Passage I, in a 10% 
DMSO in BEGM growth medium solution and rehydrated. Also, thawing of frozen 
cells was only successful when placed into smaller (T75) flasks and then split and 
seeded directly into inserts for the third passage.
2.4.1.1.3 F ila m ento u s  G r o w th  in m e d iu m
One cryovial of NHBE cells, (November 2007, donor 7F1624), was seeded into 
two T75 flasks and after one day small filamentous structures were observed 
(Figure 2.7 (A) and (B)), in the T175 flasks. These filamentous structures were 
also observed again in the next passage in the T175 flasks. These filamentous 
structures increased in size over time (Figure 2.7 (B)).
2.4.1.1.4 S plitting  r ea g en ts
Cells had been successfully ‘split’ using a .05% Trypsin/ 
Ethylenediaminetetracetic Acid (EDTA) solution purchased by Invitrogen as 
described in Section 2.3.1.2. The Lonza reagent pack subculture kit was 
purchased, which contained a trypsin/EDTA 0.25% solution, a trypsin neutralizing 
solution (TNS) and Hanks buffered saline solution (HBSS). Cells were removed
24 hours Passage 1 72 hours Passage 1 90 hours Passage 1
24 hours Passage 2 48 hours Passage 2 72 hours Passage 2
Insert Day 1 
Passage 3
Insert Day 17 
Passage 3
Insert Day 33 
Passage 3
Non adherent 
cells
Non adherent 
cells
Insert Day 13 
Passage 4
Insert Day 13 
Passage 4
Insert Day 30 
Passage 4
Figure 2.6 Phase contrast light microscope images of the NHBE cell cultures, both in the tissue 
flasks (Passage 1 and 2) and in the Transwell ® Cell Inserts (Passage 3 and 4). Cells from 
Passage 1 were derived from post 24 hours rehydration from cryovial in T75 flasks. Passage 2 
images were taken from 24 hours after cells seeded into T175 flasks. Passage 3 cells shown were 
started 1 day after being seeded into inserts. All images at 400X.
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from adherent culture using the Lonza 0.25% trypsin/EDTA solution and the TNS 
solution was then used to deactivate the trypsin solution, to which HBSS was 
added before the cells were spun-down. After the cells were spun down in the 
TNS, large chunks or strings of dead cells were observed and cell counts 
revealed that only one quarter of the normal cell numbers for confluent T175 
flasks were found and able to be seeded into cell inserts.
(A)
Figure 2.7 (A) A cluster of unidentified filaments observed in the T175 culture flasks, (B), a 
detailed view of unidentified filamentous growth.
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2.4.2 Passage  T h r ee : G rowing  in the  A ir -L iquid  Interface
2.4.2.1 O ptim al  G r o w th  C o n d it io n s
Twenty four hours after the cells were placed in the inserts they began to take on 
a regular pavement or ‘cobblestone’ style appearance (Figure 2.6). Real-time 
observations using the light microscope (LM) revealed ciliary action that was 
manifested as tiny ‘flickers’ after 5 days growth on the insert.
2.4.2.2 Pa ssa g e  N um ber s
It was determined that the NHBE cells taken to passage 4 did not demonstrate 
the same morphological characteristics as passage 3, when grown in the ALI in 
the inserts i.e. the pavement type appearance was less defined (Figure 2.6). Also, 
the passage 4 cells did not secrete mucus, there was no evidence of ciliogenesis 
observed, and TEER readings were very low (average 100 Q/cm2) (Figure 2.10). 
The passage 3 cultures showed evidence of mucus secretion (Figure 2.12) and 
exhibited high TEER values (average 3000 O/cm2) (Figure 2.9).
2.4.2.3 P eriph er a l  G r o w th
The first unusual growth pattern observed was that of a ‘peripheral’ growth 
observed (February 2007). One batch of NHBE cells at the third passage (donor 
#7F1169) were seeded into inserts (Section 2.3.2) and 2 days later exhibited a 
pattern of cell growth around the periphery of the inserts only (Figure 2.8). In the 
middle of the inserts there was a region devoid of cells where ‘bubbles’ were 
apparent (Figure 2.8).
2.4.2.4 C entral G r o w th
The second unusual growth pattern was that of central growth, (observed in April 
2007). One cryovial of cells (donor #7F1169) were grown-up through the third 
passage and seeded into inserts (Section 2.3.2). Twenty four hours after 
removing the apical growth medium from cell culture inserts, the cultures revealed 
a pattern of normal growth in the centre of the insert and no cell growth at the 
periphery of the inserts. When examined under the microscope, it was observed 
that there was a volume of liquid or growth medium around the edges of the cell 
inserts (approximately 10pl).
(A)
(B)
(C)
Figure 2.8 (A) A phase contrast image depicting the transitional regions between the middle 
(‘bubbly’) zone and the ‘normal’ zones at the edge of the membrane (magnification of 40X). (B) 
The image shows the ‘bubbly’ growth area in the middle of the insert membrane (magnification of 
40X.). (C) The image shows the area of normal cell growth at the edges or periphery of the insert 
membrane (magnification 40X.).
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2.4.3 Trans-Epithelial Resistance
TEER measurements were made every 3 days on three batches of inserts of 
passage 3 NHBE cells (n = 4) over a 36 day period (Figure 2.9). The 
measurements demonstrated that from days 1 to 3, the TEER values had an 
average of aproximately 300 Q/cm2. After day 3, there was an increase in the 
average value. The TEER values remain over 3000 O/cm2 (average) from day 6 
through to day 30. The TEER values decreased between days 30 and 36, 
followed by a slight rise in the average TEER value. TEER measurements were 
conducted every 5 days on inserts from passage 4 NHBE cells (one experimental 
batch), with triplicate readings (three inserts) taken at each time point, over a 
thirty six day period (Figure 2.10). The passage 4 cell culture elicited only a slight 
increase in average TEER values between days 5 and 20, from 40 O/cm2 to 51 
O/cm2. There was a slight increase in average TEER values between days 20 
and 25 (from 51 O/cm2 to 74 O/cm2) and between days 25 and 30 (from 74 O/cm2 
and 106 O/cm2). The only significant increases in TEER were those on days 25 
and 30, when compared to day 1.
2.4.4 M e ta b o lic  A c tiv ity  A ssay
The Cell Titer Blue™ assay was performed on passage 3 NHBE cell cultures in 
inserts (Figure 2.11). The assay was performed on three inserts every three days, 
from day 1 to day 36, after seeding the cells on the inserts. The values were read 
using a plate-reader at 540 nm. There was a dramatic increase in the reading 
between days 6 and 9, from 0.38 to 1.65. The readings then continue to stay 
high, with some variation, through to day 36. The mean values between days 9 
and 36 remained within a range of 1.5 and 2.25. Statistically significant (p<0.05) 
changes in viability occurred after day 15, when compared to day 1.
2.4.5 B ra d fo rd  Assay
The Bradford assay was performed on the apical washes of passage 3 NHBE cell 
cultures, in inserts. The washes were made every 3 days for 36 days. The assay 
was performed on two batches of cells derived from two different donors and four 
inserts were measured for each time point. The Bradford assay data (Figure 2.12)
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Figure 2.9 TEER readings from three batches of passage 3 NHBE cell inserts, taken every three 
days, for 36 days. Readings were taken on four inserts, for each time point and batch. TEER 
values given in Ohms, as measured using an EVOM and Endohm chamber.
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Figure 2.10 TEER readings from passage 4 NHBE cell inserts, from one batch of cell inserts, 
taken every 5 days for 30 days in inserts. Three inserts were measured for each time-point. 
TEER values given in Ohms, as measured using an EVOM and Endohm chamber; p-values 
indicated by the following * = significant (p ^ 0.05), ** = highly significant (p £ 0.01) when 
compared to day 1.
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Figure 2.11 Fluorimeter readings taken at 540 nm, with 150 pi aliquot of apical medium of the Cell 
Titer-Blue reagent solution, on passage 3 cells. N = 3, p-values indicated by the following * = 
significant (p ^ 0.05), ** = highly significant (p ^ 0.01), when compared to day 1.
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Figure 2.12 Bradford protein analysis, in pg/ml protein, from apical wash samples, taken every 
three days from two NHBE donors, over 36 days (passage 3 cells), N = 4.
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showed an increase in protein in the apical wash on the day 9 collection and the 
protein quantities remained high throughout the rest of the thirty six days, with 
quite a bit of variation between samples.
2.4.6 In se r t  M e m b r a n e s : TEER
TEER measurements were made (Section 2.3.4) on passage 3 cells, after thirty 
days of growing in the ALI on inserts. The three different batches of cells were 
derived from three different donors (Table 2.1). The TEER readings (Figure 2.13) 
were taken on all insert membrane types; BD Falcon™, ThinCerts™, 
Transwells®, and Millicells® (Table 2.2). The numbers of inserts measured for 
each membrane type were a minimum of three. The inserts which showed the 
lowest average TEER value were the BD Falcons™, and the inserts which 
showed the highest average TEER value were the Millicells®. There was wide 
deviation in TEER values, particularly in the Millicells®, Thincerts™ and BD 
Falcon™ insert membrane types.
2.4.7 Insert Membranes: MTT Metabolic Activity Assay
The MTT assay was performed for the three donors at day 30 for all four
commercial inserts types (on four individual inserts) (Figure 2.14). The Mann- 
Whitney test showed that; there was no significant difference in the MTT values 
for the Thincerts™ and the BD Falcon™ inserts (p = 0.08), Millicells® showed 
significantly higher MTT values then the other three samples, and the 
Transwells® showed significantly higher MTT values then the ThinCerts™ or BD 
Falcon™ inserts.
2.4.8 In s e r t  M em branes: H is to lo g y
Semi-thin sections were prepared for 3 membrane types for donor 7F1169 and 
for all four membrane types for donor 6F4180 and donor 6F4181. For the donor 
7F1169, the semi-thin images revealed thicker and more developed cultures in 
the Transwell® and Millicell® samples (Figure 2.15). For this donor, the 
Transwell® membrane exhibited ciliated cells and the greatest thickness of 
culture (Figure 2.15). In donor 6F4180, the Transwell® and Millicell® inserts 
depicted the greatest thickness in culture with the Transwell® cultures exhibiting 
a more columnar shaped upper cell layer (Figure 2.16). In donor 6F4180, all 
insert types did develop cultures that exhibited differentiation, with ciliated and
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Figure 2.13 TEER data collected from passage 3 NHBE cells growing in an ALI culture, from 
three different NHBE cell donors, grown on four different types of commercially available 
membranes.
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Figure 2.14 MTT absorbance reading data collected from passage 3 NHBE cells growing in an 
ALI culture, from three different NHBE cell donors, grown on four different types of commercially 
available membranes.
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Figure 2.15 Passage 3 NHBE tissue from donor 7F1169, grown at an ALI, for 30 days. Samples 
were resin embedded, semi-thin sectioned and toluidine blue stained. Scale bar equivalent to 
10pm. GC = Goblet cell; CC = Ciliated cell; BC = Basal cell.
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Thincerts Membrane
Millicell® Membrane
Figure 2.16 Passage 3 NHBE tissue from donor 6F4180, grown at an ALI for 30 days. Samples 
resin embedded, semi-thin sectioned and toluidine blue stained. Scale bar equivalent to 10pm.
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Figure 2.17 Passage 3 NHBE tissue from donor 6F4181, grown in an ALI for 30 days. 
Sample resin embedded, semi-thin sectioned and toluidine blue stained. Scale bar 
equivalent to 10pm.
(A)
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Figure 2.18 Passage 3 NHBE tissue from donors; (A) 6F4180 and (B) 6F4181, grown in 
an ALI for 30 days. Sample resin embedded, semi-thin sectioned and toluidine blue 
stained. Scale bar equivalent to 10pm. Both donors were grown here on BD Falcon™ 
membranes.
goblet cells present (Figure 2.16). In donor 6F4181, the Transwell® and Millicell® 
cultures revealed thicker cultures, with the Millicell® culture exhibiting the greatest 
number of ciliated cells (Figure 2.17).
2.5 Discussion
2.5.1 P a s s a g e  O n e  a n d  T w o : S u b m e r g e d  c e l l  c u l t u r e s
2.5.1.1 S e e d in g  E f f ic ie n c y
It was concluded that choosing donors with greater seeding efficiencies was 
optimal. For example donor 6F4181, with a seeding efficiency of 35%, did not
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grow successfully when split from one T75 into three T175 flasks at the second 
passage. However, previous donors with seeding efficiency values of 65% did 
successfully grow to confluence when split from one T75 into 3 T175 flasks at the 
second passage. In the event that the only donors available had low seeding 
efficiencies, then the flask numbers or seeding densities had to be adjusted 
accordingly.
2.5.1.2 F r e e z in g , F ila m e n to u s  str u ctur es  and  S plitting  R eag en ts  
The experiments performed proved that freezing down cells at low passages was 
possible, but would not result in optimal numbers of cell culture inserts. Work was 
carried out to explore the possible source of the filamentous structures (Figure
2.6). Ten T75 flasks were set up, each with BEGM basal medium mixed with just 
one of the ten bullet kit growth supplements. The flasks were then placed in the 
incubator for 24 hours. The results of the examination of the flasks showed 
evidence of the filamentous growths only in the flask containing the BEGM and 
the transferrin growth supplement. (This work was carried out by PhD student, 
Zoe Prytherch). The evidence suggested a possible lack of quality control in the 
Lonza growth supplements. The remaining samples of the transferrin supplement 
from this lot number were discarded and the Lonza Corporation informed of the 
issues experienced.
The Lonza Corporation will only guarantee the health and success of their cells if 
all growth medium, supplements and splitting reagents used with the cells are 
those sold by the Lonza Corporation. The trypsinization protocol recommended 
for the Lonza reagent subculture kit was followed. However, large percentages of 
cells did not survive this splitting procedure. The Lonza splitting reagent kit 
proved to be too aggressive for the NHBE cells grown with our lab cell culture 
protocols. The Lonza subculture kit contains a trypsin/EDTA solution with five- 
times the concentration, (0.25% versus 0.05%), of the standard trypsin solution 
commonly used. The standard trypsin solution caused no apparent adverse 
effects to the cell cultures when used to subculture, which suggested that the 
lower trypsin/EDTA concentration would be advisable.
2.5.2 Passage  T h r e e : C ell Inserts
There were a number of issues encountered in the inserts, where optimal 
conditions had not been achieved. These involved cell insert contamination and 
unusual growth patterns. Alternative, commercially available, cell inserts were 
also explored. The feeding regime established with the passage 3 cell inserts also 
involved a number of optimization experiments.
2.5.2.1 Pa ss a g e  N u m b er s
It was determined that the NHBE cells had the greatest success when seeded at 
passage 3 versus passage 4. Earlier passages might prove equally or even more 
successful. However, these would equate to smaller cell culture insert numbers 
and would be less economical. For example, if cells were placed into cell inserts 
from two T75 flasks, where they are grown in passage 1, the resulting cell insert 
would be approximately one sixth the number of inserts resulting from from 
seeding cell inserts with the passage 2 cell cultures grown in the six T175 flasks.
2.5.2.2 G ro w th  Pa tte r n  Issu e s
Questions still remain as to whether the two irregular growth patterns were the 
result of insert manufacturing or production related problems. Corning, the maker 
of the of the Transwell® inserts, suggested that the growth pattern seen where 
the cells were not growing in the middle of the membrane, could have been the 
result of ‘external vibrations’ in the environment. There were no such additional 
external vibrations in the laboratory during this cell culturing time. The Corning 
company took the relevant lot numbers of the inserts that had both the central 
and peripheral growth pattern issues, to perform quality control analysis. Although 
the results of these analyses have not been communicated, Corning did 
reimburse for all inserts that produced unusual or unexplained growth problems.
In the cell cultures in which there were no cells growing in the peripheral region, 
and it was observed that there was a volume of liquid or growth medium around 
the edges of the cell inserts, the liquid was removed. After 24 hours, the cell 
inserts were observed and liquid was again found around the periphery of the 
inserts, and cell growth was not observed in this peripheral zone. The liquid was 
again removed, and this continued for a number of days. The volume of liquid
needing removal decreased daily. The liquid was no longer present in the inserts 
after a number of days. As the apical liquid volume decreased, cells began to 
spread out into the peripheral region, until they had grown completely across the 
membrane. It was determined that excess culture medium may have been 
leaking from the basal region into the apical zone. This was attributed to an insert 
or membrane defect in the Corning product. When the liquid was removed from 
all of the inserts, the air-liquid interface was re-established. The volume of liquid 
needing to be removed from the inserts became smaller and diminished at the 
same time that the cell culture developed across the membrane. TEER 
measurements were taken of the cell cultures at days 10 and 12, and the cell 
cultures elicited the same high TEER values seen in previous cultures grown on 
non-defective inserts at these time points (Section 2.4.3). The TEER values 
increased on day 16. This peripheral growth pattern appeared to be resolving 
itself with regular removal of ‘leaked’ liquid. It must be noted that other 
laboratories in the UK and USA also experienced the peripheral growth pattern 
problem and reported similar conclusions.
2.5 .2 .3  A lter na tive  feed in g  r eg im e s
The cell inserts were fed using a number of alternative feeding regimes, including 
feeding a regular volume of 300 pi of growth medium Monday through Friday and 
feeding a higher volume (400 pi) of medium every other day. The cell inserts 
which were fed the higher volume every other day did not succeed. The result of 
this feeding regime was that the cells were observed to have detached from the 
membrane, with growth medium observed to have come ‘up’ through the 
membrane. It was deduced that the higher volume presented upward force or 
pressure on the insert membrane which hindered successful cell attachment and 
development.
2.5.3  T ra n s -E p ith e lia l R esistance
It was apparent from the TEER values that tight junctions begin to form within the 
first week of growth on the inserts. The steady increase in TEER between days 3, 
6 and 9 were indicative of this event. The TEER values, in these passage 3 cell 
cultures, remained over 2000 Q/cm2 from day 6 through day 36, and hence, 
evidence that the tight junctions were maintained throughout this period of time. 
There was some variation in the TEER values, with a peak on day 17 and a slight
drop on day 36. These variations could be reflective of different amounts of 
secreted mucin, present on the surface of the cultures, affecting the resistance 
reading. They do not appear to represent a trend and may also be due to natural 
variations or slight fluctuations in environmental factors, such as changes in 
culture temperature.
In the passage 4 cells, TEER values were much lower then passage 3 cells, with 
the average between 40 and 60 O/cm2. These cultures demonstrated slightly 
higher readings on days 25 and 30, but this may be due to higher cell numbers. 
The passage 4 TEER readings suggested that the cell cultures had not 
successfully formed tight junctions. These findings also lend further evidence to 
previous research, which reported that these primary cells do not exhibit the 
same level of differentiation after passage 3 (Wu et a/., 1990).
2.5.4 M etabolic  A c tivity  A ssay
The colour change observed in the cell cultures and the increases in readings at 
540 nm give evidence that cell cultures became more robust and metabolically 
active after 6 days of culture, and quickly reached a maximal plateau of viability. 
The readings remained in the same range, with minimal variation between days 9 
and 36, inferring that the cell cultures were healthy and active throughout this 
time.
2.5.5 Bradford  (Protein) A ssay
The data from the Bradford assay provided evidence to support the light 
microscope observations, with regard to mucin production. The Bradford assay 
data revealed an increase in apical proteins between days 6 and 9, and again 
between days 9 and 12. The levels then remained fairly constant. Once the 
NHBE cells were growing in the inserts, a thin layer of clear liquid could be 
observed by eye, on the top of the cells by day 7. When a small pastette was 
used to collect this liquid, it was observed to be thick or viscous; indicative of a 
mucin glycoprotein. The Bradford assay suggested that once the cells began to 
produce apical protein (or mucin), this product remained fairly constant 
throughout the culture morphogenesis.
2.5.6 Insert M embranes
2.5.6.1 In ser t  M e m b r a n e s : TEER
The Mini-tab statistical analysis program was used to examine TEER values 
derived from cultures grown on the same membrane and it was discovered that 
there was a lack of homogeneity of variance or normal distribution from this data. 
The Mann-Whitney non-parametric test was then used to examine any significant 
differences between the median values for the TEER for the four membrane 
types. The Mann-Whitney results showed a significantly higher median TEER 
value for the Transwell® inserts versus the Thincerts™ (p = 0.04). The Mann- 
Whitney results also showed that the Millicell® inserts had significantly higher 
values for TEER then did the Thincerts™ (p = 0.01). No other significant 
differences were shown. The TEER data suggests that the NHBE cells grown in 
the Millicell® and Transwell® inserts were more successful at forming tight 
junctions, then those grown on the Thincert™ inserts. The Transwell® and 
Millicell® inserts are the two inserts with the highest pore densities (Figure 2.2).
2.5 .6 .2  In s e r t  M em b r a n es  : M TT
The MTT data proved to be a better means of comparing the success of the 
NHBE growth and development on the different membranes. There was less 
deviation in the MTT assay data then in the TEER data. However, the data again 
did not show homogeneity of variance or normal distribution among samples from 
the same membrane. The Mann-Whitney non-parametric test was used to 
examine the significance of differences in the median values for MTT in the four 
membrane types. The results revealed that the Millicell® inserts had a 
significantly higher median MTT value then any of the other membranes (p-values 
£0.05 in all instances of comparison). The Transwell® inserts were significantly 
higher in median MTT values when compared with the Thincerts™ and the BD 
Falcons™ with p-values £ 0.05. This test showed that the NHBE cells grown in 
the Millicell® inserts were the most successful in terms of cell viability. This brings 
into question whether this may be a result of the Millicell® insert membrane 
having the greatest pore density, or if this success might be a result of the 
thickness of the membrane, which is known to be thicker then the Transwell®.
2.5 .6 .3  In ser t  M e m b r a n e s : H istolo gy
For the donor 7F1169, there were not enough BD Falcon™ inserts available to 
examine using this method. The semi-thin sections of the NHBE cells on 
membranes showed variations in the development of different donors, even on 
the same membrane. For example, the Thincert™ samples from donor 6F4180 
(Figure 2.16), appeared much thicker and more differentiated, when compared to 
the donor 7F1169 and donor 6F4181 samples, grown on the Thincert™ 
membrane. The Millicell® samples from donor 7F1169, were not as thick and 
well-differentiated as the Millcell® samples from donor 6F4180 and donor 
6F4181. The donor variations may suggest that some donors develop more 
slowly than others, resulting in different degrees of maturation by day 30. The 
semi-thin sections infer that the Transwell® and Millicell® cultures exhibit greater 
thickness and more differentiation versus the BD Falcon™ and Thincert™ 
membranes. In donor 6F4180, the BD Falcon™ samples revealed large gaps 
between cell layers and cells appeared flattened (Figure 2.16). The ThinCert™ 
cultures also exhibited intercellular gaps and a greater number of intercellular 
vacuoles when compared to the Transwell® of Millicell® samples (Figure 2.16). In 
donor 6F4181, the BD Falcon™ samples appeared thicker and slightly less 
flattened (Figure 2.17). The Thincert™ sample demonstrated a great degree of 
vacuolization and large intercellular gaps were apparent (Figure 2.17). The 
Transwell® samples contained the greatest thickness, however, the Millicell® 
samples exhibited the greatest degree of differentiation with many ciliated cells 
present (Figure 2.17).
The success of the cell cultures on the Millicell® and Transwell® inserts may be 
related to the membrane pore densities, which were highest in the Millicell® 
membranes (1 X108) and the Transwell® membranes (4 X106), versus the 
Thincerts™ (2 x106) and the BD Falcons™ (1.6 x 10 6). The differences in the 
membrane thickness may also play a role. The Millicell® membranes had a 
thickness of 12 pm, and the Transwell® membranes were 10 pm; while the others 
were not known. Another possible factor of culture success may have been the 
feeding regime and the insert design. The optimal volume of food for one insert 
brand may not be optimal for another. Higher volumes of growth medium may be 
needed for membranes with lower pore densities. Due to questions raised about
the quality control of the Transwell® inserts in connection with the unusual growth 
patterns, the decision was made to use the Millicell® inserts.
2.6 C o n c l u s io n s
2.6.1 C e ll  G r o w th  C o n d it io n s
Data from these protocol development experiments suggest that the NHBE cell 
culture system would be a viable model for further exploration in toxicological 
studies. Changes in parameters such as TEER, cell viability and mucus secretion 
would contribute to a better understanding of the human, tracheo-bronchial 
airway, epithelial response to inhaled toxins. The findings of the 36-day cell 
culture characterization experiment would suggest that under optimal conditions, 
experimentation might be performed within a fairly wide time frame, beginning 
anywhere between days 19 to 20 in the inserts, up to 36, and possibly beyond. 
This wider experimental time window presents an advantage to working with this 
system versus other commercial models (e.g. EpiAirway™). It would be possible 
to perform both acute and chronic exposures with this cell model as well as 
repeat-dose toxicity testing.
The cells generally took 5 weeks from the first steps of rehydration of the frozen 
cell cryovial until the last steps when the fully-differentiated cell cultures were 
ready for dosing with xenobiotics. During these weeks critical sub-culturing 
routines were developed to avoid issues concerning the confluence of cells. 
These sub-culturing routines were vulnerable to contamination that could result in 
the demise of these cultures. Previous work performed with NHBE primary cells 
have also shown similar patterns of growth and development. DeJong et al. found 
NHBE cells grown in ALI conditions formed greater numbers of cell layers and 
demonstrated differentiation (DeJong et al., 1994). Gray et al., demonstrated that 
passage 2 and 3 NHBE cells showed the greatest TEER and the greatest mucin 
secretion between day 4 and 20 (Gray et al., 1996). Krunkosky et al. grew 
passage two NHBE cells in inserts, first submerged for 5 to 10 days and then in 
ALI conditions. This group confirmed the formation of tight junctions with TEER 
values of approximately 1444 Q/cm2 (Krunkosky et al., 2007). Le Visage et al. 
grew NHBE cells as single cultured cells and as well as co-culturing them with 
mesenchymal stem cells. This research group discovered that the co-cultured
cells demonstrated a peak of mucin secretion between days 18 and 25, and in the 
single cultured cells this peak was on day 21 (Le Visage et al., 2004).
The patterns of cell growth patterns where cells were only growing successfully 
on either the centre of the membrane or the edges of the membrane, experienced 
in this project were never rectified or clearly explained by plastics manufacturers 
or cell reagent suppliers and the decision was made that future work with the 
NHBE cell cultures in the lab will be performed using the Millicell® inserts from 
Millipore.
Table 2.3 summarizes the cell culture variables used in these experiments and 
the outcomes.
A summary of the NHBE cell culture protocol established follows.
1.) One cryovial of NHBE cells was defrosted and seeded into two T75 flasks. 
Cells were grown submerged, up to approximately 60-70% confluence.
2.) Confluent passage one cells were trypsinized and the cells from each T75 
were split or seeded into three T175 flasks. Passage two cells were grown 
submerged, up to approximately 60-70% confluence.
3.) Confluent passage two cells were trypsinized, spun down and pelleted. 
The cells were then suspended and diluted to a 5 X 105 viable cells/ml 
BEGM growth medium and 150 pi of this solution was seeded into the 
apical region of each insert. 500 pi of BEGM medium was placed in the 
lower compartment or insert well.
4.) Twenty four hours after seeding passage three cells into inserts, growth 
medium was removed from the apical surface of the cell culture to 
establish ALI. The basal growth medium was then replaced with a volume 
of 300 pi fresh medium.
5.) Growth medium was replaced daily Monday through Friday for a maximum 
of 36 days.
6.) Once mucin secretion was observed, mucin was removed every third day.
CULTURE VARIABLE VARIABLES USED OUTCOMES
Number of T75 flasks used for 
seeding passage 1 NHBE primary 
cells
1 defrosted cryovial of Lonza, of passage 1 NHBE 
primary cells (~ 500,000 cells) was seeded into either 
1, 2, 3 or 4 T75 flasks and observed.
Lonza passage 1 NHBE primary cells were found to 
successfully reach confluency when seeded into a 
maximum of 2 T75 flasks.
Number of T175 flasks used for the 
seeding of passage 2 NHBE cells.
60-70% confluent T75 flasks of passage 2 NHBE 
cells were trypsinized and seeded into either 1,2, 3 or 
4 T175 flasks and observed.
Passage 2 NHBE cells seeded from 60-70% 
confluent T75 flasks were found to successfully grow 
to confluence when seeded in a maximum of 3 T175 
flasks.
Passage number of NHBE cells able 
to form successfully differentiated cell 
cultures at ALI.
150 pi of a 500,000 cell/ml or -  75,000 passage 3 or 
passage 4 NHBE cells were seeded onto a 33 mm2 
cell culture insert membrane and observed.
NHBE cells seeded onto the cell culture membrane at 
passage 3 displayed optimal characteristics - a
cobblestone appearance, showed TEER reading and 
evidence of ciliogenesis and passage 4 cells 
appeared to have lost the NHBE phenotype.
Feeding regime for passage 3 NHBE 
cells at ALI.
Passage three NHBE cells growing on a cell culture 
membrane in ALI were fed either everyday Monday 
through Friday, every other day, or every other day 
and were observed.
Passage 3 cells growing on a cell culture membrane 
at ALI which were fed everyday Monday to Friday
showed the greatest response in terms of 
development of a cobblestone appearance and 
higher TEER readings.
Splitting/Try psinization Reagents 
used for adherent passage 1 and 
passage 2 NHBE cells.
Passage 1 and passage 2 adherent NHBE cells were 
trypsinized with either a 0.05% Trypsin/EDTA reagent 
from Invitrogen and deactivated with 10% FCS in 
RPMI or a 0.25% Trypsin/EDTA reagent from Lonza 
and deactivated with TNS in HBSS.
The 0.05% Trypsin/EDTA reagent from Invitrogen 
had the greatest success in terms of harvesting the 
highest numbers of viable cells from flasks.
Cell culture membranes used to grow 
passage three NHBE cells.
150pl of a 5 X 105 cell/ml (~ 75,000cells) passage 3 
NHBE cells were seeded onto either Millicell®, 
Transwell®, ThinCert™ or BD Falcon™ cell culture 
insert membranes with an approximate area of 33 
mm2 and observed.
In terms of morphology and MTT data the passage 3 
NHBE cells grew most successfully on the Transwell® 
and Millicells® membranes, with the cells grown on 
the Millicells® membranes exhibiting slightly higher 
MTT values then the Transwells®
Table 2.3 A summary of the NHBE cell culture variables used in the development of the cell culture protocol experiments and their 
outcomes.
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3.0 Introduction
In Chapter 2, the optimization of the cell culture parameters were considered 
along with the biochemical characteristics of the NHBE cell culture model of the 
respiratory epithelia. In order to support the biochemical findings, the concomitant 
morphological characteristics of the model had to be corroborated. To this end, 
complimentary light and electron microscope technologies were employed to 
analyse cell culture development, using the same time course for the biochemical 
investigations, i.e. 1 - 36 days.
Light microscopy (LM) provided an overall picture of the state of confluence in a 
cell culture, the pattern of growth (e.g. cobblestone appearance), and number of 
cells. In addition, cells were fixed, sectioned, stained and mounted on slides for 
histological evaluation to provide a cross-sectional view of the cells at a low level 
microscopic resolution. Morphometric analysis on such sections only revealed 
parameters that include numbers of cell layers, pseudo-stratification, and super­
ciliary structures. However, electron microscopy (EM), more specifically 
transmission EM (TEM), permits a view of the cell ultrastructure (i.e. sub- 
microscopic). TEM permits the identification of fine structural features, such as 
junctional complexes and sub-cellular organelles. The counterpoint of TEM can 
then be used to examine the surface features of the NHBE cultures, i.e. scanning 
EM (SEM). The examination of the culture surface topography can then be used 
to confirm the successful development of a differentiated tissue, especially one 
that undergoes ciliogenesis. The following images were taken from cell cultures 
which were grown using the cell culturing protocol outlined in Section 2.6.1, using 
cells from the Lonza NHBE donor # 3F1675.
3.1 A ims of the  C hapter
This chapter presents the morphological data gathered by the means of light 
microscopy, and transmission and scanning electron microscopy, during the 
development of the third passage NHBE tissue growing in the ALI for the first 
thirty six days. This chapter also presents a comparison of the morphological 
characteristics of this NHBE in vitro model to those found in in vivo tissue.
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3.2 Materials
3.2.1 Sto c k  S o l u tio n s
Sigma Dorset, UK.
10% Neutral Buffered, Wintergreen Scented Formalin 
Mayers Hematoxylin (S1275)
Xylene (cat# 95690)
PBS (cat# P3813)
Agar Scientific 
25% Glutaraldehyde (R1010)
Osmium Tetroxide (R1015)
200-mesh 3.05mm Copper Grid (G246)
Uranyl Acetate (2%) (R1260)
Sodium Cacodylate (R1102)
Araldite CY212 (R1040)
Carbon Adhesive Discs (G3347)
SEM Specimen Stubs (G301)
Reynolds Lead Citrate (R1210)
Propylene Oxide (R1080)
R A Lamb
Aqueous Eosin (1%) (LAMB/100-D)
Mayer Haemalum (Lamb/170-D)
BDH Lab Supplies 
DPX-mountant for microscopy (product # 360292)
Santa Cruz Biotechnology Inc. Santa Cruz, CA, USA
Tracheo-bronchial mucin antibody (140CI) sc-523.(cat# 52329)
Goat Serum (cat# sc-2043)
Mouse ImmunoCruz Staining System (cat # sc-2050)
Fisher Scientific Manchester, UK
Absolute Grade Ethanol (CAS 64-17-5)
Vector Labs Burlingame, CA, USA
ImmEdge Wax Pen (cat# H-4000)
Eastbourne, UK
Poole, UK
3.2.2 Eq u ip m e n t  
Leica Ltd.
Leica RM2135 Microtome
Milton Keyes, UK
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Leica Ltd.
Embedding Centre
Vacuum Tissue Processor
DFC 320 Digital Camera
DM 2500 Phase Contrast Light Microscope
Phillips
TEM 208
Balzers
Critical Point Dryer (CPD 030)
EMScope
Sputter Coater (Model Code # AE1231)
Milton Keyes, UK Leica EG1140
Cambridge, UK
Balzers, Liechtenstein
Ashford, UK
3.3 M ethods
3.3.1 L ig h t  M ic r o s c o p y
3.3.1.1 T iss u e  F ixa tio n
The cell culture inserts were immersed in 10% neutral buffered formalin (NBF) at 
4°C for 24 hours in preparation for paraffin embedding and sectioning. Tissue 
processing, i.e. paraffin embedding, sectioning and staining, was carried out by a 
histology technician, Mr Derek Scarborough, at the School of Biosciences, Cardiff 
University. A brief overview of these procedures has been outlined below in 
Sections 3 .3 .1.2 to 3 .3 .1.5.
3.3.1 .2  T issue  P r o c es s in g
Once the tissue had been fixed (Section 3.3 .1 .1 ), it must be processed into a form 
in which it can be made into thin microscope sections. This was achieved by 
embedding tissues in paraffin that was similar in density to tissue and could be 
sectioned from 3 to 10 microns. The main steps in this process dealing with wet- 
fixed tissue were “dehydration”, “clearing” and “paraffin infiltration”.
Wet-fixed tissues, such as the NHBE cell cultures from this study, cannot be 
directly infiltrated with paraffin. The water from the tissues must be removed by 
“dehydration” via a series of alcohols (e.g. 70% , 95%, 100%). Following 
dehydration, the next step was “clearing” and consisted of replacement of the 
dehydrant, i.e. alcohol, with a substance that would be miscible with the paraffin. 
The common clearing agent was xylene and the tissues were processed through 
several changes of xylene. The final step in processing was to infiltrate the tissue
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with molten paraffin wax at 60°C; several changes of wax were used. Tissues 
were placed in plastic processing cassettes prior to loading on the automatic 
processing machine. All the above processes were automated using a fully 
enclosed Vacuum Tissue Processor.
3.3.1.3 Pa r a ffin  E m b ed d in g
It was important for the tissue to be fully supported by paraffin wax to prevent the 
tissue shredding during sectioning. This was achieved by placing the “cleared” 
tissue into a vacuum to remove all air pockets. The NHBE cell culture was then 
placed into a plastic “embedding mould” and a Leica EG1140 Embedding Centre 
was used to embed the tissue in warm paraffin wax. After allowing the wax to set 
(30 minutes on a cold plate), the tissue was removed from the embedding mould 
and the sample was ready for sectioning.
3.3 .1 .4  S e c tio n in g
Following tissue processing and paraffin embedding, the NHBE cell culture had to 
be cut into sections that could be placed on a glass slide for the purpose of LM. 
Sectioning was achieved using a Leica RM2135 microtome (i.e. a knife with a 
mechanism for advancing a paraffin block standard distances). The embedded 
lung tissue samples were placed on ice to ensure uniform sections were obtained. 
The ice hardens the wax and softens the tissue so the entire sample is of the 
same consistency for sectioning. The tissue was then cut into 5 pm sections 
using the microtome.
Once the sections were cut, they were floated on a warm water bath (40-50°C) 
that facilitated the removal of any wrinkles and air bubbles produced during 
sectioning. The paraffin embedded sections of lung tissue were then collected on 
a pre-coated glass microscope slide. The slides used were coated in poly-L-lysine 
to improve adhesion of sections. The samples were then left to bind to the slides 
on a hot plate for 15-30 minutes, then in an oven at 37-45°C for a minimum of 24 
hours.
3.3.1 .5  Haem ato xylin  a n d  Eo s in  Stain
To evaluate the cell culture architecture by LM, the tissue sections were stained 
with Haematoxylin and Eosin (H and E); a routine stain chosen for its ability to
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stain various cellular components of tissue. Haematoxylin is a basic dye that 
stains nuclear heterochromatin and cytoplasm rich in ribonucleoprotein blue. 
Eosin is an acid dye that stains cytoplasm, muscle and connective tissue various 
shades of pink.
The embedding process must be reversed in order to remove the paraffin wax 
from the tissue and allow water soluble dyes to penetrate the sections. Therefore, 
before any staining could be done, the slides were “deparaffin ized” by running 
them through xylene followed by series of graded alcohol (e.g. 100%, 70%). The 
dewaxed tissue sections were stained with Mayer’s haematoxylin for 1.5 minutes. 
Sections were washed in running tap water for 5 minutes, and then stained with 
1% aqueous eosin for 10 minutes. Following a 20 second wash in running tap 
water, sections were dehydrated once again (increasing strengths of alcohol and 
subsequently replaced by xylene). The stained section on a slide must be 
covered with a glass coverslip to protect the tissue from being scratched, to 
provide better optical quality for viewing under the LM and to preserve the tissue 
section for archival purposes. The stained slides were taken through the reverse 
process that they went through from paraffin section to water, (i.e. series of 
graded alcohol to xylene). The mountant DPX was placed over the section and 
the coverslip on top of the mountant. The sections were imaged using a Leica 
Phase Contrast LM (DM2500) attached to a digital camera (Leica DFC 320) and 
the images saved as TIF files.
3.3.2 T ransmission  Electron  m icroscopy
3.3.2.1 T issue  F ixation
The cell inserts were placed in a 25 ml Universal tube with approximately 2 ml 
gluteraldehyde (3%) fixative, for 4 hours at 4°C. This method of fixation preserves 
the cellular structure of the tissue by cross-linking proteins via their amine groups. 
The sample was then removed from the Universal and placed in a fresh 25 ml 
Universal tube with approximately 2 ml of phosphate buffer and washed overnight 
(~12 hours). Tissue processing, sectioning and staining for TEM was carried out 
by an electron microscopist, Dr. Stuart Faulkner, at the School of Biosciences, 
Cardiff University. A brief overview of these procedures has been outlined below 
in Sections 3.3.2.2 to Section 3.3.2.4.
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3.3.2 .2  T is s u e  P r o c es sin g
Once the tissue had been fixed (Section 3.3.2.1), it must be processed into a form 
in which it can be made suitable for TEM. This was achieved by embedding the 
fixed cell culture and membrane in a resin (Araldite), that acts as a support matrix 
for the culture, permitting ultra-thin (e.g. 60 to 90 nm) sections to be cut.
Prior to tissue processing, a piece of fixed cell culture and membrane was cut into 
1 mm square pieces. The culture square cubes were placed into a squat, glass 
sample vial that was used to carry the tissues through the various stages of 
dehydration, post-fixation and resin infiltration. The sample vials were kept on a 
rotating wheel inside a fume cupboard.
Post-fixation was carried out by osmicating (1% osmium tetroxide in phosphate 
buffer) for 60 minutes at 4°C. The tissue was then passed through a series of 
graded alcohols, (30%-90%: 15 minutes in each, then 2 x 100%: 30 minutes 
each). Once dehydrated, the cell culture samples were placed into new sample 
vials and immersed in propylene oxide for 30 minutes. This was followed by 
overnight (~12 hours) rotation in a fume cupboard in a 50/50 mix of propylene 
oxide and Araldite CY212. During this time the propylene oxide dissipated leaving 
only the Araldite. The following day the tissue was infiltrated with Araldite for 8 
hours.
Finally, the tissue samples were embedded in Araldite. This process involved 
placing one cube of tissue into a plastic/disposable embedding capsule and 
topping up the capsule with fresh Araldite. The capsule was then placed into a 
resin oven and polymerised at 60°C for 48 hours.
3.3.2.2 S ec tio n in g
Following resin polymerisation, the capsule was cut away from the resin/tissue 
block using a razor blade. Excess resin was trimmed from the blocks until the 
tissue was exposed. Semi-thin survey sections (2 pm) were taken using a glass 
knife and mounted onto glass slides, and the tissue stained with toluidine blue; 
the stain helps to reveal cellular architecture. Appropriate areas for ultra-thin 
sectioning were identified from the semi-thin sections and the blocks trimmed 
accordingly. The resin blocks were sectioned to 60-90 nm on an LKB 3
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Ultramicrotome using a diamond knife. Sections were expanded on a water 
trough and collected onto clean 200-mesh, 3.05 mm copper grids.
3.3.2 .3  C o u n te r  Sta in in g
Prior to visualisation of the tissue sections via TEM, heavy metal staining or 
“counter staining” was required to help resolve the ultrastructure of the cell 
culture. Counter staining was achieved by using Reynold’s lead citrate and 2% 
aqueous uranyl acetate. These heavy metal stains were of general purpose and 
not very specific. Uranyl acetate stains membranous structures and structures 
containing nucleic acids. The lead in lead citrate binds to RNA-containing 
structures and hydroxyl groups of carbohydrates.
Droplets (10 pi) of each stain were placed in rows on the sterile side of parafilm 
and the grids were floated section side down on a given drop. Sections were 
stained for 10 minutes with uranyl acetate, followed by staining with Reynolds 
lead citrate for five minutes. Finally, the grids were washed by transferring over 3 
drops of filtered de-ionised water. The grids were allowed to air dry at room 
temperature in filter paper-lined Petri dishes prior to viewing in the TEM. The 
sections were imaged using a Phillips TEM 208 at an acceleration voltage of 80 
KeV.
3.3.3  S c a n n in g  E lec tr o n  M ic r o s c o p y
3.3.3.1 Sa m ple  F ixatio n  a n d  T is su e  P r o c es s in g
NHBE tissue insert samples were processed in the same manner as those 
samples prepared for TEM until the point where the tissue sample membranes 
were cut from the inserts and placed into the propylene oxide, i.e. Sections
3.3.2.1 to 3.3.2.2. At this point in post-osmication (Section 3.3.2.2), the tissue 
samples for SEM were placed into new sample vials containing 100% ethanol 
solution, in preparation for critical point drying (CPD).
3.3.3.2 C ritical  P o in t  D r ying
A CPD chamber, containing the ethanol solution and samples, was placed in the 
critical point dryer, next the temperature in the chamber was brought down to 4°C. 
Next the alcohol was flushed out of the chamber and replaced with liquid carbon 
dioxide. This was done in a series of “flushes” using the ‘MEDIUM IN’ and
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‘MEDIUM OUT’ control buttons and observing the liquid level changes through 
the chamber ‘window’. Once the liquid carbon dioxide replacement was complete 
and no alcohol remained in the chamber, the heating process began. The 
temperature inside the chamber was brought up to 37°C and the pressure 
brought up to 80 BAR. This took up to 60 minutes, with some fluctuations in 
pressure, before completion. The ‘critical point’ drying condition was achieved and 
maintained for approximately two hours, before slowly reducing the pressure 
down to 0 BAR. The samples were left in the critical point dryer overnight (~ 12 
hours).
3.3.3.3 M o u n tin g
The CPD membranes were examined using a stereoscope to deduce the side of 
the membrane that contained the cells. The dried membrane was placed cell side 
up onto a double-adhesive sided ‘carbon tab’ which was placed on to the surface 
of a SEM sample stub (metal, 12 mm).
3.3.3.4 S pu tter  C o a tin g
The SEM sample stubs were placed into ‘holding slots’ inside the chamber of a 
sputter coater (AE1231, EMScope). The top was placed onto the sputter coater 
chamber and a tank of Argon gas was turned on to replace the air in the chamber. 
Once the air was replaced by Argon, the coating process was initiated. Inside the 
chamber, a ‘cloud’ of gold particles was generated and spread across the 
specimens, forming a layer or ‘plating’ the specimen with approximately 0.5 pm 
thick layer of gold. After the sputter coating took place, the vacuum inside the 
chamber was released and the coated specimens removed from the sputter 
coater and ready for observation in the SEM.
3.4 RESULTS
3.4.1 L ig h t  M ic r o s c o py
NHBE cells were prepared for LM using standard techniques (Section 3.3.1). The 
cells were stained with H & E to reveal their general cellular organization and 
stained with toludine blue which enabled closer inspection of the sub-cellular 
organisation. LM preparations were made over the 36-day growth interval and 
samples from the key stages of cell culture development were collected for 
morphological assessment (Figures 3.1-3.6).
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3.4.1.1 M o r p h o g e n e s is : Da ys  1 -15
NHBE cells prepared from day 1 inserts demonstrated patchy adherence (i.e. 
gaps between cells), but general cellular integrity was verified as observed by 
intact cellular membranes and nuclear components (Figure 3.1 (a)). There were 
no noticeable tight junction formations, as determined by the inter-cellular gaps 
(Figure 3.1 (a)). By day 6, the intercellular gaps were no longer present, 
suggesting the formation of intercellular junctions. The cultures also displayed two 
distinctive cell layers (Figure 3.2 (a)), and three cell layers were apparent in the 
semi-thin sections (Figure 3.2 (b)). With regard to the intracellular organisation of 
the cells, at the H & E staining level only the cytoplasm (pink) and nuclear (blue 
colour) compartments were visible. However, the thinner toludine blue sections 
revealed vacuoles and/or vesicle like bodies in the cytoplasm and the nucleolus in 
some of the nuclei. The semi-thin sections also made evident numerous and 
diffuse interdigitations around all the cells. By day 15, cilia could be observed on 
the apical surface of the culture, although individual cilia were not clearly defined 
in the H & E sections (Figure 3.3 (a)). On day 15, as well as in consequent days, 
basal cells could be identified at the posterior or ‘basal’ surface of the culture, as 
denoted by their flattened appearance (Figure 3.3 (a)). Intermediate cells were 
also present at the suprabasal level in the tissue, i.e. between the apical and the 
basal levels (Figure 3.3 (b)). The semi-thins revealed dark staining bodies near 
the apical surface of the cultures (Figure 3.3 (b)), that may have been precursors 
of cilia.
3.4.1 .2  M o r p h o g e n e s is : Da ys  24  - 36
In the day 24 cultures, refractive bodies were observed in the apical region of the 
cells, representative of mucin filled vacuoles (Figure 3.4 (b)). These structures 
appeared as darkly staining bodies in the semi-thin images (Figure 3.4 (b)). The 
day 27 cultures revealed distinctive pseudo-stratification of three cell layers 
(Figure 3.4 (a)). In the subsequent cell culture days, i.e. 30 to 36, there did not 
appear to be any further developmental changes taking place (Figure 3.5 (b) and 
Figure 3.6 (b)).
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Figure 3.1 Light microscope images of passage 3 NHBE cells grown in ALI at day 1, the 
one measurement bar applies to both images (a) H & E stained cells; the cells form a 
mono-layer on the membrane but continuous intercellular junctions between all cells was 
not apparent. The general cellular organisation shown included the cytoplasm (pink) and 
the nucleus (blue) components, (b) Toluidine blue stained cells; the increased level of 
image resolution permitted more detailed observations of subcellular organisation, 
whereby the nucleolus and cytoplasmic vacuoles and vesicles could be discerned, as 
well as plasma membrane appendages.
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Figure 3.2 Light microscope images of passage 3 NHBE cells grown in ALI culture at day 
6, the one measurement bar applies to both images (a) H & E stained cells; cells have 
formed a confluent, at least bilayered culture, and intercellular junctions have formed, (b) 
Toluidine blue stained cells; three layers of cells can be identified in the tissue, along with 
inter-digitations between and around all cells in each layer. Cytoplasmic vesicles were 
prominent in all cells and plasma membrane protrusions were evident on the apical 
surface of the cells in the external (or top) tissue layer. N = nucleus; PM = plasma 
membrane.
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Figure 3.3 Light microscope images of passage 3 NHBE cells grown in ALI culture at day 
15, the one measurement bar applies to both images (a) H & E stained cells microvilli 
have become visible in the form of a ‘blurry’ region on the apical surface of the tissue 
culture. Basal cells can now be observed in the posterior surface of the tissue, (b) 
Toluidine blue stained cells; three cell layers could be identified which now included the 
apical, suprabasal and basal levels. Intermediate cells have developed above the basal 
cells and below the goblet and ciliated cells. B = basal cell ; CP = cilia precursor; I = 
intermediate; MG = mucin granules.
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Apical surface
 suprabasal region
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Figure 3.4 Light microscope images of passage 3 NHBE cells grown in ALI culture at day 
24, the one measurement bar applies to both images, where the measurement bar 
applies to both images (a) H & E stained cells; refractive bodies were observed in the 
suprabasal and apical regions of the tissue, (b) Toluidine blue stained cells; darkly 
stained bodies identified at the apical surface may be either mucin granules or cilia 
precursors.
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Cilia
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Figure 3.5 Light microscope images of passage 3 NHBE cells grown in ALI culture at day 
27, the one measurement bar applies to both images (a) H & E stained cells; three cell 
layers were present and more definite apical protrusions appear to be cilia, (b) Toluidine 
blue stained cells; columnar shaped goblet cells can be identified. G = goblet cell.
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Mucin release ?
Figure 3.6 Light microscope images of passage 3 NHBE cells grown in ALI culture at day 
36, the one measurement bar applies to both images (a) H & E stained cells; a single 
cluster of cilia can be identified. (b) Toluidine blue stained cells; no apparent 
developmental or morphological changes could be discerned when compared to day 27. 
One raised region at the apical surface could indicate a goblet cell expelling mucin at the 
apical surface.
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DAY 1 DAYS 3- 6 DAYS 6 - 12 DAYS 12 -15 DAYS 18 -27 DAYS 30 - 36
Epithelial Integrity
(TEE I R , 45 1891 3729 4444 5374 4150
Cell Viability
(Absorbance) 0.5 0.5 1.22 1.74 1.58 1.89
Secreted Protein
(jjg/ml) 0.83 pg/ml 1.63 pg/ml 7.89 pg/ml 12.90 pg/ml 11.93 pg/ml 11.17 pg/ml
Ultrastructural
changes
(LM & TEM)
• 1 cell layer 
•Adherence to
membrane
• Incomplete 
intercellular 
junction 
formation
• Lacking 
distinctive 
organelles
• 2 cell layers.
• Membrane 
bound 
organelles 
present
• Formation of 
intercellular 
junctions
• Microvilli 
observed
• Goblet cell 
formation
• Mucin 
granules and 
vacuoles 
observed
• Intercellular 
interdigitations 
observed
• 3 cell layers
• Formation of 
cilia
• Differentiation 
of ciliated, 
Goblet and 
basal cells
• Ciliated cells 
displayed 
columnar 
shape.
•After day 36, 
vacuoles were 
observed and 
deterioration 
of culture
Surface
Morphology
(SEM)
•Adherent cells, 
rounded in 
centre, 
covered with 
micovilli
• Cells
Octagonal and 
hexagonal in 
shape
• Gaps between 
cells
• Cells 
displayed a 
more 
flattened 
appearance 
with jagged 
edges
• Evidence of 
intercellular 
junction 
formation
• Lines of 
raised 
microvilli 
delineated 
individual 
cells
• Surface of 
cells covered 
with evenly 
distributed 
microvilli
• Cilia observed • On day 27 many 
ciliated cells 
were observed
• Cell culture 
surface
exhibited varied 
morpholohgy
•After day 36, 
cultures 
exhibited less 
variation or 
differentiation
Table 3.1: Table comparing biochemical data (Chapter 2) and morphological changes of the passage 3 NHBE cell cultures grown on Insert 
membranes in an ALI.
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3.4.2 T r a n sm iss io n  E lec tr o n  M ic r o s c o py
TEM was used to compliment the LM findings, especially with regard to the fine 
ultrastructural details of cells, e.g. tight junctions (TJ), ciliogenesis and mucin 
granule formation (Table 3.1).
M o r p h o g e n e s is : Da ys  1 - 9
Day 1 TEM images showed a single layer of cells, which appeared to have 
adhered to the membrane, but had not formed complete intercellular junctions 
(Figure 3.7). The NHBE cells exhibited typical eukaryotic cellular organization 
(e.g. nucleus, vacuoles, etc.) and were covered in apical surface protrusions. 
Individual cells were separated from others with gaps of empty space, in these 
spaces cellular protrusions or pseudopodia type structures appeared to ‘reach 
out’ toward neighbouring cells. In some areas these protrusions could be seen as 
‘coming together’, with neighbouring cells in some cases overlapping or forming a 
secondary layer with protrusions between intercellular gaps (Figure 3.7 (b) and 
(c)). By day 3, intercellular junctions were visible and the initiation of ciliogenesis 
was evident in the formation of microvilli, in the first instance (Figure 3.8 (a) and 
(b)). By day 6, tight junctions near the apical surface of the culture, and 
mitochondria and mucin granules were identified (Figure 3.9 (b) and (c)). Goblet 
cells could be distinguished by their so called ‘goblet’ shape and abundance of 
mucin granules (Figure 3.9 (a)). It was also apparent in day 6 TEM images that a 
two-layer culture had developed (Figure 3.9 (a)). Day 9 TEMs revealed the 
formation of a desmosome junction, present in the mid-basal region, between a 
basal cell and an intermediate cell (Figure 3.10 (d)).
M o r p h o g e n e s is : Da ys  1 2 - 3 4
By day 12, intercellular junctions could be seen as apparent membrane bound 
gaps and links between cells (Figure 3.11 (b)), as well as complex series of ‘inter- 
digitations’ (Figure 3.11 (c)). The day 12 TEMs revealed the presence of rounded, 
darkly-staining structures below the apical surface that could be basal bodies 
leading to the formation of cilia (Figure 3.11 (d)). The day 15 TEM images 
illustrated the development of cilia, as the internal microtubular structures of the 
cilia could be observed (Figure 3.12 (d)). By day 18, ciliogenesis had taken place 
and cilia could be distinguished from the microvillus by their larger size (e.g. > 1 
pm but < 10 pm); (Figure 3.19 (d)). Day 18 TEM images also suggested that
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Figure 3.7 TEM images of passage 3 NHBE cells growing in an ALI at day 1. (a) Overall view of 
an individual NHBE cell adherent to the culture membrane. NHBE cell exhibited typical eukaryotic 
cellular organization (e.g. nucleus, vacuoles, etc.) and covered in apical surface protrusions, (b) 
Overall view showing that some individual cells were separated from others with gaps of empty 
space, in these spaces cellular protrusions or pseudopodia type structures appear to ‘reach out’ 
toward neighbouring cells. In some areas these protrusions appeared to be coming together, (c) 
Overall view showing neighbouring cells in some cases overlapping or forming a secondary layer 
with protrusions between intercellular gaps, (d) A closer view of the apical surface displaying 
cellular protrusions, perhaps developing microvilli.
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Figure 3.8 TEM images of passage 3 NHBE cells growing in an ALI at day 3. (a) Overall view of 
cellular organization at lower magnification, demonstrating the polarity of the NHBE ALI model 
with a layer of adherent cells growing on the insert membrane (basal surface) and the apical 
surface denoted by cell surface protrusions. Cultures appear to be two to three cell layers thick 
with all cells merged in a cohesive or confluent manner, with only small gaps between cells or cell 
layers. Basal cells can be distinguished from intermediate cells, as they were found at the base of 
the culture. Intermediate cells were found above the basal cells and were yet to be defined or 
differentiated. 1C = Intermediate cell, BC = Basal cell, (b) Apical surface displaying cell surface 
protrusions or microvillus. MV = microvillus, (c) Tight junctions were forming close to the apical 
surface between cells, as well as adherent junctions below the tight junctions. TJ = tight junction; 
AJ = adherent junction, (d) Interdigitations or convoluted lamellae-like membranes were present 
between cells and with adherent junctions.
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Figure 3.9 TEM images of passage 3 NHBE cells growing in an ALI at day 6. (a) Overall view of 
the tissue culture. Goblet cells were now distinguished by a number of characteristics including 
shape and the existence of mucin vacuoles. GC = goblet cell; BC = basal cell; 1C = Intermediate 
cell, (b) Tight junctions were observed between cells, just below the apical surface, and 
interdigitations were apparent beneath the tight junctions. Microvillus could also be identified. TJ = 
tight junction; MV = microvilli; ID = interdigitations. (c) Mucin vacuoles appeared as lightly 
coloured circular objects within the goblet cells and close to the apical surface, mitochondria were 
also distinguishable. TJ = tight junction; MV = microvillus, (d) Goblet cell shown.
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Figure 3.10 TEM Images of passage 3 NHBE cells growing in an ALI at day 9. (a) Overall view of 
tissue culture, two to three layers thick with what appeared to be differentiated goblet cells. GC = 
goblet cell; IC = intermediate cell, (b) A closer view of the apical surface with microvillus, (c) Apical 
surface view with microvillus tight junctions and adherent junctions. TJ = tight junctions; AJ = 
adherent junctions, (d) Linder higher magnification, a desmosome junction, found at the mid-basal 
surface or zone.
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300 nm
Figure 3.11 TEM images of passage 3 NHBE cells growing in an ALI at day 12. (a) Overall view 
of tissue culture, (b) A closer view of the apical surface with microvillus, tight junctions and 
adherent junctions. TJ = tight junctions; AJ = adherent junctions, (c) Intercellular interdigitations. 
ID = interdigitations. (d) Dark circular structures seen just under the apical surface, which may be 
basal bodies or the possible precursors to cilia.
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Figure 3.12 TEM images of passage 3 NHBE cells growing in an ALI at day 15. (a) Overall view 
of tissue culture showing some cells which had a more columnar shape, (b) Overall view with a 
ciliated cell visible, (c) A closer view of the apical surface with microvillus, tight junctions and 
adherent junctions. TJ = tight junction; AJ = adherent junction, (d) A closer view of the cilia with 
internal microtubules evident.
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Figure 3.13 TEM images of passage 3 NHBE cells growing in an ALI at day 18. (a) Overall view, 
(b) Microvillus and tight junction, (c) Mucin vacuoles and apparent mucin release, (d) On the 
apical surface microvilli can be distinguished from cilia where basal bodies, just under the apical 
surface, and internal microtubules were evident. BB = basal bodies.
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Figure 3.14 TEM images of passage 3 NHBE cells growing in an ALI at day 27. (a) Overall view 
with goblet cells and microvilli visible, (b) Overall view with a ciliated cell clearly distinguishable. 
CC = ciliated cell, (c) Microvillus with a tight junction. TJ = tight junction (d) Cilia and microvilli. MV 
= microvilli.
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Figure 3.15 TEM images of passage 3 NHBE cells growing in an ALI at day 30 and day 33. (a) 
Goblet cell with mucin vacuoles releasing mucin at day 30. (b) Cilia with internal microtubules 
visible at day 30. (c) Overall view with ciliated cell revealing pronounced columnar and cuboidal 
cell organisations at day 33. CC = ciliated cell, (d) Inter-cellular interdigitations were less 
extended (i.e. less bilateral) in well differentiated cells at day 33.
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Figure 3.16 TEM images of Passage 3 NHBE cells growing in an ALI at Day 36. (b) Overall view 
with a number of large vacuoles present.
mucin vacuoles merge with the apical surface to release mucin (Figure 3.13 (c)). 
By day 21, the ciliated cells were now distinguishable from the goblet cells, which 
had only microvilli on their apical surface and darkly staining mucin granules. Day 
27 TEM images illustrated differentiated cultures with ciliated and goblet cells 
clearly identifiable (Figure 3.14 (a) and (b)). Day 30 images demonstrated goblet 
cells protruding above the apical surface with numerous mucin granules (Figure 
3.13 (a)). By Day 33, the ciliated cells had taken on a more columnar shape with 
many apparent intercellular interdigitations visible (Figure 3.15 (c) and (d)). Day 
36 TEM images revealed numerous intercellular vacuoles, less well-differentiated 
cell cultures, with no ciliated cells distinguished (Figure 3.16).
3.4.3 S canning  Electron  M ic r o sco py
SEM was used to evaluate the 3 dimensional organization of the cell model, more 
specifically on the surface level. SEM preparations were made over the 36 day 
growth interval from the key stages of cell culture development for surface 
morphology assessment (Figures 3.17 -  3.24). The tissue images were compared 
in terms of the shapes and physical characteristics of individual cells, as well as 
any observed connections between cells. The cultures were also examined in 
terms of the variety of cell types present and numbers of ciliated versus 
undifferentiated or other cell types. The only images shown are those from days 
where notable morphological changes had occurred, i.e. 1, 6, 12, 15, 24, 27, 33, 
and 36.
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3.4.3.1 Morphogenesis: Days 1 -6
On day 1 (Figure 3.17), the cells had adhered to the membrane. The cells had 
spaces or gaps between them, and individual cells were rounded in their centre 
and exhibited octagonal and hexagonal type shapes. The apical surfaces 
appeared to be covered in a dense network of microvilli. On days 3 and 6, (Figure 
3.18), the cells were more flat, with jagged edges, and were not connected to one 
another. The microvilli were less dense when compared to cells on day 1.
3.4.3.2 Morphogenesis: Days 9 - 1 2
On Days 9 and 12, (Figure 3.19), lines of dense and raised microvilli had formed 
and acted to delineate individual cells. Individual cells displayed distinctly 
octagonal and hexagonal shapes. Microvilli exhibited uniform distribution across 
the cell surfaces and at higher magnification displayed rounded apical ends.
3.4.3.3 Morphogenesis: Day 15 -24
On day 15, (Figure 3.20), a number of cells developed cilia. At the higher 
magnifications, the cilia were observed as thicker and longer structures then the 
microvilli. The ciliated cells appeared to have microvilli interspersed between 
them. On days 18 through 24 the numbers of differentiated cells increased. Some 
of the cells exhibited patterns of raised or tufted cilia. On day 24 ciliated cells 
appeared in groups of two or three (Figure 3.21).
3.4.3.4 Morphogenesis: Day 27 - 36
On day 27, (Figure 3.22), there were greater numbers of ciliated cells. The 
undifferentiated were flatter and had a larger surface area. Also seen on day 24 
were spherical balls which appeared to be ‘packets’ of mucus secreted from 
mucus secreting cells. On day 30 there were a variety of cell types present. Some 
cells had ‘tufted’ or raised dense structures that did not look like cilia or microvili. 
On Day 33, (Figure 3.23), mucus secreting cells could be identified by their balls 
of mucus. There were also cells with the brush-like structures. On Day 36 (Figure 
3.24), the cultures had a small number of ciliated cells and most of the cells were 
flattened (i.e. depressed) and undefined.
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Figure 3.17 SEM images of passage 3 NHBE cells growing in ALI at day 1. (a) The 
individual cells were attached to the insert membrane, (b) Individual cells appeared 
rounded towards the centre and had octagonal and hexagonal type shapes, (c) There 
were intercellular gaps between cells, (d) The cells were covered with a dense network of 
microvilli with uniform shape and length.
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F ig u re  3 .18  SEM images of passage 3 NHBE cells, growing in an ALI on day 6. (a) The 
jagged edges of what now look like groups of cells remained visible, (b) Microvilli were 
visible across the cell surfaces, (c) Filamentous structures or connections appeared to be 
forming between cells, (d) The microvilli remained less dense then observed on day 1.
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Figure 3.19 SEM images of passage 3 NHBE cells, growing in an ALI at day 12. (a) A 
number of cells appeared ‘raised’. Some cells had a greater concentration of microvilli 
then others (as shown by circle), (b) and (c) Individual cells were delineated by distinctive 
‘lines’ of dense microvilli, just inside the dotted lines shown, (d) The microvilli covering 
individual cell surfaces exhibited a uniform distribution and were rounded on the apical 
ends.
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Figure 3.20 SEM images of passage 3 NHBE cells growing in an ALI at day 15. (a) and 
(b) A number of the cells developed cilia (circled), (c) The cilia could be seen as thicker 
and longer structures then the microvilli, (d) The cells with the developing cilia had 
microvilli between their cilium.
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Figure 3.21 SEM images of passage 3 NHBE cells, growing in an ALI at day 24. (a) A 
greater number developed into ciliated and goblet cells, (c) Ciliated cells were distinctly 
raised when compared to the goblet cell, (d) The ciliated cell surface exhibited microvilli 
surrounding the cilia.
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Figure 3.22 SEM images of passage 3 NHBE cells, growing in an ALI at day 27. (a) 
Greater numbers of cells showed signs of differentiation, (b) Cells with larger surface 
areas were flatter and undifferentiated, (c) Ciliated cells and goblet cells (mucus 
secreting cells) were distinctive. Balls or spherical ‘packets’ of mucin were evident, (d) 
Two spherical balls of mucin are circled.
Tracy Hughes 109
CHAPTER THREE MORPHOLOGICAL CHARACTERISATION
(b)
10 jjm
id)-
M R
2 nm
Figure 3.23 SEM images of passage 3 NHBE cells, growing in an ALI at day 33. (a) The 
surface of the tissue was varied, with a variety of cell types, (b) Cells were covered with a 
regular pattern of ‘tufted’ microvilli, as well as smaller cells with larger ‘brush-like’ 
structures, (c) A number of spherical balls of mucin were observed, (d) Cilium were 
surrounded by and could be distinguished from microvilli.
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Figure 3.24 SEM images of passage 3 NHBE cells, growing in an ALI at day 36. (a) The 
majority of cells were larger in surface area, flat and less distinctive, (undifferentiated), (b) 
and (c) Ciliated cells were observed surrounded by undifferentiated cells.
Tracy Hughes 111
v 'H A K  ! h K ! H R L b  M ) ! \ P H O 1.0  ( \ i . t I • .k.AC ’ L K iH A . [ ! O N
3.4.4 In Vivo M o rp h o lo g y  V e rs u s  NHBE C e l l  C u ltu r e  M o rp h o lo g y  
The morphology exhibited by the NHBE cells in ALI cultures were compared to 
the human in vivo respiratory epithelium (e.g. Rhodin 1966 and Jeffery and Li 
1997). The key morphological features to note in order to establish working 
parallels between the in vivo situation and the NHBE model system included: 
ciliated, goblet, basal, and intermediate cells (Figures 3.26 -  3.28). The human 
tracheo-bronchial epithelium (TBE), as observed via TEM and excised from its in 
vivo situation, displayed similar organisation of these three principle cell types, 
when compared to TEM images of the cellular organisation of the NHBE cell 
model in ALI (Figures 3.25 to Figure 3.27). SEM images of both the human TBE 
in vivo (Jeffery and Li 1997) and the passage 3 NHBE cells grown in the ALI were 
used to compare surface morphology (Figure 3.28).
3.5 D isc u ssio n
It was necessary to determine the corresponding morphological changes that took 
place in the NHBE cell cultures during growth and development to compliment the 
biochemical characterization (i.e. Chapter 2).
3.5.1 L ig h t M ic ro s c o p y  an d  Transm ission  E le c t r o n  M ic ro s co p y
The initial use of LM enabled the observation of general cellular organization at a 
microscopic but not sub-micron level. It was possible to discern the nuclear 
compartments, some vesicles and mucin granules (refractive bodies). LM 
observation also revealed the various stages of cell culture differentiation from 
day 1 to 36. Most notable, one could distinguish between mono-layered adherent 
cells that lacked intercellular gaps and undefined phenotypes to well-differentiated 
mucociliary phenotypes. The use of TEM permitted confirmation of the formation 
of organelles, junctions between cells, and the precise time line of differentiation 
from an undefined cellular monolayer to a well defined pseudo-stratified layer of 
cells.
The LM and TEM information provided a thorough morphological survey 
throughout the developmental and differentiation process of the passage 3 NHBE 
cells growing on the Transwell™ inserts in an ALI. Upon comparison with the
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Figures 3.25 A comparison of human in vivo tracheobronchial tissues, and in vitro 
engineered NHBE primary cell tissue, (a) Human tracheobronchial tissue (magnification, 
X 1,400) (Rhodin 1966). (b) Pulmonary surface epithelium and the underlying lamina 
propria (Jefferey & Li 1997). (c) TEM image of passage 3 NHBE cells growing in an ALI 
at day 31. (d) TEM image of passage 3 NHBE cells growing in an ALI at day 27. GC = 
goblet cell; CC = ciliated cell; BC = basal cell; MC = mucous cell; IC = intermediate cell; V 
= a bronchial vessel; M = mast cell.
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Figure 3.26 A comparison of human in vivo tracheobronchial tissue and in vitro 
engineered NHBE primary cell tissue, (a) Human ‘mucous cell’ (magnification, X 12,000) 
(Rhodin 1966). (b) TEM image of a passage 3 NHBE cells growing in an ALI at day 31. 
(c) Human ciliated cell (magnification, X 9,500) (Rhodin 1966). (d) TEM image of 
passage 3 NHBE cells growing in an ALI at day 27. CC = ciliated cell; GC = goblet cell; 
MG = mucin granules; MC = mucous cell; MV = microvillus.
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Figure 3.27 A comparison of human in vivo tracheobronchial tissue, and in vitro 
engineered NHBE primary cell tissue, (a) Human Transitional cell, “with characteristics of 
both a ciliated and a mucous producing cell (Jeffery and Li 1997). (b) TEM image of 
passage 3 NHBE cells growing in an ALI at day 31. (c) Human intermediate cell 
(Magnification, X 1,400) (Rhodin, 1966). (d) TEM image of NHBE cells growing in an ALI 
at day 24. IC = intermediate cell; BC = basal cell.
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Figure 3.28 SEM images of; (a) The human bronchial epithelium (Jeffery and Li 1997). 
and (b) SEM image of passage 3 NHBE cells growing in an ALI at day 33.
biochemical observations previously established (Chapter 2), there were 
examples of a direct relationship between morphological data and the 
biochemical counterpart. For example, the formation of tight junctions observed 
using TEM at day 6, corresponded directly to a very large increase in average 
TEER values between day 1 and days 3 through 6 (42 times greater). The 
formation of goblet cells observed between days 6 through 12 related to 
increases in secreted protein from the same time interval (9.5 times greater). 
Following day 12, there were not great changes in the biochemical values of 
average TEER, cell viability and apical wash proteins, despite the observed 
(TEM) morphological changes. Taking into consideration the detailed intracellular 
structures, the point at which the morphological differentiation process appeared 
to be completed would be between days 24 and 27. The LM and TEM data would 
suggest that toxicological experimentation might be best performed after 
complete differentiation has occurred, i.e. day 24. Gray et ai, demonstrated that 
passage 2 and 3 NHBE cells showed the greatest TEER and ciliogenesis on day 
18 in ALI (Gray et at., 1996). Krunkosky et at. grew passage two NHBE cells in 
inserts. These cells were grown submerged for 5 to 10 days and then in ALI 
conditions. These cultures demonstrated cilia formation after approximately two 
weeks in ALI (Krunkosky et a!., 2007).
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3.5.2 Scanning  Electron M icroscopy
The SEM provided a survey of the surface characteristics of the cell culture, from 
which the differentiation of cell types and the numbers of ciliated versus mucous- 
secreting cells could be seen. The surface morphology of the NHBE cell culture 
was very distinctive and could not be clearly discerned using TEM alone. For 
example, on day 1, the cells appeared to be covered in dense microvilli which 
were not seen in the LM or TEM images. On days 3 and 6, the cell borders 
exhibited jagged edges and the microvilli on the surface were less dense then on 
day 1. At day 6, filamentous structures or connections formed between cells (i.e. 
pseudopodia). These apparent connections corresponded to increases in TEER  
values. On days 9 and 12, the cell culture surface morphology revealed that the 
cells had joined together with a flat surface covered with microvilli type structures. 
Distinctive raised ‘lines’ delineated the individual cells; these lines had not been 
seen in the LM or TEM images. On day 15, the SEM images demonstrated the 
first appearance of cells with longer projections (or cilia). This corresponded to the 
time-points when they were first viewed via LM (day 15) and TEM (day 18). The 
ciliated cells also had smaller apparent surface areas, when compared to those 
cells which had flatter and less distinct surface areas (i.e. goblet cells or 
undifferentiated cells).
The SEM data also provided an estimate of the comparative numbers of ciliated 
to non-ciliated cells. The number of ciliated cells were observed to increase 
between days 15 and 33, with approximately a 3:1 ratio of non-ciliated to ciliated 
cells on day 33. On day 30, at the higher magnifications, branched clumps of 
microvilli were evident. These structures looked to be distinctively different from 
the cilia, in that they were multiple-branched structures or brush-like. These may 
be representing microvilli undergoing ciliogenesis. Another possible cell type was 
the ‘brush’ cells, which have been described as having microvilli which were taller, 
wider and more uniform, and contained more prominent intercellular axial 
filaments than the microvilli of goblet cells or potential ciliated cells (Breeze, 
1997). These structures had not been noted in LM or TEM images. On day 33, 
the surface of the tissue appeared to be much less flat and undefined than on any 
other time points previous to this. The surface looked very complex with a great 
variety of types of cells, including ciliated cells, and mucus secreting cells. After
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day 33 the surface morphology changed to a flatter surface with fewer distinctive 
cells types, denoting the demise of the cell culture.
3.5.3 In  Viv o  M o rp h o lo g y  V e rs u s  NHBE C e l l  C u lt u r e  M o rp h o lo g y
We compared the overall tissue morphology of the human TB tissue in vivo 
versus the NHBE cell cultures. The two displayed a similar cellular architecture, 
where the cells were differentiated into ciliated and mucus-secreting cells. 
However, the human in vivo tissue showed more columnar shaped cells. When 
comparing individual cell types, one could observe close similarities between 
human in vivo respiratory cell types and those found in the NHBE cell cultures. 
TEM images of excised human ciliated cells, transitional cells and intermediate 
cells, respectively, demonstrated parallel morphology to their ALI counter-parts 
(Rhodin, 1966). Finally, SEM images of both the human TB epithelium in vivo 
(Jeffery and Li 1997), and the NHBE cells grown in the ALI, demonstrated a 
similar pattern or surface morphology or organization.
3.6 C o n c lu sio n s
When comparing microscope images of the human TB tissue in vivo, to the NHBE 
cell culture model, a parallel overall structural morphology was observed. These 
morphological similarities suggested that the NHBE cell model is a suitable 
system to explore morphological (and biochemical Chapter 2) changes which 
might occur due to exposure of the tissue to inhaled toxicants. Morphological 
analysis in conjunction with biochemical characterization, demonstrate that dosing 
of the tissue should be performed between days 24 and 33, when tissues reached 
a steady maturation state. Comparative microscopy provided an additional means 
of validation of the model and were used in following toxicological experiments 
with commercial polymers.
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4.0 In t r o d u c t io n
In this chapter the term dosing refers to exposure of the NHBE tissue model at the 
apical surface (i.e. the air-liquid-interface; ALI) to exogenous material in the form of 
commercial synthetic polymers. The polymers used in these experiments were of 
interest to the Unilever corporation (Unilever designated polymer numbers 
S2429901, S2218600, S221880 and S2219200). Toxicological studies on several 
of these polymers explored the histological effects to the alveolar region and 
effects on bronchial alveolar fluid components in rats (Carthew et al., 2002), as 
well as transcriptomic responses, in the rat lung (Carthew et a i, 2006). Also, other 
in vitro toxicology studies have shown these polymers to induce mild changes in 
cytokine expression (Grainger, 2008) which have been found to be specific to the 
cell type and culture used (Daly, 2008). A good correlation in the fibrogenic 
potential of the polymers both in vivo and in vitro has also been found (Gaiser, 
2007) although again the quality of the in vitro response is modulated by the cell 
culture used. This again highlights the relevance of developing and using a 
relevant cellular reporter system which responds in a manner which can be related 
to expected effects in the human lung.
The NHBE exposures were performed with the intent of stimulating the cell 
cultures into initiating protective or adaptive actions that might include: (1) up- 
regulation of the production of antioxidants, (2) cell signalling of pro-inflammatory 
cytokines, (3) apoptosis or cell proliferation. The cellular RNA could then be 
examined to explore any changes in gene expression that were associated with 
any of these events (Chapters 5 and 6). The toxic doses (TD) 5% and 20% (i.e. 
TD05 and TD20) for all polymer types were selected as the toxicological endpoints 
for the dosing experiments, in order to induce toxicological effects without resulting 
in total loss of viable tissue. The TD05 concentration of polymer reflects a 5% 
decrease in the ability of the cell cultures to metabolize MTT and TD20 a similar 
20% decrease. MTT has been used as a measure of cytotoxicity in a number of 
different cell models (i.e. embryonic carcinoma cells, Nojehdehian et al., 2009; Hep 
G2 cells and primary rat hepatocytes, Liu 2009), including the BEAS-2B cells 
(Schmid et a i, 2007) and the bronchial cultures cells (Balharry et a i, 2008; Sexton 
et al., 2008). Alterations to TEER values in NHBE cell cultures have been found 
inconsistent and to be dependent on the compound which is being applied to the 
culture (personal communication from Zoe Prythech, Cardiff University). Some
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compounds (i.e. LPS), cause TEER values to reduce dramatically at low doses 
indicating a loss of tissue integrity but no significant changes to metabolic activity 
and/or morphology were found in the cultures. Whereas with the application of 
compounds such as paraquat and whole cigarette smoke results in an increase in 
TEER at lower concentrations compared to controls (personal communication from 
Zoe Prythech, Cardiff University). Therefore due to variability observed in the 
TEER assay, the loss of MTT metabolism was considered to represent a loss of 
cellular activity and/or function and was chosen as a toxicological endpoint.
The histopathological effects of the TD05 and TD20 polymer treatments were 
examined using correlative transmission and scanning electron microscopy (TEM 
and SEM). In this way the toxicological endpoints could be associated with any 
morphological (phenotypic) alterations following polymer treatments. The 
histopathological alterations to NHBE cell cultures were examined following 
treatment with either phosphate buffered saline (PBS) solution or TD05 and TD20 
concentrations of the S 2219200 polymer suspended in PBS. Three of the four 
polymers were suspended in a water based carrier solution which also contained 
small percentages of solvents (i.e. 0.91%). Initial studies found that the effects of 
the carrier solutions alone at the percentages being tested had no significant 
effect. PBS solution was used as a control in the dosing experiments.
4.1 Aims o f  th e  C h a p te r
The aims of this chapter were:
•  Use conventional toxicology to evaluate the comparative toxicities four 
commercial polymers
• Use TEM and SEM to investigate the effects of the commercial polymer 
S2219200 on the in-house NHBE and commercial (EpiAirway™) cell culture 
models
• Identify phenotypic changes following commercial polymer S2219200 exposure 
which could be associated with a TD05 and TD20 dose
4.2  M a t e r ia ls
4.2.1 Stock Solutions
Sigma Dorset, UK
In Vitro Toxicology Assay Kit: MTT Based (cat TOX1-KT)
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Sigma Dorset, UK
Dulbecco’s Phosphate Buffered Saline (cat D8662)
Dimethyl Sulfoxide (cat 154938)
Thiazolyl Blue Tetrazolium Bromide (cat M2128)
Agar Scientific Stansted, UK
25% Glutaraldehyde (R1010)
Osmium Tetroxide (R1015)
200-mesh 3.05mm Copper Grid (G246)
Uranyl Acetate (2%) (R1260)
Sodium Cacodylate (R1102)
Araldite CY212 (R1040)
Carbon Adhesive Discs (G3347)
SEM Specimen Stubs (G301)
Reynolds Lead Citrate (R1210)
Propylene Oxide (R1080)
Unilever Corporation Bedfordshire, UK
Polymer A (S2429901), a white powder
Polymer B (S2218600), in carrier solution
LMW Polymer (S2218800), in carrier solution
HMW Polymer (S2219200), in carrier solution
Lonza Wokingham, UK
NHBE Primary Cells (cat CC2540)
MatTek Corporation Ashland, MA., USA
Epi-Airway™ Cells (cat AIR-100)
4.2.2 E q u ip m e n t
Leica Ltd. Milton Keynes, UK
Leica RM2135 Microtome
Leica EG1140 Embedding Centre
Vacuum Tissue Processor
DFC 320 Digital Camera
DM 2500 Phase Contrast Light Microscope
Phillips, UK Cambridge, UK
TEM 208
Dynex Technologies Inc. Chantilly, VA, USA
Opsys MR™
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Dynex Technologies Inc.
Microplate Reader 
Balzers
Critical Point Dryer (CPD 030)
EMScope Laboratories
Sputter Coater (Model Code AE1231)
Dynex Technologies 
Opsys MR-Dynex Microplate Reader 
World Precision Instruments 
ENDOHM-6 EndOhm Chamber 
Greiner Bio-One Ltd.
96-Well Plates (650161)
Thincerts™ Cell Culture Inserts (662641) 
Corning Life Sciences 
Costar Transwell® Cell Culture Inserts (3470) 
Millipore UK
Ashford, UK
Worthing, UK
Chantilly, VA, USA
Stevenage, U.K.
Balzers, Liechtenstein
Gloucestershire, UK
Watford, UK
Schipol-Rijk, Netherlands
Millicell® Cell Culture Inserts (PIHT 12R 48)
4.3 Methods
4.3.1 Dosing
Third passage NHBE cells grown in the ALI, were dosed after 30 days culture 
growth and development on PET (polyethyleneterephthalate) membranes (chapter 
2, section 2.3). Cell insert cultures were dosed with a wide range of concentrations 
(0 - 1,000 pg/cm3; 0 - 4,000 pg/cm3; 0 - 10,000 pg/cm3; 0 - 30,000 pg/cm3; 0 -
50,000 pg/cm3; 0 - 250,000 pg/cm3; 0 - 300,000 pg/cm3) of the four different 
polymers, (S2429901, S2218600, S2218800 and S2219200). In order to achieve a 
homogeneous distribution of the polymers at the ALI, they were suspended in PBS 
to obtain the desired polymer concentrations for dosing. Three of the four polymers 
were suspended in a water based carrier solution, and the exact formulations for 
the polymers in water based carrier solutions are found in Appendices 3 to 5. The 
powdered and solution-based polymers were added to the PBS prior to their use, 
and the resultant solutions shaken for one minute using a vortex mixer immediately 
before their application, to assure even mixing. Each insert was dosed with 50 pi of 
polymer/carrier/PBS solution applied to the apical cell culture surface. The inserts 
were placed back into the incubator and polymer solutions were left on the apical
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surface of the cell cultures for 24 hours or for a 24 hour dosing ‘exposure’. All of 
the preliminary dosing experiments were performed using Lonza donor 6F4181.
4.3.2 MTT M etabolic Activity Assay
Twenty four hour following application of the polymer solutions, the MTT assays 
were performed, using the method described in Chapter 2 (Section 2.3.5.2).
4.3.3 E le c t r o n  M ic ro s c o p y
Three different in-house NHBE donors were sub-cultured to day 30 in passage 3 at 
ALI conditions. These were then each dosed with the TD05 (2500 pg/ml) and 
TD20 (6590 pg/ml) S2219200 polymer concentrations. The same dose 
concentrations were also applied to the EpiAirway™ model for comparison. 
Separate dosing experiments were performed using the S2219200 polymer carrier 
solution diluted to an equivalent concentration to evaluate whether the carrier 
solution alone conferred any effect on the cell cultures. In separate experiments, 
the carrier solution was found to have no effect on the viability of the culture at up 
to a 25% carrier in PBS solution concentration (or 2.5% of carrier solvent), which 
was over twice the concentration of carrier in the TD20 polymer solution (data not 
shown).
Twenty four hours after dosing, inserts were either placed in 5% glutaraldehyde 
and refrigerated for TEM and SEM processing and examination or placed into RNA 
later and into the - 20 °C freezer for future RNA extraction and microarray analysis 
(Chapter 5). The EM sample processing and examination was performed 
according to the methods outlined in Chapter 3 (Sections 3.3.2-3.3.3).
4.4 RESULTS
4.4.1 P o ly m e r S2429901 Dosing
Five dosing ranges, of increasing concentrations, were used to determine the 
TD05 and TD20 value for polymer S2429901 (figure 4.1). Dose range 1 (0 to 4,000 
pg/ml) showed an increase in metabolism at higher concentrations, whereas dose 
range 2 (0 to 100,000 pg/ml) achieved a TD20 value between 0 and 10,000 pg/ml. 
The final dose range data is shown in figure 4.1. The TD05 concentration was 
approximately 1000 pg/ml and the TD20 concentration approximately 5,700 pg/ml.
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Polymer S2429901 MTT data
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Figure 4.1 MTT data as a percentage of control for the final dose range experiment (following 3 
preliminary dose range experiments) for polymer S2429901, where n = 3, TD05 = approximately 
1,000 pg/ml and TD20 = approximately 5, 700 pg/ml.
4.4.2 Po lym er  S 2218600 Dosing
Six dosing ranges, of increasing concentrations, were used to determine the TD05 
and TD20 value for polymer S2218600 (figure 4.2). Dose ranges 1, 2 and 3 
showed only slight increases in the cell culture metabolism. Dose 4 was repeated 
due to unexplained fluctuations. In order to narrow the concentration range, two 
additional dose experiments were performed. The TD05 value for dose 6 was 
approximately 1000 pg/ml and the TD20 value was approximately 5750 pg/ml.
4.4.3 P o lym er S 2218800 Dosing
Five dosing ranges, of increasing polymer concentrations, were used to determine 
the TD05 and TD20 values for the S2218800 (LMW) polymer (figure 4.3). The final 
dosing experimental data is shown in figure 4.3. Dose 5 derived a TD20 value of 
approximately 470 pg/ml and a TD05 concentration of approximately 140 pg/ml.
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Figure 4.2 MTT as a percentage of control for the final dosing range experiment for polymer 
S2218600, (following 5 preliminary dosing ranges), where n = 3, TD05 = approximately 1000pg/ml 
and TD20 = approximately 5750 pg/ml.
Polymer S2218800 MTT data
TD05120
TD20100
600 800 1000200 400
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Figure 4.3 MTT data as a percentage of control for the final dosing experiment (following 4 
preliminary dose range experiments), for polymer S2218800 where n = 3, TD05 = approximately 
140 pg/ml and a TD20 = approximately 470 pg/ml.
Tracy Hughes 126
CHAPTER FOUR: POLYMER DOSING EXPERIMENTS
Polymer S2219200 Dosing
140,
TD05
120
TD20
 ii
C  80
M TT A ssay60
20
93001000 2000 3000 4000 5000 6000 7000 8000
S2219200 polymer concentration (pg/ml)
Figure 4.4 MTT data as a percentage of control for the final dose range experiment (following 4 
preliminary dose range experiments) for polymer S2219200, where n = 3, TD05 = approx. 2,500 
pg/ml and TD20 = approx 6,590 pg/ml.
4.4.4 P o lym er S2219200 Dosing
Five dosing ranges, of increasing polymer concentrations, were used to determine 
the TD05 and TD20 values for the S2219200 polymer. Dose range 1 (0 to 3,000 
pg/ml) showed only a slight increase in viability in the higher ranges. Dose 2 
exhibited some fluctuation between 0 and 10,000 pg/ml, with a loss of viability 
followed by a rise. The final dose range (0 to 9,000 pg/ml) experimental results are 
shown in figure 4.4, with a TD20 concentration obtained at approximately 6,590 
pg/ml and a TD05 concentration of approximately 2,500 pg/ml.
4.4.5 C om parative P o lym er Toxic ity
The following table compares the TD05 and TD20 polymer concentrations for the 
four commercial polymers. Polymers S2429901 and S2218600 exhibited very 
similar concentrations for both the TD05 and TD20 target doses (Table 4.1). 
Polymer S2218800 inflicted the highest level of toxicity, or had the lowest 
concentration values for the TD05 and TD20 doses. Polymer S2219200 produced 
a higher concentration for the TD05 dose (versus the others), and a higher TD20 
concentration when compared to the S2429901 and S2218600 polymers.
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4.4.5.1 EM f o r  p o ly m e r S2219200 TD05 and TD20 D osing  
Electron micrograph images were taken using cell culture inserts, treated apically 
with TD05 (2,500 pg/ml) and TD20 (6,590 pg/ml) polymer S2219200 solutions. 
Three different donors for the in-house NHBE cells at passage 3 on day 30 were 
dosed. Electron micrograph images of the EpiAirway™ cells were also captured 
following the same dosing regime used for the in-house model.
POLYMER TD05 TD20
S2429901 1000 pg/ml 5700 pg/ml
S2218600 1000 pg/ml 5750 pg/ml
S2218800 140 pg/ml 470 pg/ml
S2219200 2500 pg/ml 6590 pg/ml
Table 4.1 A comparison of the TD05 and TD20 concentrations of four polymers based on data 
collected on passage 3 NHBE cell cultures on day 30 in the ALI.
4.4.5.1.1 TEM O b s e rv a tio n s
The PBS treated in-house NHBE tissue cultures (figure 4.6) revealed tissue 
morphology that was denoted by dilated intercellular gaps at the basolateral region 
of the tissue. The apical cell layer of tissue appeared undisturbed. The TD05 
S2219200 polymer-treated tissue cultures exhibited even greater gaps between 
basal and intermediate cell layers, as well as a loss of tissue structural conformity 
and the formation of internal cellular vacuoles. The TD20 S2219200 polymer- 
treated tissue cultures demonstrated cellular degradation, especially in the supra- 
basal region. In some cells (e.g., Figure 4.5 (f)) chromatin condensation was 
evident. The same morphological changes were observed in other in-house NHBE 
donors (i.e. Figure 4.6 (a) - (f)), as well as the EpiAirway™ tissue culture samples 
(Figure 4.7 (a) -  (f)), demonstrating an excellent correlation in the responses.
Tracy Hughes 128
CHAPTER FOUR: POLYMER DO:
Figure 4.5 TEM images of NHBE donor 7F1169, treated on day 30 in ALL (a) and (b) PBS treated 
samples exhibited degradation of intercellular junctions, (c) and (d) TD05 dose-treated samples 
revealing further degradation of intercellular junctions, (e) TD20 treated sample demonstrating a 
loss of viable cellular architecture, (f) TD20 dose-treated sample suggesting cytoplasmic blebbing 
(circled) or chromatin condensation.
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Figure 4.6 TEM images of NHBE donor 6F4181, treated on day 30 in ALL (a) and (b) PBS treated 
samples exhibited dilated intercellular gaps at the basolateral region of the tissue, (c) TD05 dose 
sample, revealing regional hypertrophy and increased vacuolation (circled), (d) TD05 dose-treated 
sample demonstrating large intercellular gaps and possible changes in cellular development, (e) 
TD20 dose-treated sample exhibiting signs of cytolysis or cytoplasmic release and a breakdown of 
cellular structure, (f) TD20 dose-treated sample showing possible evidence of lipid vacuolation.
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Figure 4.7 TEM images of EpiAirway™ NHBE treated cells growing in ALI. (a) and (b) PBS treated 
samples demonstrated expansions to suprabasal intercellular gaps, as well as vacuole formation, 
(c) and (d) TD05 treated samples revealing larger gaps between cell layers or intercellular gap 
degradation and apical cells containing large nuclei, suggestive of reactive cell synthesis; N = 
nucleus, (e) and (f) TD20 dose-treated samples with regional hypertrophy at the apical surface and 
changes in basal cell development or hyperplasia; RH = regional hypertrophy, BH = basal 
hyperplasia.
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4 .4 .5 .1 .2  SEM O b se r va tio n s
The PBS treated in-house NHBE tissue cultures demonstrated an undulating 
apical surface, demarcated by ciliated and goblet cell populations (Figure 4.8 (a) 
and (b)). The borders between cells were denoted by populations of raised 
microvilli (Figures 4.8, 4.9 -  4.10). The TD05 S2219200 polymer treated samples 
revealed that the surface morphology had altered when compared to the control 
(or PBS tissue), in terms of an apparent smaller number (or ratio) of ciliated cells 
versus goblet cell types (e.g., Figure 4.8). The loss of the ciliated cell population 
was also observed in the TD20 S2219200 polymer treated tissue cultures (Figure 
4.8 -  4.10). The surface morphology exhibited a breakdown in cellular structures 
and the appearance of cells sloughing off the surface of the tissue (Figure 4.9 (e) 
and (f)). The EpiAirway™ tissue culture sample (Figure 4.10), demonstrated 
similar responses but to a greater effect, with surface area swelling and the 
formation of intercellular gaps (Figure 4.10 (c) - (f)).
4.5  D isc u ssio n
Four different commercial polymers (along with their carrier vehicles), were tested 
using conventional toxicology: (1) polymer S2429901, (2) polymer S2218600, (3) 
polymer S2218800, a low molecular weight polymer; and (4) polymer S2219200, a 
high molecular weight polymer. These four polymers had different chemical 
formulas and weights and varied toxicological profiles in vivo. Therefore, we 
hypothesised that they exerted equally heterogeneous effects on the NHBE cells in 
vitro. When stimulating protective mechanisms, care was taken not to inflict drastic 
or irreversible damage, or to kill the majority of cells in culture. Experiments were 
performed to determine the toxic dose concentration at which 5% of the cellular 
metabolic activity was lost (TD05), and toxic dose concentration at which 20% of 
the cellular metabolic activity was lost (TD20) for the different individual polymers. 
In order to determine these respective concentrations for the four polymers (and 
their carriers), a series of conventional toxicology experiments were performed, 
beginning with a wide-range of polymer solution concentrations. Successive 
dosing experiments were then conducted to narrow the concentration ranges, with 
the result of attaining more precise TD05 and TD20 values for the different 
polymer solutions.
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Figure 4.8 SEM images of NHBE cells from donor 7F1169, treated on day 30 in ALI. (a) and (b) 
PBS treated samples revealing a varied cell culture surface morphology with numerous ciliate cells, 
(c) and (d) TD05 treated samples demonstrating a dramatically reduced number of ciliated cells 
present when compared with PBS treated samples. Cracks in cultures were an artefact of sample 
preparation, (e) and (f) TD20 treated cell cultures showing a breakdown in overall cell culture 
morphology, with a complete loss of cell culture architecture and the presence of clusters of 
individually adherent cells, (g) TD05 treatment demonstrated a greatly reduced ciliated cell 
population. Cracks in the cultures were an artefact of sample preparation, (h) TD05 polymer 
treatment, where one ciliated cell was shown surrounded by a number of goblet or undifferentiated 
cells, (i) TD20 polymer treatment increased crack formations, (j) TD20 polymer treatment depicting 
a particulate on the cell culture surface (e.g. a S2219200 polymer particle).
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Figure 4.9 SEM images of NHBE cells from donor 46F4181, treated on day 30 in ALL (a) and (b) 
PBS treated samples, in which the culture did not exhibit as highly a varied surface morphology, 
when compared to other PBS treated samples, (c) and (d) TD05 polymer-treated samples exhibited 
a cell surface morphology with a slightly higher concentration of ciliated cells when compared to 
other TD05 membranes, (e) and (f) TD20 polymer-treated samples where the culture surface 
appeared to be covered with detached or sloughed off cells, (g) and (h) TD05-polymer treated 
samples with fewer ciliated cells presented when compared to the PBS treated samples, (i) and (j) 
TD20 polymer-treated samples demonstrated less tissue restructuring when compared with other 
TD20 membrane samples, with some evidence of cells having been sloughed off (j).
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Figure 4.10 SEM images of EpiAirway™ NHBE treated cells growing in ALI. (a) and (b) PBS 
treated samples demonstrated a varied surface morphology with ciliated and goblet cells present, 
(c) and (d) TD05 polymer-treated samples exhibited alterations to surface morphology with areas of 
swelling and the formation of gaps or in-foldings, (d) and (f) TD20 polymer-treated samples in 
which cells detached from one another and took on a more rounded appearance.
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Cytotoxicity analysis of the S2219220 polymer-carrier solution solvent component 
(methyl aminopropanol) was performed using monolayer epithelial fibroblasts. No 
observed effects were found for up to or until 10 pl/ml or a 1% carrier solvent 
solution (Gaiser, 2008). The NHBE cultures showed no effect level up to 2.5%, 
suggesting that the NHBE culture is more resilient and robust in response to 
potential toxicants when compared to monolayer cultures. The highest 
concentration of carrier solvent applied in these applications was 1.5%, indicating 
that the effects to the NHBE cultures were due to the polymers applied, not the 
carrier solvent.
The results of the conventional toxicology dosing experiments performed with four 
polymer types, using the MTT assay, revealed varying degrees of toxicity between 
the four polymers. Polymers S2429901 and S2218600 demonstrated similar 
patterns of response, and closely related polymer concentrations for the TD05 and 
TD20 dose. Polymer S 2218800 was shown to be the most toxic of the four types, 
with the lowest concentrations for the TD05 and TD20 doses. Finally, the polymer 
S2219200 exhibited a higher concentration for the TD05 and TD20 response 
compared with polymers S2429901 and S2218600, but higher then S2218800. 
This suggested that polymer S 2219200 had a toxicity that was mid-range. Due to 
constraints of both time and finance, as well as existing comparable data sets on 
polymer S2219200 (Carthew et al., 2002, 2006), it was deemed to yield the most 
fruitful results for the impending transcriptomic work (Chapter 5).
Three out of the four polymers tested showed an increase in viability values at the 
lower polymer concentrations. These increases in viability were then followed by 
decreases in viability with subsequent higher doses. This presents a challenge in 
determining exactly which concentration is determined to be TD05. For all three of 
these polymers, TD05 concentration was taken as the values as the cultures were 
experiencing an increase in viability. Taking the TD05 value at this point, prior to 
the peak of MTT would be more reflective of a protective response as opposed to 
the post peak reading, at which point the model was experiencing damage and cell 
death as reported by Balharry et al., 2008. This pattern of response is also referred 
to as a hormetic response (Calbrese 2004), and was observed by other members 
of our research group in the EpiAirway™ cultures, when they were treated with 
tobacco smoke components (Balharry et al., 2008).
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The TEM evaluation of the NHBE cell culture ultrastructure revealed that the PBS 
solution alone affected (enlarged) the size of the intercellular junctions. Similar 
images of the NHBE cultures challenged with the S2219200 polymer treatments 
also exhibited dilation of the intercellular junctions, but at a more extreme level 
when compared to control cells. The S2219200 polymer-treated samples also 
demonstrated internal degradation of individual cells, even at the lower TD05 
concentration levels; this was not evident in the PBS (control) cell cultures. In the 
TD05 doses, TEM revealed hypertrophy or a thickening of the tissue, which did not 
correspond to increases in the cell numbers. This thickening may have resulted 
from the increased vacuolation of the tissue and the breakdown of intercellular 
junctions, or a decrease in cell adhesion causing the separation of cells from within 
the tissue (Balharry et al., 2008). These effects were most prevalent at the supra- 
basal region of the tissue. In contrast, there was less disturbance to junctions and 
tissue organization in the apical regions. The S2219200 polymer TD20-treated 
tissues demonstrated evidence of cells sloughing off. The internal degradation of 
individual cells within the tissue and the concomitant restructuring accomplished by 
the sloughing off of cells suggests irreversible tissue damage at the higher polymer 
doses. This same type of internal cellular restructuring was found in EpiAirway™ 
cultures in response to cadmium treatment (Balharry et al., 2008).
Previous published experimental work performed with these polymers was done 
using various time exposures in rats (Carthew et al., 2002, 2006). These studies 
focused on the effects of these polymers on the alveolar regions of the lung and 
components of the bronchial alveolar lining fluid, making it difficult to compare to 
NHBE data(Carthew et al., 2002, 2006). These studies however, did show 
toxicological tissue restructuring at acute dose levels, as did the NHBE model at 
the higher dose.
4.6 Conclusions
The conventional toxicology experiments with the in-house and EpiAirway™ NHBE 
cell models suggest that the S2219200 polymer induced a medium ranged toxicity, 
without resulting in a total loss of viable cells or tissue. Both models revealed 
parallel morphological responses to the two applied polymer doses. The 
corresponding histopathology revealed phenotypic biomarkers in terms of ‘regional 
hypertrophy’ in the supra-basal regions of the tissue at the TD05 dose, and tissue
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remodelling at the TD20 target dose. The transcriptomic data (Chapters 5 and 6) 
may now be linked to these toxicological and morphological biomarkers for this 
commercial HMW polymer.
The data presented demonstrates that the in-house NHBE cell model presents a 
robust yet sensitive model which displays consistent dose dependent toxicity 
responses.
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M icro array  T echnology: 
G eneS pring  A nalysis
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5.0 In tr o ductio n
Microarray technology has been applied to the NHBE model to explore alterations 
in gene expression as a result of exposure to cigarette smoke, asbestos and 
benzo(a)pyrene diol epoxide (BPDE), as well as compressive stress (Maunders 
et al., 2007, Sexton et al., 2008, Belistkaya-Levy et al., 2007, Chu et al., 2006). 
This chapter explores the use of microarray technology to examine changes in 
the gene expression of the passage 3, in house, NHBE cells following polymer 
S2219200 treatment with toxic doses TD05 and TD20 (Figure 5.1). In addition to 
the NHBE in house tissue engineered model (n = 3 donors; Chapter 3), a 
commercially available 3D, fully differentiated NHBE tissue (EpiAirway™, MatTek) 
(n = 1 donor) was used as a validation model. The aim of the microarray analysis 
was to explore the biological processes which have been both up-regulated and 
down-regulated at the lower dose (TD05), in comparison to the higher dose 
(TD20). The global gene response of the in-house developed NHBE tissue was 
compared to that of the EpiAirway™ tissue. These sub-lethal concentrations were 
chosen with the aim of gaining a better understanding of the point at which 
endogenous protective mechanisms (e.g., antioxidants, inflammatory and 
immune responses) may be surpassed by adaptive mechanisms (e.g., 
hyperplasia, fibrosis and apoptosis). Microarray data was mined in terms of 
alterations of individual gene expressions, and the resulting alterations of 
biological processes and cell signalling patterns. The appearance of 
transcriptomic indicators for irreversible lung cell damage could have applications 
in the establishment of toxin-specific thresholds and new risk assessment 
strategies in vitro (personal communication; Dr. Leona Merolla, Unilever, UK, 
2009). The only information which is known to exist about the transcriptomic 
effects of polymers are those presented by Carthew et al. (2006), who examined 
rat lung tissue. Carthew et al. examined the transcriptomic effects of two 
polymers, polymer 020310, a low molecular weight polymer similar to polymer 
S2218800, and a high molecular weight polymer similar to polymer S2219200. 
Three dose levels of polymer 020310 (a low, medium and high dose), and one 
dose of the high molecular weight polymer were administered. Rats were given 
three separate intratracheal instillations of the polymers at two week intervals 
between instillations. At 9 weeks and 22 weeks after the last polymer instillation, 
animals were sacrificed and the lung tissue excised. RNA was extracted from the 
excised rat lung tissue. 591 rat oligonucleotides from Sigma Genosys were
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printed in quadruplicate onto Amersham microarray slides using a biorobotics 
arrayer. Microarrays were scanned and gene expression data was examined 
using GeneSpring. The lowest dose of the polymer 020310 represented the 
biological NOAEL or no observed adverse effect level and therefore the 
transcriptomic fingerprint of the tissue gave an understanding of the molecular 
events at a dose which dose not induce irreversible change in vivo. Higher doses 
tested gave an understanding of the irreversible events induced by this polymer 
given greater exposure. Greater numbers of gene changes were observed at 22 
weeks after instillations when compared to 9 weeks post-instillations. Higher 
numbers of gene changes were seen in the high dose of polymer 020310 when 
compared to the medium dose. The high dose of the 020310 polymer and the 
high dose of the high molecular weight polymer showed similar gene changes 
and these included cytochrome P450s, cell adhesion molecules and matrix 
proteases. The transcriptomic response to polymers at 9 weeks included a 
macrophage-mediated response causing increases in cytokines (11-12, IL-18, 11-10 
and IL-1), leading to increases in recruitment via adhesion molecules including 
integrins and subsequent cascade effects leading on to further immune cell 
recruitment and tissue remodelling. At 22 weeks gene alterations were indicative 
of a wound response. Several genes demonstrated a continuous or increasing 
upregulation over the 9 to 22 week period including the macrophage stimulating 
protein, metalloprotease 7 and macrophage inflammatory protein, all of which 
would be suggestive of a prolonged antigenic stimulation. As the data from the 
Carthew study was generated using more limited arrays and rodent tissue from 
whole lungs, it is highly unlikely that the data will be directly comparable to that 
generated from this study. However, it does give a basis for comparison for the 
types of pathway responses observed and changing severity of the responses.
5.1 Aims o f  th e  C h a p te r
The aims of this chapter are;
•  Present the quantification/quality analysis of extracted RNA from control and 
polymer treated NHBE and EpiAirway™ tissue samples.
Using a number of visualization tools available in the GeneSpring software 
program (i.e. PCA, Line Graphs, Gene Trees and Venn Diagrams), compare the 
overall gene expression patterns generated from the microarray data for
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Figure 5.1 A work flow diagram outlining the steps involved in the S2219200 polymer treatment of 
the in-house NHBE cell cultures and their subsequent microarray analysis. Step 1 represents the 
dosing of the S2219200 polymer solutions applied to the apical surface of the cell cultures. Step 2 
depicts the RNA extraction, quantification and quality analysis processes. Step 3 shows the RNA 
amplification, reverse transcription (to cDNA) and transcription of cyanine-3 labeled cRNA 
processes. Step 4 demonstrates the hybridization of the RNA to the array chip. Step 5 reveals the 
scanning of the hybridized array chip. Step 6 involves the extraction of array-scanned data into 
data files. Step 7 denotes the GeneSpring software program as the first data analysis. Step 8 
depicts the Metacore Online database analysis as the final exploration tool to be employed for 
pathway analysis with the array data (Chapter 6).
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the three NHBE donors, control and polymer treated samples, as well as the 
EpiAirway™ control and polymer treated samples.
•  Using the GeneSpring software, generate and compare lists of those genes 
which were most up-regulated and down-regulated in response to the 
polymer treatments for both the ‘in-house* NHBE cell cultures and the 
EpiAirway™ tissue.
•  Explore the functional roles and known relevance of those genes most altered 
by the polymer treatments.
•  Using GeneSpring explore the main functional groups represented in the 
altered genes lists as well as the Go:Ontologies or biological processes most 
greatly effected by the polymer treatments.
5 .2  M a t e r ia l s  A n d  E q u ip m e n t
5.2.1 M a te r ia ls
Source
MatTek Corporation Maryland, USA
EpiAirway™ Cell Culture Inserts (3001900190)
Lonza Corporation Maryland, USA
NHBE Bronchial Epithelial Cells (CC-2540)
Agilent California, USA
Agilent RNA 6000 Nano Kit (RNA Nano Chips, 2 Electrode Cleaners, Ladder,
RNA Nano Dye, RNA Nano Marker, Nano Gel Matrix) (5067-1511)
Agilent One-Colour RNA Spike-in Kit (5188-5282)
Agilent Low RNA Input Linear Amplification Kit PLUS, One-Colour (5188-5339) 
Gene Expression Hybridization Kit (5188-5242)
Whole Human Genome Oligo Microarray Kit with SurePrint Technology (G4112- 
60520)
Gasket Slides (G2534-60013)
Wash Buffer #1 (5188-5325)
Wash Buffer #2 (5188-5326)
Agilent Scan Control Software Version A.7.01 (June 12, 2006)
BDH Prolabo (VWR) Leicestershire, UK
Acetonitrile (152516Q)
Qiagen West Sussex, UK
RNeasy Mini Spin Column
Tracy Hughes 145
CH APTER FIVE M IC RO ARRAY TECHNOLOGY GENE SPRIN G ANALYSIS
Qiagen West Sussex, UK
QIAshredder Column (79654)
RNAeasy Mini Kit, (RW1 Solution, RPE Solution, RNAeasy Mini Column and 
RNAase Free Water) (74104)
QIAZOL Lysis Reagent (79306) 
Sigma
The RNA later™ (R0901) 
Isopropanol (1-9516)
Terumo
20 G Needle (NN-2038R) 
Ambion (Applied Biosystems) 
RNaseZap® (9780)
Fisher
Chloroform (CAS67-66-3) 
Ethanol (CAS64-17-5)
St. Louis, USA
New Jersey, USA
Warrington, UK
Manchester, UK
5.2.2 Equipm ent 
Source
Thermo Scientific
Nano-Drop 1000 Spectrophotometer 
Genesys 6 Spectrophotometer 
Agilent
Agilent 2100 Bioanalyzer 
Chip Priming Station 
Agilent Scanner Model G2505B 
MWG AG BIOTECH 
Primus 96 PLUS Thermocycler
Delaware, USA
California, USA
Ebersberg, Germany
5.3 M ethods
5.3.1 C e ll  C u ltu r e  Po ly m e r  T r e a t m e n t
NHBE cell cultures from three different donors (7F1169, 7F3000 and 6F4181) 
were dosed with the S2219200 polymer, as previously described in Chapter 4 
(section 4.3.1). The EpiAirway™ cell culture inserts arrived in a tray filled with 
chilled holding gel. The individual inserts were then placed in 300 pi of fresh 
warmed medium in a 24 well plate, and incubated overnight at 37°C. The
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EpiAirway™ cells (figure 1.7, Chapter 1), were treated with polymer the following 
day; in the same manner as the in-house NHBE cell cultures. The TD05 treated 
samples received 50 pi of 2,500 pg/ml S2219200 polymer solution and the TD20 
treated samples received 50 pi of 6,590 pg/ml S2219200 polymer solution. All 
inserts were incubated with the apical solution applied for 24 hours in the 
incubator. Following the incubation, the treated cultures were placed into 
RNAIater™ and into the -20 °C freezer until required for further processing.
5.3.2 RNA E x t r a c t io n
After the treatment in RNAIater™, the membranes on which the cells were grown 
were carefully cut out of the plastic insert, the cells scraped off the membrane 
(using a razor blade) and placed into a 1.5 ml eppendorf tube. The cellular 
material from two inserts was combined into one eppendorf tube. Then, 1 ml of 
QIAZOL lysis reagent was added to each cellular sample and the eppendorf tube 
was inverted and incubated at room temperature for 5 minutes. The QIAZOL lysis 
reagent acted to lyse cells and further inhibited RNase activity. The samples were 
each taken up through a 2.5 gauge needle with a 2 ml syringe and triturated 
through the needle to disrupt the cellular membrane, lyse the cells and release all 
the RNA contained in the sample. The samples were then placed in a Qiagen 
shredder and centrifuged for 15 seconds at 12000 rpm to homogenize the 
material and reduce the viscosity of the lysate. Next the samples, which had been 
through the shredder, were mixed with 200 pi of chloroform, vortexed, incubated 
at room temperature for 3 minutes and spun in the centrifuge at 12000 rpm for 15 
minutes. This step is essential for phase separation. The top clear aqueous layer, 
containing the RNA, was removed and placed into a fresh 1.5 ml eppendorf tube. 
The middle and lower phases containing DNA and proteins was no longer needed 
and was discarded. The aqueous solution was mixed with 0.53 volumes of 
absolute ethanol and inverted, precipitating the RNA. The aqueous/ethanol mix 
was placed in the RNeasy column (Qiagen) and spun for 1 minute at 13000 rpm. 
The RNA precipitate which was bound to the column was washed with 700 pi of 
RW1 buffer and centrifuged for 1 minute at 10000 rpm. Next, it was rinsed with 
500 pi RPE buffer and centrifuged again for 1 minute at 10000 rpm. The 500 pi 
RPE buffer rinse was repeated and the column was centrifuged at 10000 rpm for 
2 minutes. Total RNA was eluted off the column into a fresh eppendorf tube using 
30 pi of RNase free water. The sample was placed on ice and its RNA
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concentration was read using the UV spectrophotometer. These measurements 
were given in micrograms per microlitre (pg/pl).
5.3.3 RNA Q u a n t if ic a t io n  a n d  In te g r ity  A n a lysis
5.3.3.1 Na n o -D r o p  1000
RNA was extracted from tissue using the technique described in Section 5.3.2. 
The Nano-Drop 1000 spectrophotometer was used for preliminary RNA 
quantification, using the ratio of 260 nm and 280 nm absorbance values to obtain 
RNA values in nanograms per microlitre (ng/pl). One microlitre of the RNA 
extraction sample was required per measurement in the sample pedestal.
5 .3 .3 .2  2100  A g ile n t  B io a n a lyzer
Following the quantification of the RNA with the Nano-Drop 1000, the 2100 
Agilent Bioanalyzer (Figure 5.2) was used to measure the RNA quality and 
integrity. A fluidic gel was brought to room temperature and spun for 10 minutes 
at 1500 g, and alliquoted into 65 pi samples. A 65 pi aliquot of gel and Nano-Dye 
stain were brought to room temperature. For use in the Bioanaylzer, fluorescent 
dye is bound to the RNA segments, which were loaded into the wells of a 
nano-chip. The nano-chip was placed inside the Bioanalyzer, where the actions of 
microfluidics and microcapillary electrophoresis separated the RNA segments in 
the chip according to size (i.e. the 28S and 18S species). The fluorescence of the 
molecules was measured as they passed by a laser detector. The strength and 
times of the fluorescent signals picked up from the detector were recorded as 
peaks on a graph (e.g. Figure 5.6). This data was then used to calculate the ratio 
between the 28S and 18S RNA fragment species, as well as the level of 
degradation in the sample. This data was then used to calculate an RNA Integrity 
Number (RIN). One microlitre of Nano-Dye was added to the 65 pi gel aliquot, 
and was mixed with gentle flicking and spun at 13000 g for 10 minutes in a micro­
centrifuge. The RNA Nano-chip was placed in the Chip Priming Station (Appendix 
7), and loaded with gel-dye mix. Five microlitres of a dye front marker was added 
to each of the 12 sample wells and the ladder well. One microlitre of RNA ladder 
was placed in the ladder well, and 1 pi of each sample was added to each of the 
12 sample wells. The chip was placed in a special adapter and shaken for one 
minute at 2400 rpm to mix the samples, gel and dye, and to remove any bubbles.
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Next the chip was loaded into the Bioanalyzer (Figure 5.2) and detector data was 
available in 30 minutes (see also Step 2, Figure 5.1).
5.3.4 C o n c e n tr a t io n  of RNA sam ples
Each sample volume was made up to a volume of 100 pi with RNase-free water 
and 350 pi of RLT (RNase lysis buffer) buffer was added to each sample. 
Samples were mixed well with vortexing for 10 seconds and spun down for 10 
seconds. To each sample 250 pi of ethanol was added and mixed thoroughly by 
pipetting. Samples were transferred to the RNeasy MinElute column in a 2 ml 
collection tube. The columns were spun for 15 seconds at 13000 rpm and the 
flow-through discarded. Seven hundred microlitres of RW1 was added to each 
column. The columns were spun for 15 seconds at 13000 rpm and the flow­
through discarded. The columns were then placed in a new 2 ml collection tube. 
First 500 pi of RPE was added to each column, and then the columns were spun
Nano-chip
Figure 5.2 The 2100 Agilent Bioanalyzer as shown with a Nano-chip loaded into place. Once the 
lid was closed and the electrodes lowered into each well, detector data was ready in 30 minutes.
at 13000 rpm for 15 seconds and the flow through discarded. Next 500 pi of 80% 
ethanol was added to each column and they were spun in the centrifuge for 2
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minutes at 13000 rpm and the flow through discarded. The samples were then 
placed into a new 2 ml collection tube. The lids of the spin columns were opened 
and the samples were spun for 5 minutes at 2000 rpm and the flow through 
discarded. The spin columns were placed in new 1.5 ml collection tubes. Next, 
13 pi of RNase-free water was added directly to the centre of the spin column 
membrane of each column and the samples were incubated at room temperature 
for 10 minutes. The samples were then spun in the centrifuge for 1 minute at 
2000 rpm. The eluted RNA samples were placed in the -80 °C freezer until further 
processing.
5.3.5 RNA Sample Preparation: Labelling, Amplification, Quantification
5.3.5.1 P r ep a r a tio n  o f  t h e  O n e  C o lo ur  S pike-M ix
The following sections, 5.3.5.1 through 5.3.5.5, were represented by Step 3 on 
Figure 5.1. One-colour spike-mix stock was vigorously vortexed for 10 seconds. It 
was heated to 37 °C for 5 minutes, vortexed again and spun down for 10 seconds 
at 13000 rpm. The spike mix was diluted 1 in 5000 (according to the 
manufacturer’s protocol). This was vortexed thoroughly for 10 seconds and spun- 
down for 10 seconds at 1000 rpm.
5.3.5.2 P r ep a r in g  La b elled  cDNA (RT a n d  tr a n s c r ip t io n  r ea c tio n s )
A volume of the RNA sample (containing 300 ng of RNA), was placed into a 0.2 
ml micro-centrifuge tube to which a volume of one-colour spike-mix (1 pi at the 1 
in 5000 dilution) for every 100 ng of RNA, 1.2 pi of T7 promoter primer and 
nuclease-free water was added, Nuclease-free water was also used to bring the 
reaction master mix up to the total volume of 11.5 pi.
The one-colour spike-in with RNA sample master mix was placed in the 
thermocycler at 65 °C for 10 minutes, to denature the primer and template; the 
annealing step. The samples were then placed on ice for 5 minutes. During the 
cooling, 5X first strand buffer was pre-warmed at 80 °C for 4 minutes to 
resuspend. Next, it was vortexed for 10 seconds, spun-down for 10 seconds and 
kept at room temperature until use.
The cDNA master mix (Appendix 8) was added (8.5 pi) to each sample which was 
incubated in a 40 °C water bath for 2 hours. Next, they were incubated in a 65 °C
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incubator for 15 minutes. The resulting samples were placed on ice for 5 minutes. 
During this time the PEG solution was pre-warmed at 40 °C for 1 minute. It was 
then vortexed for 10 seconds, spun down for 10 seconds and kept at room 
temperature until the time of use.
5.3.5.3 T r a n s c r ip t io n  R eac tio n  to  s yn th esize  cRNA (C y  3 -  labelled)
The samples which had been on ice were micro-centrifuged for approximately 10 
seconds at 1000 rpm and 60 pi of the transcription master mix (Appendix 9) was 
added to each sample and mixed by pipetting. The mixture was incubated at 40 
°C for 2 hours.
5.3.5.4 P u r if ic a t io n  o f  t h e  cRNA
Twenty microlitres of nuclease-free water was added to each cRNA sample to 
make a final volume of 100 pi. Three hundred and fifty microlitres of RLT buffer 
was then added to the sample, and it was thoroughly mixed by pipetting, vortexed 
for 10 seconds and spun down for 30 seconds. Two hundred and fifty microlitres 
of ethanol (£ 96 %) was added to these samples and they were mixed well by 
pipetting for 10 seconds. Seven hundred microlitres of the samples were placed 
into the RNeasy mini column and into a collection tube. The samples were spun 
down at 13,000 rpm for 30 seconds and the flow through discarded. The column 
was transferred to a fresh collection tube and 500 pi of RPE buffer was added to 
the column. It was spun at 13,000 rpm for 30 seconds and the flow through 
discarded. This step was repeated with the column spun an additional 30 
seconds to completely remove all RPE. The column was then transferred to a 
fresh collection tube and 50 pi of RNase-free water was used to elute the cRNA. 
After the water was applied to the membrane of the column, it was first incubated 
for 1 minute and then spun at 13,000 rpm for 30 seconds. The eluted cRNA was 
placed on ice and frozen at -80 °C until further use.
5.3.5.5 Q u a n tif ic a tio n  of  cRNA u s in g  t h e  UV-VIS S pec tr o ph o to m eter
The Implen cuvette was placed in the spectrophotometer. A 5 pi sample of 
nuclease-free water was used to zero the machine. The absorbance readings in 
the spectrophotometer were taken at two wavelengths (A), 260 and 550 nm. The 
260 A was absorbed by RNA, and the 550 A was absorbed by the Cy3 Dye. The 
RNA samples were run one at a time on the spectrophotometer, with the sample
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window being wiped clean between each sample. The RNA concentration for 
each sample was calculated using the spectrophotometer absorption data and 
the following formula: R(260) X Df X OD (where; R = spectrophotometer reading 
at 260 nm, Df = Dilution Factor (10), and OD = Optical Density of RNA (40 
ng/pl)).
5.3.6 H y b r id iz a t io n  o f  cRNA Sa m ple  to  th e  A r r a y  C hip
5.3.6.1 P r ep a r a tio n  o f  t h e  10X Blocking  A g en t
Sections 5.3.6.1 through 5.3.6.4 were represented by Step 4 on Figure 5.1. The 
blocking agent was prepared by adding together 500 pi of nuclease-free water to 
dry or lyophilized 10X blocking agent from the gene expression hybridization kit. 
The mixture was vortexed and spun down for 10 seconds. Then the blocking 
agent was aliquoted and stored at -20 °C for up to 2 months.
5.3.6.2 P r ep a r a tio n  o f  cRNA Sa m p le s  fo r  Hybr id iza tio n
For each array, the following mixture was prepared in a 0.5 ml eppendorf tube. 
Two micrograms of RNA was needed for each microarray. The 10X blocking 
agent and fragmentation buffer were added to each tube (Appendix 10). This 
solution was mixed by flicking and spun down for 10 seconds at 13,000 rpm. The 
reaction tubes were placed in a 60 °C water bath for 30 minutes. Then the 
samples were spun down for approximately 10 seconds at 1000 rpm. The 
fragmentation reaction was stopped by adding 55 pi of 2X GE hybridization buffer 
to each tube. The solutions were mixed well by flicking and spun down for 1 
minute at 13,000 rpm.
5.3.6.3 P r epa r a tio n  of  th e  Hy b r id iza tio n  A s sem b ly
The plastic covering was peeled off the top of a microarray gasket slide (Figure
5.3). The gasket slide was loaded into the SureHyb chamber base (Appendix 11), 
with the “Agilent” label facing up and the sample wells on the top surface (Figure
5.3), to which 100 pi of each sample was loaded. The array slide was slowly 
lowered down on top of the gasket slide with the “Agilent” label facing down, i.e. 
the active array side. The chamber cover was put in place over the sandwiched 
slides and the clamp assembly slid into place and tightened to hold the entire 
assembly together (Appendix 12). The assembly/microarray slides were placed 
into the hydridization rotisserie overnight at 65 °C for 17 hours (Appendix 13).
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5 .3 .6 .4  W a s h in g  of  H y b r id iz e d  S lides
Each SurHyb chamber assembly was first dissembled, the slides removed from 
the chamber and placed inside a beaker which contained approximately 200 ml of 
wash buffer #1. Under the surface of the wash buffer #1 solution, forceps were 
used to remove the gasket slide from the array slide. The array slides were 
placed into a slide holder which was located in a glass tank of wash buffer #1 with 
a stirring flea. The holders/tank was placed on a stirring table at a rate of 750 rpm 
for 1 minute. Then the holder and array slides were placed in another tank 
containing wash buffer #2 and a stirring flea, which was placed on the stirring 
table at 7 5 0  rpm for 1 minute. Next the holder and array slides were placed in a 
tank containing acetonitrile and a stirring flea, and placed on the stirring table at 
750  rpm for 1 minute. Each slide was individually placed into a 50 ml Universal 
tube containing stabilization solution for approximately 30 seconds, and then 
placed on a paper towel array side up to dry at room temperature for 5 minutes.
Figure 5.3 The microarray gasket slide depicting four black rectangles (raised rubber edges of the 
wells), which act to hold the hybridization solution in place over each individual array. They were 
sandwiched together with the 4 array microarray slide.
5 .3 .7  S cann ing  o f  Chips
This section of work was represented by Step 5 on Figure 5.1. Chips were loaded 
into the slide holders of the scanner carousel. The scan settings were verified for 
the one-colour scan. The bar codes located at the side of each slide acted to 
indicate the type of array (e.g. Whole Human Genome), and the scanner control 
software, (Agilent Scan Control Software Version A.7.01 (June 12, 2006)), 
determined that the one-colour gene expression settings were used. Each slide
Array
Wells
Agilent label
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was scanned at both a high (100) and low (10) power PMT (Photomultiplier Tube) 
setting, at a 5 pm resolution. Each 50 pm spot was comprised of approximately 
100 pixels at this resolution. The data for each one of the pixels for each spot was 
combined and the scanner calculated one signal value for each spot or gene. The 
scanner data was compiled into a tif image. The Feature Extraction Software 
(GE1_v5_95_Feb07) took all the data points for the array spots and generated a 
number of documents which were used to examine the gene expression profiles, 
i.e. Step 6 , Figure 5.1. These documents included: one quality control (QC) 
document, metric set (for each set of arrays), Jpeg image (for each array run in 
the set [in this case 28 arrays]), and a text document for each array.
5.3.8 M icroarray Data Analysis: GeneSpring: Data Screening 
The basic methodology for the 5 main tools utilized in the GeneSpring Software 
Program (Step 7, Figure 5.1) has been outlined in Table 5.1. The individual array 
text files generated by the Feature Extraction Software were loaded into 
GeneSpring Version 7.3 for further analysis. The text files included all the scanner 
signal data and the corresponding Agilent gene identification numbers (ID#s). 
Upon entry into GeneSpring, each array data set was classified or categorized 
according to sample number, Donor (e.g., 7F3000, 7F1169, 6F4181 and 
EpiAirway™) and Experimental Condition (e.g. Control, TD5, TD20). The data 
was then normalized. In this step, normalization was performed separately for the 
data from each individual donor. In normalization, the array data for the control or 
untreated data was combined to represent normal or baseline expression of 
genes. The polymer treated sample data was examined in terms of any 
alterations or changes which may have occurred from the expressions of the 
control samples. Once the data for all the 44,000 genes were inputted, the gene 
expression data was filtered (or transformed) to remove negative values, by 
selecting a signal reading cut-off of 1 0 ; where any values lower then 1 0  were 
brought up to a value of 10. Then the data was filtered by flags; a step where data 
for genes which were found to be absent in 27 of the 28 arrays were eliminated 
from further analysis. This left a list of 41,000 genes considered relevant for 
further analysis, e.g. Table 5.1. Individual array gene lists could be filtered by 
using False Discovery Rate (FDR) values, fold-changes and p-values. Gene 
expression profiles were examined using a number of tools of visualization that 
included principle component analysis, line graphs, gene trees, Venn diagrams
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and Go:Ontologies (Table 5.1). A great deal of information could have been 
gathered and compared by examination of the control samples gene expression 
profiles for both the NHBE model and the EpiAirway model. This information has 
not been explored in this chapter. The potential applications of this control gene 
expression data will be discussed briefly in the Conclusions section (5.6).
5.3.8.1 PCA
The PCA tool or type of analysis was utilized to present a visual comparison of 
the condensed overall array data for each donor and each condition. In 
GeneSpring, the array data files for all of the arrays were highlighted, and the 
‘PCA option’ was chosen.
5.3 .8 .2  L in e  G r a ph s
Gene lists were selected in the GeneSpring programme and viewed as line 
graphs using the View menu and selecting the Line Graph option. Those genes 
which had been up-regulated appeared as lines ranging from the 1 value at the 
control axis to above the 1 at the TD05 or TD20 axis (Figure 5.11 and 5.12). They 
also appeared as red lines. A sub-selection of genes could be performed 
manually using the mouse (as shown on Figure 5.11 and 5.12).
5.3.8 .3 Top 25 Up- and Down-regulated Genes Lists
The up-regulated and down-regulated gene lists for the TD05 and TD20 
treatments were generated in GeneSpring, using the line graphs. These lists were 
exported to Excel and placed in descending order according to fold-change, with 
those genes in the Top 25 open to further analysis. Lists of the Top 25 most 
down-regulated genes were generated by exporting from GeneSpring into Excel 
and organising the list in ascending order. These lists only included those genes 
that had a value for p of less then 0 .0 1 .
5.3 .8 .4  V enn  D iagram s
Two or more gene lists were selected and the Venn diagram option chosen. The 
Venn diagram was created, with circles representing each gene list and those 
number of genes that were unique, shared and common, appeared in the unique 
or overlapping regions of the circles (Figure 5.4). Right clicking the appropriate
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Analysis Method Purpose Data Type Yielded References
Principle Component Analysis:
Visualization tool in which all data points or 
signal readings for each array were 
compressed into a single spot on a graph 
and variance between different array data 
sets is measured using 3 variables or 
‘components’._________________________
To compare the variation and trends between 
the array gene expression profiles. To 
illustrate the degree or percentage of variance 
between array data sets, as well as 
relatedness.
Line Graphs: Visualization tool in which 
each line on a graph represented the 
expression of one gene in an array or group 
of arrays compared to the control.
To compare the expression of individual 
genes from control to treated conditions for a 
number of sample types. To indicate the 
degree of up- and down-regulation by the 
colour of the line on the graph.
(Gibson and Muse, 2004) 
(Ivosev et at ,2008)
(Chu et al., 2006)
(Ross et al., 2007)
Gene Trees: Visualization tool in which 
genes having similar expression patterns 
were clustered. Those genes showing similar 
changes in expression were located closer in 
proximity on the tree.
To compare the expressions of genes across 
a number of tissue types or treatments 
through the method of hierarchical clustering.
(Gibson and Muse, 2004) 
(Chu et al., 2006)
(Rolph eta!., 2006)
Venn Diagrams: Visualization tool in which 
genes from two or more lists were compared 
in terms of genes which were unique, shared 
and common to the lists.
To compare the composition of two or more 
lists of genes in terms of the numbers of those 
genes which are unique, shared and common.
(Ross et at, 2007) 
(Gold et al., 2004) 
(Ah I bom et at, 2007)
Go:Ontologies: Database analysis tool in 
which list of genes were examined with 
reference to the representation of genes 
from biological and functional groups.
To examine which types of biological activities 
may have been altered as a result of the 
treatment of cells or tissue.
(Chu etal.,2006) 
(Greene etal.. 2008) 
(Kleemann etal., 2007)
Table 5.1 Table showing the five analysis methods applied to NHBE S2219200 polymer-treated samples microarray data, using the Agilent GeneSpring software 
program.
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#2
#3 # 3  #3
Unique Genes Similar or Shared Genes Common Genes
Figure 5.4 Venn diagrams of three different gene lists (#1, #2 and #3) and the areas that were 
unique, shared and common genes. In GeneSpring, the numbers of the genes in each area were 
shown in the shaded areas and with a right-click of the mouse over the shaded areas, the list of 
these genes could be derived and saved as a new list.
region of the diagram permitted the user to save the list of the genes found in this 
region as a newly created list.
5.3.8.5 G o :O n to lo g y  l i s t s
The Go:Ontology option in GeneSpring, could be used to examine a list of genes 
in terms of how many of those genes were involved in either designated cellular 
processes, molecular functions or biological processes. Making a Go:Ontology list 
was performed by choosing or highlighting a gene list and then selecting the ‘view 
Go:Ontologies option’. The Top 10 categories from the Go:Ontology lists 
generated by the altered gene lists from the TD05 and TD20 polymer treatments, 
for both the in-house NHBE sample and the EpiAirway™ samples were saved as 
Excel files and exported out of GeneSpring.
5.4 Results
The data from all the NHBE and EpiAirway™ donor samples, in terms of the RNA 
processing, scanning and preliminary examination with GeneSpring, was 
conducted to determine if the RNA yielded data that was acceptable for advanced 
gene expression analysis.
5.4.1 RNA Q u an tificatio n  and  In teg r ity  A nalysis
All RNA quantification data was combined onto Table 5.2.
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Sample Concentration 
ng/MI 
(NanoDrop) ND
Ratio 26CV280 
(NanoDrop) ND
Bioanalyzer 
(BA) cone 
■g.-U
Bioanalyzer 
RIN (BA)
Total RNA amt 
(ng) based on 
Bioanalyzer 
quantification
ratio cone 
N DvBA
Action Rneasy
concentration
batch
Concentration of 
concentrated 
(~11ut) sample 
(ngAil)
RIN yield
(ng)
recovery enough for 
118ng 
synthesis?
6F4181 Control #1 55.4 1.76 16 9.9 288 3.46 concentrate 1 18 9.3 198 0.69 Y
6F4181 Control #2 110.6 1.77 34 10 612 3.25 concentrate 1 36 9.7 396 0.65 Y
6F4181 Control #3 74.9 1.68 16 10 288 4.68 concentrate 3 16 9.2 176 0.61 Y
6F4181 TD20#1 48.9 1.72 15 9.6 270 3.26 concentrate 1 16 9.6 176 0.65 Y
6F4181 TD20#2 50.2 1.68 12 9.2 216 4.18 concentrate 1 15 9 165 0.76 Y
6F4181 TD20#3 30.9 1.49 2 na 36 15.45 concentrate 3 4 na 44 1.22 N
6F4181 TD5 #1 64.6 1.82 13 10 234 4.97 concentrate 1 29 9.5 319 1.36 Y
6F4181 TD5 #2 74.3 1.77 28 10 504 2.65 concentrate 1 36 9.8 396 0.79 Y
6F4181 TD5 #3 48.6 1.68 6 na 108 8.1 concentrate 3 9 na 99 0.92 N
7F1169 Control #1 49.1 1.79 9 na 162 5.46 pool, then 1 49 9.8 539 2.14 Y
7F1169 Control #2 71.3 1.61 3 na 54 23.77
7F1169 Control #3 45.8 1.69 2 na 36 22.9 concentrate
7F1169TD20#1 21.9 1.53 0 na 0 #OIV/0! pool, then 1 13 9.8 143 3.97 Y
7F1169TD20#2 35.3 1.54 0 na 0 #DIV/0!
7F1169TD20#3 58.9 1.68 2 na 36 29.45 concentrate
7F1169 TD5 #1 33.4 1.6 1 na 18 33.4 pool, then 1 69 9.7 759 3.01 Y
7F1169TD5#2 544 1.67 5 na 90 10.88
7F1169 TD5 #3 84.5 1.81 8 na 144 10.56 concentrate
7F3000 Control #1 101.7 1.81 23 10 414 4.42 concentrate 3 53 10 583 1.41 Y
7F3000 Control #2 139.4 1.93 66 10 1188 2.11 concentrate 1 102 9.9 1122 0.94 Y
7F3000 Control #3 72.3 1.8 21 9.8 378 3.44 concentrate 2 62 9.5 682 1.8 Y
7F3000TD20#1 13.5 1.45 1 na 18 13.5 concentrate 3 1 na 11 0.61 N
7F3000TD20#2 71.5 1.85 33 9.4 594 2.17 concentrate 1 30 9.8 330 0.56 Y
7F3000TD20#3 83.7 1.88 33 9.6 594 2.54 concentrate 2 101 9.7 1111 1.87 Y
7F3000 TD5 #1 25.3 1.64 4 na 72 6.33 concentrate 3 11 6.3 121 1.68 N
7F3000 TD5 #2 104.2 1.86 64 9.9 1152 1.63 concentrate 1 138 9.9 1518 1.32 Y
7F3000 TD5 #3 88.3 1.94 44 9.7 792 2.01 concentrate 2 68 9.7 748 0.94 Y
EpiAirway Control #1 164.3 2.02 63 8.5 3024 2.61 concentrate 2 389 8.5 4279 1.42 Y
EpiAirway Control #2 164.4 2.03 95 8.9 4560 1.73 concentrate 2 409 8.8 4499 099 Y
EpiAirway Control #3 160.4 2.01 84 8 4032 1.91 concentrate 2 394 8.3 4334 1.07 Y
EpiAirway TD20 #1 48.3 1.81 26 7 1248 1.86 concentrate 2 87 7.5 957 0.77 Y
EpiAirway TD20 #2 68.4 1.73 19 4.8 912 3.6 concentrate 2 92 6.8 1012 1.11 Y
EpiAirwayTD20 #3 45 1.78 20 7.2 960 2.25 concentrate 2 65 8.1 715 0.74 Y
EpiAirway TD5 #1 173 1.54 17 7.4 816 10.18 concentrate 2 69 8.5 759 0.93 Y
EpiAirway TD5 #2 112 1.69 37 7.7 1776 3.03 concentrate 2 228 8.4 2508 1.41 Y
EpiAirway TD5 #3 110 1.8 52 8 2496 2.12 concentrate 2 239 8.5 2629 1.05 Y
Table 5.2 RNA quantification from samples of HM W  polymer treated and control NHBE tissue from Donors 6F4181, 7F 1169 and 7F3000 and the EpiAirway tissue
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Figure 5.5 The electrophesis gel image from RNA Samples 1 through 12 on Nano-Chip 1. The 
ladder (in the far left lane), was comprised of 6 RNA segments which ranged in size from 25 to 
4000 nt. The lines (shown at approximately 2000 and 4000 nt time points) were the 18S and 28S 
sized RNA segments. Sample 1 was donor 6F4181 Control and Sample 12 was the EpiAirway™ 
TD20.
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Figure 5.6 Examples of two electropherograms generated by detector data from two RNA 
samples run on the Bioanalyzer. The peak located at the 25 nt represented the standard aliquot 
of RNA marker segment added to all RNA samples. The example on the left, Sample 1, has a RIN 
value of 9.90. Sample 1 has two main peaks at approximately 2000 and 4000 nt (time points), 
representing the 18S and 28S RNA segment species, respectively. The example on the right, 
Sample 12, had two very small peaks at 2000 and 4000, with a number of smaller peaks, 
indicating contamination or RNase activity generating degradation of the sample. Sample 1 was 
donor 6F4181 control Sample 1 and Sample 12 was the EpiAirway™ TD20 Sample 2.
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5.4.1.1 Nano -drop  1000
The EpiAirway™ samples exhibited a higher yield of RNA when compared to the 
in-house NHBE samples. The levels of RNA decreased in the samples treated 
with the polymer, especially with the higher (TD20) doses.
5.4.1.2 A gilent Bioanalyzer
For each Nano-chip run on the Bioanalyzer, a PDF file was generated with both 
electrophoresis gel type images (Figure 5.5) and electropherograms (Figure 5.6) 
for each individual RNA sample. The Bioanalyzer data showed that RIN numbers 
varied. For donor 6F4181, all samples had high RIN values, (above 9), except for 
two samples, TD20 Sample #  3 and TD05 Sample # 3; both of which did not have 
readings. For donor 7F1169, no RIN values were reported for any sample. For 
donor 7F3000, all samples had RIN numbers above 9, except for 2 samples, 
(TD20 Sample # 1 and TD05 Sample #1 ) ,  both of which had no detachable RIN 
values. The EpiAirway™ samples RIN numbers varied, with one value particularly 
low (TD20 with an RIN of 4.8) and others ranging from 7.2 for TD20 sample # 3 to 
8.9 for Control Sample #2.
5.4.2 Scanner  Data
The Jpegs (Figure 5.7), for each array were all examined for any evidence of 
abnormal brightness or ‘smudges’. All Jpegs looked normal and consistent. The 
text file generated for each array contained all the Agilent spot ID or identification 
numbers and the corresponding signal reading data for each array. The extraction 
software also generated a PDF file, which was a three page Quality Control (QC) 
document for each individual array (e.g., Appendices 15 to 17). The individual QC 
documents were examined to look for any indications of array contamination or 
signal abnormalities. The spike-in data for each array was provided in the form of 
a graph, as the log of the signal versus the log of the concentration. These graphs 
all showed a linear relationship and a linear regression. This was reflective of the 
spike-in concentrations accurately corresponding to signal readings and there 
was good quality control exhibited in the scanner signal data.
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Figure 5.7 A Jpeg image of the normal Tif. array (EpiAirway™ TD20 Sample # 3).
5.4.3 G en eS pring  R esu lts
5.4.3.1 P r in c ip a l C o m p o n e n t A n a ly s is
The 3-dimensional PCA (Figure 5.8) revealed that PC-1 or principle component 
1 (x-axis) showed a 27.73% variance, PC-2 (y-axis) a 24.02% variance and PC-3 
(z-axis) variance of 10.28%. All variance values were out of 100 and were low, 
particularly component 3 (z-axis) with a variance of 10.28%. The EpiAirway™ 
sample array data spots were yellow, (Figures 5.8) and separated by PCA from 
the other NFIBE donors, which were more closely grouped together. Donor 
7F1169 array data points appeared as red (Figures 5.8) spots; a number of which 
were more distant from the other two donor array spots. The control, TD05 and 
TD20 treatment samples could be observed to be more closely located to one 
another for the in-house and EpiAirway™ NHBE models.
5.4.3.2 Gene T re e s
The first gene tree analysis (Figure 5.9) revealed all donors shared a similar 
pattern of response with many of the same genes being up-regulated and down- 
regulated at the TD05 S2219200 polymer treatment. It was apparent that a 
greater number of genes were altered at the TD20 treatment. It was also 
illustrated that many of the genes altered at the TD05 polymer treatment 
experienced an even greater degree or up- and down-regulation at the TD20 
treatment.
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Figure 5.8 Three-dimensional PCA, showing one point for each NHBE sample array. Each point 
coloured by donor. PC-1 (x-axis) reveals a 27.73% variance, PC-2 (y-axis) a 24.02% variance and 
PC-3 (z-axis) a 10.20% variance. All variance numbers were out of 100.
In the second gene tree (Figure 5.10), the NHBE data for all three donors was 
merged and illustrated that those genes which had been significantly up-regulated 
and down-regulated in the EpiAirway™ donor appeared, to have shown a similar 
up-ward and down-ward shift in expression in the NHBE samples.
5 .4 .3 .3  L ine  G r a p h s
The line graph of 239 genes (Figure 5.11) illustrated a very similar pattern of 
expression across all of the three NHBE donors and the EpiAirway samples. Most 
of the down-regulated genes could be observed to be further down-regulated 
(dropping below the #1 control expression line) at the TD20 treatment. This line 
graph also illustrated that most of the genes which had been up-regulated at the 
TD05 treatment, had higher levels of up-regulation at the TD20 treatment (raising 
above the #1 control expression line). The line graph of 1328 genes (Figure 5.12), 
revealed that many genes which had a significant fold-change at the TD20 also 
had significant changes at the TD05.
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Figure 5.9 A gene tree showing the in-house NHBE and EpiAirway™ (marked Mattek) expression 
of the 1376 genes found to have changed significantly (fold-change £ 2.0 and p-value ^ 0.01) by 
at least one treatment (TD05 or TD20) of the S2219200 polymer in all donors. Gene expressions 
were normalized to the controls of each donor. Sample names were along the X-axis with the 
control samples shown first (left), followed by the TD05 samples and TD20 samples. The first 
sample is unlabeled and should read “Donor 64181 expt..”, and represents the first control sample 
for this donor. Donors 6F4181, and 7F1169 have two samples for each condition, donor 7F3000 
had two samples of each condition and a duplicate of one of the TD05 polymer treatments and the 
EpiAirway™ samples have three samples for each condition. The expressions of each specific 
gene in each sample were signified by coloured horizontal lines located above the sample names. 
The colour of the line related to the fold-change of the gene. The colour legend on the right of 
each tree indicated which fold-changes were represented by which colours. The up-regulated 
genes appeared red in colour and the down-regulated genes were blue in colour.
Selected Gene Tree: 
Colored by:
Gene Ust
080228 norm to control (Interpretation! a)Gene tree with allsamples 
080228 norm to control (Default Interpretation)
1376 changed by at least 1 treatment (1376)
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Figure 5.10 A gene tree showing the in-house NHBE and EpiAirway™ expression of the 868 
genes found to have changed significantly (fold-change > 2.0 and p-value < 0.01) by at least one 
treatment (TD05 or TD20) of the S2219200 polymer in the EpiAirway™ samples. Gene 
expressions were normalized to the controls of each donor. Sample names were along the X-axis 
with the control samples shown first (left), followed by the TD05 and TD20 samples. The samples 
on the left were the EpiAirway™ samples (Controls, TD05 and TD20) and the samples on the right 
were the NHBE samples (Controls, TD05 and TD20). The data for all the NHBE donors was 
merged. The expressions of each specific gene in each sample were signified by coloured 
horizontal lines located above the sample name. The colour legend to the right of each tree 
indicated which fold-changes were represented by which colours. The up-regulated genes 
appeared red in colour and the down-regulated genes were blue in colour.
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Y-axis: 080228 norm to control, Interpretation! a
Colored by: TD 05 6F4181
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Figure 5.11 A line graph illustrating the expression pattern of 239 genes from the combined in- 
house NHBE and EpiAirway™ array data. The data was filtered on a volcano plot and changed by 
> 2-fold with the application of the TD05 dose of polymer, FDR of < 0.05 applied. The data was 
normalized using the Control samples for each donor. One (1) on the y axis represents the control 
expression level. The colour of the lines was determined by the fold-change in expression of the 
gene for the TD05 polymer treatment for the donor 6F4181. The colour bar on the right shows 
how the colour of the line representing each gene related to fold-change.
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Figure 5.12 A line graph illustrating the expression pattern of 1328 genes from the combined in- 
house NHBE and EpiAirway™ array data. The data was filtered on a volcano plot and had 
changed by > 2-fold with the application of the TD20 dose of polymer, with a FDR of < 0.05 
applied. The data was normalized using the Control samples for each donor. One (1) on the y-axis 
represents the control expression level. The colour of the lines was determined by the fold-change 
in expression of the gene for the TD05 polymer treatment for the donor 6F4181.The colour bar on 
the right shows how the colour of the line representing each gene related to fold-change.
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5 .4 .3 .4  T o p  25  G en e  L is ts
5.4.3.4.1 Top 25 U p -re g u la te d  Genes L is t: In -house  NHBE
When the combined in-house NHBE donor and TD05 altered gene lists were 
filtered, using a p-value £ 0.05 and an increased fold-change value of £ 2 fold, 
there were a total of 438 significantly up-regulated genes. When the combined 
in-house NHBE donor and TD20 altered gene lists were filtered, using these
same criteria, there were a total of 658 significantly up-regulated genes. From
these significantly up-regulated altered genes lists, the 25 genes which had the 
lowest p-values, i.e. the most significant, were examined in terms of their main 
‘functional’ roles. The majority were stress response related (52% at TD05 and 
64% at TD20), and included chemokines, cytokines and genes involved in the 
immune response (Figures 5.13 and 5.14).
5.4.3.4.2 Top 25 D o w n -re g u la te d  G enes L is t: In-house NHBE
Using combined lists of NHBE in-house samples of altered genes for TD05 and 
TD20 S2219200 polymer treatments, genes were filtered by using a p-value < 
0.05 and a fold-change > 2, and only those genes down-regulated were 
examined. For the TD05 polymer treatment, the down-regulated gene list
■ Transporters and Signal Transducers
■ Cell Growth, Proliferation & Differentiation 
□  Apoptosis
■  Stress Response
4%
\
20%
Figure 5.13 A pie chart illustrating gene percentages found in the main functional categories, for 
the NHBE Top 25 most up-regulated genes at the TD05 S2219200 polymer treatment. The major 
functional category was represented by the Stress Response genes (52%). This was followed by 
Transporters and Signal Transducers (24%), Cell Growth, Proliferation and Differentiation (20%), 
and lastly Apoptosis-related genes (4%).
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■ Transporters and Signal Transducers
■ Cell Growth, Proliferation & Differentiation 
□  Apoptosis
■  Stress Response ____
4%
Figure 5.14 A pie chart illustrating gene percentages found in the main functional categories, for 
the NHBE Top 25 most up-regulated genes at the TD20 S2219200 polymer treatment. The major 
functional category was represented by the Stress Response genes (64%). This was followed by 
the two categories of Transporters and Signal Transducers (16%) and Cell Growth, Proliferation 
and Differentiation (16%), and lastly Apoptosis-related genes (4%).
20%
■ Transporters and Signal Transducers
■ Cell Growth, Proliferation & Differentiation
■ Stress Response 
□ Binding
■ Cell Adhesion
■ Ubiquitin cycle and proteolysis__________
28%
Figure 5.15 A pie chart illustrating gene percentages found in the main functional categories for 
the NHBE Top 25 most down-regulated genes at the TD05 S2219200 polymer treatment. The 
major functional category was represented by Binding genes (36%), followed by Stress Response 
genes (28%) and Transporters and Signal Transducers (20%). The last three categories 
represented include the Ubiquitin cycle and proteolysis (8%), Cell Adhesion (4%) and Cell Growth, 
Proliferation and Differentiation (4%).
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■ Transporters and Signal Transducers
■ Cell Growth, Proliferation & Differentiation
■ Stress Response
□ Binding
■ Cell Adhesion
□ Ubiquitin cycle and proteolysis
Figure 5.16 A pie chart illustrating gene percentages found in the main functional categories for 
the NHBE Top 25 most down-regulated genes at the TD20 S2219200 polymer treatment. The 
major functional category represented was Binding genes (32%), followed by Stress Response 
genes (20%) and Transporters and Signal Transducers (16%). The last three categories 
represented include Cell Adhesion (12%), Cell Growth, Proliferation and Differentiation (12%) and 
the Ubiquitin cycle and proteolysis (8%).
included a total of 79 genes, and for the TD20 treatment list, over 1000 genes. 
The majority of the Top 25 down-regulated genes involved binding, with 36% for 
TD05 and 32% for TD20 (Figures 5.15 and 5.16). The second largest functional 
group was stress response genes, with 28% for TD05 and 20% for TD20 (Figures 
5.15 and 5.16). The third largest functional group involved the signal transducers 
and transporters, 20% for TD05 and 16% for TD20 (Figures 5.15 and 5.16). Other 
functional categories which were down-regulated included cell growth and 
proliferation, cell binding and proteolysis.
5.4.3.4.3 Top 25 U p -re g u la te d  G enes L is t: E p iA irw ay™
The total number of genes significantly up-regulated after filtering (Section 
5.3.3.4.1), was 167 at the TD05 treatment for the EpiAirway™ cells, and 322 for 
the corresponding TD20 treatment. At both treatments, the Top 25 genes were 
dominated by stress response genes, (48% for TD05 and 44% for TD20) (Figures 
5.17 and 5.18). The genes included cytokines (interleukins and chemokines). The 
second largest functional category represented was transporters and signal 
transducers, with 24% of the genes for both the TD05 and the TD20 treatments.
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The third largest functional group for both treatments was cell growth, proliferation 
and differentiation (with 16% for TD05 and 12% for TD20). The last three 
functional categories, i.e. apoptosis, cell cycle and cell adhesion, all contained 4% 
of the genes at TD05. At TD20, the percentage of genes in cell adhesion was 
also 4%, however, the percentages of genes in the cell cycle and apoptosis 
functional categories was 8%.
5.4.3.4.4 T op  25 D o w n -re g u la te d  Genes L is t: E p iA irw ay™
Lists of the most significantly down-regulated genes for the EpiAirway™ polymer 
treated samples were generated as described in section 5.4.3.4.2. The Top 25 
EpiAirway™ down-regulated genes were dominated by genes involved in binding, 
with 36% of the genes in this functional category at TD05 and 52% at TD20. 
Stress response was the second largest category for both target doses, with 16% 
for the TD05 treatment and 13% for the TD20 dose. The categories for the 
remaining genes were cell growth, proliferation and differentiation; and 
proteolysis, (which had the largest percentages of genes for both treatments). For 
the TD05 target dose, they were 12% in both categories and for TD20, 9% for 
both categories. For the TD05 concentration cell adhesion and transporters and
■  Transporters and Signal Transducers
■  Cell Growth, Proliferation & Differentiation 
□  Apoptosis
■  Stress Response
■ Cell Cycle
■  Cell Adhesion
Figure 5.17 A pie chart illustrating gene percentages found in the main functional categories, for 
the EpiAirway™ Top 25 most up-regulated genes at the TD05 S2219200 polymer treatment. The 
major functional category represented was Stress Response genes (48%) followed by 
Transporters and Signal Transducers (24%) and Cell Growth, Proliferation and Differentiation 
(16%). The last three categories equally represented include Cell Adhesion (4%), Cell Cycle (4%) 
and Apoptosis (4%).
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■ Transporters and Signal Transducers
■  Cell Growth, Proliferation & Differentiation 
□  Apoptosis
■  Stress Response
■ Cell Cycle
■ Cell Adhesion
Figure 5.18 A pie chart illustrating gene percentages found in the main functional categories from 
the EpiAirway™ Top 25 most up-regulated genes for the TD 20 S2219200 polymer treated cell 
cultures. The major functional category represented was Stress Response (44%), followed by 
Transporters and Signal Transducers (24%) and Cell Growth, Proliferation and Differentiation 
(12%). The last three categories represented include two categories which were at 8 %, Cell Cycle 
and Apoptosis and one category at 4%, Cell Adhesion.
8 % 1 2 %
4% 8%
12%
■ Transporters and Signal Transducers
■ Cell Growth, Proliferation and Differentiation
□ Apoptosis
■ Stress Response
□ Binding (calcium , metal, DNA, protein, etc.)
■ Cell Adhesion
■ Ubiquitin cycle and Proteolysis
■ Structural
4%
36%
Figure 5.19 A pie chart illustrating gene percentages found in the main functional categories from 
the EpiAirway™ Top 25 most down-regulated genes for the TD05 S2219200 polymer treatment 
cell cultures. The major functional category was represented by Binding genes (36%), followed by 
Stress Response genes (16%). Two functional categories represented 12% of the genes, Cell 
Growth, Proliferation and Differentiation; and the Ubiquitin cycle and Proteolysis. Two functional 
categories represented 8% of the genes, Transporters and Signal Transducers; and Cell 
Adhesion. Two functional categories represented 4% of the genes, Apoptosis and Stress 
Response.
Tracy Hughes 171
■ Transporters and Signal Transducers
■ Cell Growth, Proliferation and Differentiation
□ Apoptosis
■ Stress Response
□ Binding (calcium , metal, DNA, protein, etc.)
■ Cell Adhesion
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52% 13%
Figure 5.20 A pie chart illustrating gene percentages found in the main functional categories from 
the EpiAirway™ Top 25 most down-regulated genes for the TD20 S2219200 polymer treatment 
cell cultures. The major functional category was represented by the Binding genes (52%), followed 
by Stress Response genes (13%). Two functional categories represented 9% of the genes, Cell 
Growth, Proliferation and Differentiation; and the Ubiquitin cycle and Proteolysis. Four functional 
categories represented four percent of the genes, Cell Adhesion, Apoptosis, Transporters and 
Signal Transducers and Phospholipid biosynthesis.
signal transducers. They were both 8% of the down-regulated genes, followed by 
structural genes and apoptosis related genes; both at 4%. For the TD20 
treatment, the four remaining categories of down-regulated genes were all at 4% 
(Figures 5.19 and 5.20).
5 .4 .3 .5  V enn  D ia g r a m s
In Venn diagram A, three lists of genes were compared, each list containing those 
genes whose expressions were significantly different between two noted 
conditions (Control versus TD05 and TD20).The greatest number of gene 
expression changes (89%) occurred when comparing Control samples to TD20 
treated samples, with 1428 genes changing (Figure 5.21A).
The Venn diagram B (Figure 5.21) compared genes which showed significantly 
different expression levels when comparing the Control sample expression levels 
to those of the TD05 or TD20 polymer treated sample levels, in the three different 
in-house donors. Donor 6F4181 had the smallest number of unique or unshared 
altered genes, (462 or 21.8%) and donor 7F1169 had the greatest number of
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unique or unshared altered genes (3352 or 71 %). The greatest overlap of genes 
was between donors 6F181 and 7F3000, with 1532 genes in common (72.2% for 
6F4181 and 44% for 7F3000).
A Venn comparison was generated (Figure 5.21 C) for those genes that had 
changed in expression by at least 2-fold in Control samples versus TD05, and 
Control versus TD20 polymer treated samples. The greatest numbers of unique 
or unshared genes were found in the control versus TD20 polymer treated 
sample list, with 789 genes or 79% of the genes unique. The majority of the 
genes altered in the Control versus TD05 polymer treated samples list were also 
contained in the Controls versus TD 20 list (63%).
The final two lists of genes compared included the control cell cultures for the in- 
house and commercial models (Figure 5.21 D). The EpiAirway™ Control cells 
expressed the greatest number of unique genes with 2241 (8 % of the total 
genes). The NHBE in-house cells had only 618 unique genes (2.4% of the total 
genes expressed); sharing 97.6% of its genes with the EpiAirway™ Control 
samples.
5.4 .3 .6  G O :O n to lo g y  Da ta
The following ontologies lists (Tables 5.3 to 5.6), were generated using the lists of 
those genes which had been significantly altered (by at least 2 -fold, with a p-value 
£ 0.01) by the S2219200 polymer TD05 and TD20 treatments. These lists had not 
been additionally filtered using the Benjamini and Hochberg parametric test 
(Benjamini and Hochberg, 1995). The lists were organized in order of the 
ontologies with the highest significance, i.e. smallest p-value.
5.5 Discussion
Microarray technology can be used as a tool to compare the global gene 
expression profiles for cells of different types (i.e. healthy versus cancerous cells), 
as well as comparing untreated cells to those which have been challenged with a 
potentially toxic or therapeutic compound. Examination of gene expression can 
provide information about biological response regarding the activation or inhibition 
of certain cell signalling pathways involved with inflammation, cell apoptosis, lipid
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A NHBE COMBINED B NHBE DONORS
Control vs TD05 Control vs TD20
TD05 vs TD20
39654  
all genes
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donor 6F4181 donor7F1169
33715 
all genes
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NHBE EpiAirway™
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MattekTD05vsTD202Xp 01
13320 
ail genes
Control vs TD05 Control vs TD20
Figure 5.21 Venn diagrams comparing fold-changes and gene expressions. (A) Comparison of 
those genes which had changed by > 2 fold in expression from controls to TD05 polymer 
treatments (top left circle) from controls to TD20 polymer treatments (top right circle), and those 
genes which had changed by > 2 fold from the TD05 to TD20 treatments (bottom circle). (B) 
Comparison of genes which had changed ^ 2 fold with a p ^ 0.5, by at least one treatment with 
S2219200 polymer, in the three different in-house NHBE donors. (C) Comparison of genes 
showing a > 2 fold-change for the EpiAirway™ samples. (D) Comparison of those genes which 
have shown expression in the Control samples of the in-house NHBE Control cell cultures, and 
those genes found to be expressed in the EpiAirway™ Control samples.
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M ost s ignificant O ntologies fo r 'altered' Genes List in  NH B E Control Versus TD05 S2219200 Polym er Treatment
Category Genes in 
Category
% of Genes in 
Cateqory
Genes in List in 
Category
% of Genes in List in 
Category
p-Value
G O :9611: response to wounding 560 3.101 32 19.75 3 .77E -17
GO:9605: response to external stimulus 1038 5.748 4 2 25.93 5.95E-17
GO:43207. response to external biotic stimulus 753 4.169 36 22.22 8.91 E-17
GO:9613: response to pest, pathogen or parasite 743 4.114 35 21.6 4.04E-16
GO:9607: response to biotic stimulus 1328 7.353 45 27.78 2.68E-15
GO:6955: immune response 1163 6.44 41 25.31 1.71 E-14
GO:6952: defense response 1283 7.104 42 25.93 9.43E-14
GO:6954: inflammatory response 300 1.661 19 11.73 2 .70E -11
GO:42330: taxis 184 1.019 15 9.259 1.10E-10
GO:6935: chemotaxis 184 1.019 15 9.259 1.10E-10
M ost Significant Ontologies fo r Up-regulated Genes L ist in NHBE Control VerSUS TD05 S2219200  Polym er Treatm ent
Category Genes in 
Cateqorv
% o f Genes in Genes in List in % of Genes in List in p-Value
G O :9611: response to wounding 560 3.101 50 18.94 2.74E-25
GO:9605: response to external stimulus 1038 5.748 66 25 5.83E-25
GO:43207: response to external biotic stimulus 753 4.169 56 21.21 2.28E-24
GO:6955: immune response 1163 6.44 68 25.76 1.16E-23
GO:9607: response to biotic stimulus 1328 7.353 72 27.27 3.52E-23
GO:6952: defense response 1283 7.104 70 26.52 1.18E-22
GO:9613: response to pest, pathogen or parasite 743 4.114 53 20.08 3.29E-22
GO:6954: inflammatory response 300 1.661 30 11.36 9.16E-17
GO:42330: taxis 184 1.019 23 8.712 3.33E-15
GO:6935: chemotaxis 184 1.019 23 8.712 3.33E-15
Most S ign ificant O ntologies fo r Dow n-regulated Genes List in NHBE Control Versus TD05 S2219200 Polym er Treatmerit
Category Genes in 
Category
% of Genes in 
Cateqory
Genes in List in 
Cateqory
% of Genes in List in 
Category
p-Value
GO:50874: organismal physiological process 2699 14.94 17 41.46 3.64E-05
GO:6953: acute-phase response 37 0.205 3 7.317 8.00E-05
GO:48609: reproductive organismal physiological process 109 0.604 4 9.756 0.000107
GO:50876: reproductive physiological process 110 0.609 4 9.756 0.000111
GO:7565: pregnancy 83 0.46 3 7.317 0.00088
GO:6704: glucocorticoid biosynthesis 2 0.0111 1 2.439 0.00454
GO:16477: cell migration 170 0.941 3 7.317 0.00672
GO:6975: DNA damage induced protein phosphorylation 3 0.0166 1 2.439 0.0068
GO:6855: multidrug transport 3 0.0166 1 2.439 0.0068
G O :9611: response to wounding 560 3.101 5 12.2 0.0084
TabJe 5.3 Data generated in GeneSpring using the Go:Ontologies option for the NHBE altered genes list for the TD05 S2219200 polymer treatment.
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Most Significant Ontologies for •altered’ Genes list in NHBE Control versus TD20 S2219200 Polymer Treatment
Category Genes in 
Category
% of Genes in 
Category
Genes in Ust in 
Category
% of Genes in List in 
Category
p-Value
GO:9611: response to wounding 560 3.101 79 9.472 4.03 E-19
GO:9605: response to external stimulus 1038 5.748 114 13.67 2.17E-18
GO:9607: response to biotic stimulus 1328 7.353 129 15.47 2.34 E-16
GO:6952: defense response 1283 7.104 125 14.99 5.91 E-16
GO:6955: immune response 1163 6.44 116 13.91 1.46 E-15
GO:42330: taxis 184 1.019 34 4.077 3.60 E-12
GO:6935: chemotaxis 184 1.019 34 4.077 3.60 E-12
GO:43207: response to external biotic stimulus 753 4.169 79 9.472 6.12E-12
GO:9613: response to pest, pathogen or parasite 743 4.114 78 9.353 8.16E-12
GO 50896 response to stimulus 2873 15.91 205 24.58 2.34 E-11
Most Significant Ontologies for Up-regulated Genes U st in NHBE Controls VersiJS TD20 S2219200 Polymer Treatment
Category Genes in 
Category
% of Genes in 
Cateqory
Genes in Ust in 
Category
% of Genes in List in 
Category
p-Value
GO:9605: response to external stimulus 1038 5.748 82 20.5 1.71E-24
GO:6955: immune response 1163 6.44 86 21.5 9.33E-24
GO:9611: response to wounding 560 3.101 58 14.5 5.21 E-23
GO:9607: response to biotic stimulus 1328 7.353 90 22.5 2.95E-22
GO:6952: defense response 1283 7.104 87 21.75 1.67E-21
GO:43207: response to external biotic stimulus 753 4.169 63 15.75 4.70 E-20
GO:9613: response to pest, pathogen or parasite 743 4.114 61 15.25 5.06 E-19
GO:6950: response to stress 1531 8.477 88 22 4.01 E-17
GO50896: response to stimulus 2873 15.91 128 32 5.09E-16
GO:42221: response to chemical stimulus 518 2 868 45 11.25 4.16E-15
Most Significant Ontologies for Down-regulated Genes List in NHBE Control Versus TD20 S2219200 Polymer Treatment
Category Genes in % of Genes in 
Category
Genes in Ust in 
Cateqory
% of Genes in List in 
Category
p-Value
GO:7155: cell adhesion 944 5.227 67 11 6.18E-09
GO:7275: development 2826 15.65 147 24.14 2.01 E-08
GO:48513: organ development 845 4.679 55 9.031 2.35E-06
GO:16055: Wnt receptor siqnalinq pathway 166 0.919 18 2.956 1.31E-05
GO:6817: phosphate transport 138 0.764 16 2.627 1.70 E-05
GO:6820: anion transport 259 1.434 23 3.777 2.43 E-05
GO:9653: morphoqenesis 967 5.354 57 9.36 2.90 E-05
GO:6565: L-serine catabolism 3 0.0166 3 0.493 3.82 E-05
GO 43433: negative regulation of transcription factor activity 7 0.0388 4 0.657 4.13E-05
GO:15698: inorganic anion transport 219 1.213 20 3.284 5.50 E-05
Table 5.4 Data generated in GeneSpring using the Go:Ontologies option for the NHBE altered genes list for the TD20 S2219200 polymer treatment.
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Most Significant Ontologies for ‘altered' Genes in the EpiAirway Control versus 11)05 S2219200 Polymer Treatment
Category Genes in 
Category
% of Genes in 
Cateqory
Genes in List in 
Category
% of Genes in List 
in Category
p-Value
G 0:9611: response to wounding 560 3.101 48 17.45 1.05E-22
GO:9605: response to external stimulus 1038 5.748 64 23.27 2.02E-22
GO:43207: response to external biotic stimulus 753 4.169 53 19.27 4.37E-21
GO:9613: response to pest, pathogen or parasite 743 4.114 52 18.91 1.40E-20
GO:9607: response to biotic stimulus 1328 7.353 68 24.73 2.04E-19
GO:6955: immune response 1163 6.44 63 22.91 3.62E-19
G0:6952: defense response 1283 7.104 64 23.27 1.13E-17
GO6950: response to stress 1531 8.477 64 23.27 5.47E-14
GO:50874: organismal physiological process 2699 14.94 89 3 2 36 2.14E-13
GO:6954: inflammatory response 300 1.661 23 8.364 2.26E-10
Up-regulated Ontologies in EpiAirway Control versus TD05 S2219200 polvmer Treatment
Category Genes in 
Category
% of Gene in Genes in List in % of Genes in 
Category
p-value
GO:9611: response to wounding 560 3.101 39 30.47 3.54E-28
GO:9607: response to biotic stimulus 1328 7.353 53 41.41 5.15E-27
GO:9605: response to external stimulus 1038 5.748 48 37.5 5.19E-27
GO:43207: response to external biotic stimulus 753 4.169 42 32.81 1.39E-26
GO:6955: immune response 1163 6.44 49 38.28 8.32E-26
G 0  9613: response to pest, pathogen or parasite 743 4.114 41 32.03 9 72E-26
GO:6952: defense response 1283 7.104 50 39.06 7.55E-25
GO:6950: response to stress 1531 8.477 46 35.94 3.98E-18
GO:6954: inflammatory response 300 1.661 22 17.19 2.01 E-16
GO:50896: response to stimulus 2873 15.91 59 46.09 7.70E-16
Down-regulated Ontologies for EpiAirway Control vs TD05 S2219200 polymer Treatment
Category Genes in % of Genes in 
Category
Genes in List in 
Category
% of Genes in List 
in Cateqory
p-Value
GO:9071: serine family amino acid catabolism 15 0.0831 4 2.721 5.36E-06
GO:7171: transmembrane receptor protein tyrosine kinase activation (dimerization) 7 0.0388 3 2.041 1.81 E-05
GO:6544: glycine metabolism 27 0.15 4 2.721 6.39E-05
GO:6565: L-serine catabolism 3 0.0166 2 1.361 0.000196
GO:9069: serine family amino acid metabolism 55 0.305 4 2.721 0.00104
GO:6067: ethanol metabolism 9 0.0498 2 1.361 0.00228
GO:6069: ethanol oxidation 9 0.0498 2 1.361 0.00228
GO:6546: glycine catabolism 12 0.0664 2 1.361 0.00412
GO:9063: amino add catabolism 83 0.46 4 2.721 0.00471
GO:9310: amine catabolism 87 0.482 4 2.721 0.00556
Table 5.5 Data Generated in GeneSpring using the Go:Ontologies option for the EpiAirway altered genes lists for the TD05 S2219200 polymer treatment
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M ost S ign ificantly  G o:O ntologies fo r 'altered' Gene Lists in  EpiA irw ay C ontrol versus TD20 S2219200 Polym er Treatm ent
Category Genes in Category % of Genes in Category
Genes in List in 
Category
% of Genes in List 
in Category p-Value
GO:9605: response to external stimulus 1038 5.748 " ...  * 1 0 8 1.20E-14
G O :9611: response to wounding 560 3.101 95 6.795 2.04E -13
GO:6950: response to stress 1531 8.477 182 13.02 1.54E-09
GO:9613: response to pest, pathogen or parasite 743 4.114 103 7.368 3.87E-09
GO:43207: response to external biotic stimulus 753 4.169 104 7.439 3.97E-09
GO:9615: response to virus 87 0.482 24 1.717 2.59E-08
GO:6955: immune response 1163 6.44 140 10.01 6.92E-08
G 0:42060: wound healing 149 0.825 32 2.289 9.78E-08
GO:9607: response to biotic stimulus 1328 7.353 152 10.87 4.37E-07
GO:6954: inflammatory response 300 1.661 49 3.505 4.78E-07
U pregulated O ntologies EpiA irw ay C ontrol versus TD20 S2219200 polym er treatm ent
Category Genes in Category % of Genes in 
Cateaorv
Genes in List in 
Cateaorv
% of Genes in List 
in Category
p-Value
G O :9611: response to wounding 560 3.101 52 18.06 3.06E-25
GO:9605: response to external stimulus 1038 5.748 64 22.22 2.81 E-21
GO:6955: immune response 1163 6.44 63 21.88 4 30E-18
GO:43207: response to external biotic stimulus 753 4.169 50 17.36 6.07E-18
G O :9613. response to pest, pathogen or parasite 743 4.114 49 17.01 1.80E-17
GO:6952: defense response 1283 7.104 63 21.88 5.07E-16
GO:9607: response to biotic stimulus 1328 7.353 64 22.22 6.92E-16
G O:6954: inflammatory response 300 1.661 30 10.42 1.01 E -15
GO:6950: response to stress 1531 8.477 65 22.57 1.60E-13
GO:42330: taxis 184 1.019 18 6.25 9.40E-10
piAirw ay C ontrol vei sus TD20 S2219 200 po lym er Treatm ent
Category Genes in Category % of Genes in 
Category
Genes in List in 
Cateqory
% of Genes in List 
in Category
p-Value
GO:43449: alkene metabolism 28 0.155 10 0.901 3.50E-06
GO:9615: response to virus 87 0.482 18 1.622 4.59E-06
G O :6691: leukotriene metabolism 22 0.122 7 0.631 0.000245
G 0:42060: wound healinq 149 0.825 21 1.892 0.000311
G O :6081: aldehyde metabolism 17 0.0941 6 0.541 0.000366
GO:42445: hormone metabolism 81 0.449 14 1.261 0.000385
G O :19748: secondary metabolism 46 0.255 10 0.901 0.000395
GO:7089: traversing start control point of mitotic cell cvcle 7 0 0 3 8 8 4 0.36 0.000428
GO:6118: electron transport 488 2.702 49 4.414 0.000492
GO:7599: hemostasis 141 0.781 19 1.712 0.00103
Table 5.6 Data Generated in GeneSpring using the Go:Ontologies option for the EpiAirway altered genes list for the TD20 S2219200 polymer treatment
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metabolism and cellular regeneration that would not necessarily be detectable 
with traditional biochemical means. Microarray technology allows for the 
examination of the whole spectrum of genes, as opposed to methods which might 
target just one or several genes or proteins, such as ELISAs (enzyme-linked 
immunosorbent assay), PCR (polymerase chain reaction) or Northern blots. Each 
microarray represents thousands of separate biochemical assays performed at 
once, in a greatly shortened period of time.
The microarray platform for the transcriptomic investigations with the S2219200 
polymer was the Whole Human Genome Array (Agilent). This array system 
examined the expression of 44,000 genes per array. Microarray chips could either 
be designed based on DNA or oligonucleotide; the difference being that cDNA 
segments versus oligonucleotides would be used as the substrates. 
Oligonucleotides are shorter sequenced segments (15 to 70 nucleotides in length, 
MacLachlan et a i, 2004). In the following experiments, oligonucleotide arrays 
were used.
5.5.1 N a n o -D ro p  and  B io a n a ly z e r  D a ta
In order to accurately compare the gene expressions of different biological 
samples, all arrays must be applied with the same quantity and quality of cRNA. 
Before processing the extracted RNA it must first be quantified and the integrity 
examined. The RNA can be quantified and it’s quality assured using a 
spectrophotomer. The quantification metric was in the form of ng/pl, and the 
quality analysis in the form of a ratio of 260/280 nm absorption. Nucleic acid 
absorbs light in the 260 nm wavelength, proteins generally absorb at the 280 nm 
wavelength and salts and other solvents absorb at lower wavelengths, i.e. 
approximately 230 nm. A 2.0 ratio of 260 nm absorbance to 280 nm absorbance 
indicated that the RNA extraction sample contained pure RNA. The 260/280 ratio 
did not measure the integrity of the extraction sample, but provided information 
about possible protein contamination; and is a good rough working guide. Prior to 
array analysis, assessment of the internal composition of the RNA segment sizes 
was also required. Total RNA is comprised of two main ribosomal species, 28S 
and 18S fractions, with respective sizes of 5kb and 2kb. These species exist in a 
2 to 1 ratio in mammalian cells (Schroeder et a!., 2006).
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The traditional manner of examining the quality of RNA samples involved staining 
with ethidium bromide and running on a gel via electrophoresis. The appearance 
of two sharp bands on the gel at 2 kb and 5 kb was used as a confirmation of the 
identity of the RNA sample. Any outer lying bands (or smears) on the gel 
suggested contamination by enzyme degradation and larger bands (and smears) 
inferred genomic DNA contamination of the sample. The Bioanaylzer provided a 
measure of RNA integrity, by calculating the ratio between the 28S and 18S RNA 
to generate a RIN (i.e. RNA integrity Number). A sample with the highest level of 
RNA integrity is assigned a RIN number of 10, and a sample with the lowest RNA 
integrity is assigned a RIN number of 1 (Schroeder et a i, 2006). In these 
experiments, only those samples which were assigned a RIN number greater 
then 8.5 were further processed for application in microarrays.
When comparing the Nano-drop and Bioanalyzer data, it was revealed that the 
former generated higher concentrations of RNA. This ratio, in some cases, was 
as high as 33.4 times (as in donor 7F1169, TD05 #1). There were a number of 
samples which had concentrations of RNA that were very low, and this was 
confirmed both by the Nano-drop and the Bioanalyzer data. Due to continued low 
yield for all of the donor 7F1169 samples, when compared to other donors 
samples, all of these samples (for each condition) were pooled into one. The 
pooled and concentrated samples for donor 7F1169 showed RIN numbers of over 
9, which was considered acceptable. A number of samples, despite being 
concentrated, did not have improved RIN values, i.e. donor 6F4181 TD05 Sample 
# 3, and TD20 Sample # 3 and donor 7F3000 TD20 Sample #1. Therefore, it was 
decided to run only two sample arrays for each experimental condition for the 
donors 7F3000 and 7F1169.
5.5.2 S c a n n e r D a ta
The quality analysis data sheets showed that all scanned chips appeared to 
contain acceptable data and they were processed accordingly.
5.5.3 G eneS pring  Data
5.5.3.1 PCA
The first tool used to obtain a snapshot of how all of the 28 different gene arrays 
compared to one another, was PCA, in 3D analysis. For the 3-D graph, the array
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data sets were transformed and compressed in order to compare them in three 
components. The PCA graph illustrated that the in-house NHBE gene expression 
profiles were more closely related to each other then they were to the 
EpiAirway™ samples, as they were located more closely to one another on the 
graphs. The PCA graph also highlighted distinct differences in gene expression 
patterns between the Control samples and the TD05 and TD20 polymer-treated 
samples. Of the three in-house NHBE samples, the donor 7F1169 had the most 
distant array data points from the other two donors. The donor 7F1169 samples 
were pooled and this difference in RNA quantity and quality may explain their 
variable expression patterns, as well as different shifts between the treated and 
Control samples.
The EpiAirway™ samples formed a distinct cluster and were located at a distance 
from the NHBE samples, suggesting differences in the proportion of genes 
contributing to variance. The shifts or differences in location for the array points or 
gene expressions from the control samples, when compared to the TD05 and 
TD20 polymer samples, was similar in the EpiAirway™ and the in-house NHBE 
donors 7F3000 and 6F4181. Further analysis of alterations in gene expression 
from control to TD05 and TD20 S2219200 polymer doses was required to gain a 
better understanding of the effects of these target doses.
5.5 .3 .2  G ene  T r ees
When the expression of 1376 significantly altered genes was presented as a 
gene tree, it was apparent that there were a greater number of significant 
changes at TD20, when compared to the TD05 dose. It was evident that most 
genes that had been up-regulated in the TD05 polymer target dose had been up- 
regulated to an even greater extent at the TD20 polymer dose. Some genes that 
were shown to have not changed at the TD05 polymer dose were up- or down- 
regulated at the TD20 polymer target dose. There were a number of genes which 
appeared as bands towards the centre of the tree, and above the centre, that had 
been down-regulated at TD05 concentration and up-regulated at TD20 
concentration. Overall, there was a general trend towards an increase in the up- 
or down-regulation from the TD05 to TD20 polymer treated samples.
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Across all the NHBE donors and EpiAirway™ samples, there was a similar 
pattern of expression response to polymer treatments, with a greater response at 
the TD20 when compared to the TD05 dose. The NHBE samples exhibited a 
stronger degree of up- and down-regulation at the TD05 and TD20 doses than 
the EpiAirway™ samples; observed as a greater predominance of red and blue 
bars in the TD05 and TD20 sample columns. The second gene tree analysis 
deduced the expression patterns of the 8 6 8  genes, which were shown to be 
significantly altered in the EpiAirway™ samples. They appeared to have a similar 
response in the NHBE model. Nevertheless, in many cases, the changes were 
not as significant. Therefore, the similar gene expression patterns for the in-house 
versus the commercial respiratory epithelia model bodes well for the NHBE model 
efficacy, as well as for the representative nature of the commercial cells.
5.5 .3 .3  L in e  G r a ph s
A list of 239 genes, significantly altered by the treatment of the TD05 dose of 
polymer, was examined using the ‘line graph option’ in GeneSpring. This list of 
239 altered genes was generated using all of the TD05 dose microarray data 
gene lists (from the three in-house NHBE donors samples and the EpiAirway™ 
samples), and a number of methods of filtering. Gene lists were first filtered using 
the Filter on Confidence option, in which the Benjamini and Hochberg parametric 
test was applied. This statistical parametric test used a FDR factor of £ 0.05. This 
was not the most stringent of the parametric tests provided (i.e. Bonferroni), but it 
was a test which acted to eliminate a large portion of possible false positive data 
(Benjamini and Hochberg, 1995).
The list of genes considered to have been significantly altered using the 
Benjamini and Hochberg test were filtered on a volcano plot. The ‘volcano plot 
option’ was a tool in which genes from a gene list were displayed in a 3D scatter 
plot in which every gene was represented as a spot, and they were constructed 
using fold-change and p-value data for the genes. The volcano plot could be used 
to filter genes based on designated p-values (^ 0 .0 1 ) and fold-change ( t  2 .0 ) 
values.
A much smaller number of gene alterations were detected for the TD05 treatment 
when compared to the TD20 (e.g. 462 versus 1328), with the higher fold-changes
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observed at the TD20 treatment. The line graphs illustrated a similar pattern of 
gene changes across all three of the NHBE donors and the EpiAirway™ samples. 
The more dramatic gene alterations detected at the TD20 treatment (versus the 
TD05) could be corroborated by the morphological analysis (Chapter 4), observed 
when examining the electron micrograph images of their corresponding polymer 
treated cultures.
5.5 .3 .4  T o p  25  G e n e  L ists
5.5.3.4.1 T o p  25 U p -r eg u la ted  G enes  L is t : In-h o u se  NHBE
The dominance of stress response genes was observed at both polymer doses, 
with an increase from 52% (at TD05) to 64% (at TD20), which indicated a greater 
amount of stress inflicted on the cell cultures at the higher S2219200 
concentration. There was less cell growth and differentiation at the higher 
polymer dose (from 2 0 % to 16% of the genes), as well as fewer genes involved in 
transportation and signal transduction (from 24% to 16%), suggesting an overall 
slow down in growth and metabolic activity.
5.5.3.4 .1.1 U p-r e g u la te d  S tr e s s  R es p o n s e  G enes
The largest functional (biological) category of up-regulated genes, at both TD05 
and TD20, were the stress response genes, which included the cytokines. A 
number of cytokine families were represented on the lists: Interleukins (IL17C, 
IL23A), tumour necrosis factor ( TNF-member 2), colony-stimulating factors 
(CSF3 factors 2 and 3) and chemokines (CXCI5, CC/2, CXCL3, CCL20 and 
CXCL2). The chemokines play an important role in the inflammatory and defence 
responses, by acting as chemo-attractant molecules that control the migration of 
monocytes/phagocytes to the area and alter the binding activity of 
receptors/adhesion molecules (Wood, 2006). The up-regulation of chemokines 
has also been reported in NHBE cells for experiments which involved the 
exposure of a great number of irritants and carcinogens, e.g. asbestos and 
benzo(a)pyrene diol epoxide (Belitskaya-Levy et a!., 2007). The up-regulated 
stress response genes included the following:
• Colony Stimulating factor 3 (CSF3 or G-CSF): was the most up-regulated 
gene at TD05 and the second most up-regulated gene at TD20 (with fold- 
changes of 47.93 and 37.22, respectively). The release of CSF has been 
linked to; responses to infection, secondary immune cell recruitment, cell
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differentiation and cell death inhibition (Thompson, et e l, 1995; Barth et al., 
2002; Uemura, 2006; Saba et al, 2002). Up-regulation of G-CSF  in the in- 
house NHBE model by the commercial polymer represents both an 
inflammatory and a protective response.
•  Chemokine ligand 5  (CXCL5): otherwise known as the epithelial-neutrophil 
activating peptide-78 (ENA-78), or as the LPS-inducible CXC chemokine, was 
the third most up-regulated gene at TD05 and the fourth most up-regulated 
gene at TD20; with fold-changes of 19.54 and 28.14, respectively. CXC 
chemokines promote the migrations of neutrophils (Janeway and Travers, 
1997). The up-regulation of ENA-78 has been linked with numerous 
inflammatory conditions and lung diseases including sarcidosis, Acute 
Respiratory Disorder, and Idiopathic Pulmonary Fibrosis as well as the 
response of BEAS-2B cells to rhinovirus infection (Zineh et a l, 2006; 
Sugiyami et a l, 2006; Goodman et a l, 1996; Keane et a l, 2001; Donningeref 
a l, 2003). Up-regulation of the ENA-78 gene in the in-house NHBE 
model, by the commercial polymer, indicates a defensive response to a 
xenobiotic and an indicator of inflammation and disease like conditions.
A number of interleukins appeared on the up-regulated genes lists. Interleukins, 
like many cytokines, are mostly produced by T-cells (Janeway and Travers, 
1997). IL-17C was found in both lists, it was the fifth most up-regulated gene at 
TD05 (with a fold change of 19.19), and was the fourteenth most up-regulated 
gene at TD20 (fold-change of 13.93). IL-17F has been implicated as a major 
signalling molecule in NHBE cultures in a number of inflammatory pathways 
(Kawaguchi et a l, 2007). IL-17 is associated with tissue damage in the brain, 
joints, heart, lungs and intestines (Steinman, 2007). IL-23 was found at TD20 and 
not at TD05, and is known to drive a population of T-cells that produce IL-17, IL- 6  
and TNF (Steinman, 2007). Chen et a l found that IL- 6  and IL-17 treated primary 
human tracheo-bronchial epithelia stimulated the mucin genes MUC5B and 
MUC5AC (Chen et a l, 2003). They also demonstrated that IL-17 effects are 
partially mediated through IL- 6  and that both mediate MUC5B expression through 
the ERK signalling pathway (Chen et a l, 2003). Up-regulation of interleukins 
in the in-house NHBE model by the commercial polymer may represent the
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actions of a number of inflammatory pathways and possibly the eventual 
activation of mucin genes.
5 .5 .3 .4 .1 .2  U p-r eg u la te d  T r an spo rters  and  T r a n sd u c er s
The second largest category of up-regulated genes at TD05 and TD20 were the 
transporters and signal transducers, 24% (at TD05) and 16% (at TD20). The up- 
regulated Transporter and Transducer genes included the following:
• Defensin beta 4  (DEFB4) (an anti-biotic peptide [Cole and Waring, 2002]): 
was the second and third most up-regulated gene on the lists for TD05 and 
TD20 treatments, with fold-changes of 24.85 and 29.81, respectively. 
Defensins are anti-microbial and cytotoxic peptides that are produced as a 
defensive response and can be produced in response to inflammation (Cole 
and Waring, 2002). Defensins have been linked to wound cell closure and 
epithelial repair, chemotaxis, cytokine release and secondary immune cell 
responses (Aarbiou et al., 2004). In the NHBE cells, the defensin gene may 
have been up-regulated in response to foreign particle invasion in it’s role as 
an antimicrobial protein, or in response to tissue damage. Up-regulation of 
DEFB4 defensin in the in-house NHBE model by the commercial polymer 
treatment represents a protective and repair response.
5.5 .3 .4 .1 .3  O t h e r  U p -r eg u la te d  fu n c tio n a l  c a te g o r ies
The third largest up-regulated category was cell growth, proliferation and 
differentiation; representing 20% (at TD05) and 16% (at TD20). A growth and 
differentiation gene found on both gene lists was Small proline-rich protein 1A 
(SPRR1A), which was up-regulated by 10.82-fold at TD05 and 23.96-fold at 
TD20. SPR1A is a structural protein known to be involved in epidermal 
development. The fourth functional category up-regulated was apoptosis. The 
gene known as Tribbles homolog 3 (TRIB3), was up-regulated 6.32-fold at TD05 
and 13.14-fold at TD20, and is involved in the regulation of the stress-activated 
MAP kinase pathway.
5.5.3.4.1.4 T o p  25 U p-r eg u la ted  G e n e s  a t  TD05
The Top 25 most up-regulated genes for the TD05 polymer target dose included 
the following:
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• Chemokine Ligand 2 (CCL2): was the fourth most up-regulated gene at 
TD05, (fold-change 19.23), and it was the twenty first most up-regulated gene 
at the TD20 treatment (fold-change of 1.067). CCL2 is more commonly known 
as the monocyte chemo-attractant protein-1 (MCP-1), an example of a CC 
chemokine which promotes the migration of monocytes (Janeway and 
Travers, 1997). MCP-1 is an inflammatory chemo-attractant (Liu et al., 2007). 
Up-regulation of MCP-1 has been linked to the inflammatory response in 
asthma, the development of lung fibrosis by stimulation of IL- 6  production and 
the ERK 1/2 pathway, and responses to physical injury in BEAS-2B cell 
cultures (Garofalo et al., 2005; Liu et al., 2007; Lundien et al., 2002). Fibrosing 
granulomas and chronic inflammation was found in rats exposed to lung 
overload concentrations of related polymers (Carthew et al., 2006). Up- 
regulation of MCP-1 in the in-house NHBE model, by the commercial 
polymer, indicates a response to harm or action to enhance the move 
toward fibrosis.
5.5.3.4.1.5 T o p  25 U p - r eg u la te d  G en es  a t  TD20
The Top 25 up-regulated genes for the TD20 polymer target dose included the
following:
• Colony Stimulating Factor 2 (CSF2) or Granulocyte Macrophage Colony 
Stimulating Factor (GM-CSF): was the number one most up-regulated gene 
at TD20 and is an example of a stress response gene (a chemokine). GM- 
CSF is known to activate macrophages and B-cell differentiation and to inhibit 
the growth of T-cells (Janeway and Travers, 1997). GM-CSF has been linked 
to respiratory and allergic inflammation, as well as lung cell and lung cancer 
cell survival (Ohtoshi et al., 1991; Hashimoto et al., 2000; Uemura et al., 
2006). The up-regulation of GM-CSF in the NHBE in-house cultures 
implies an inflammatory, as well as a protective response.
• RASD1 (RAS dexamethasone-induced 1), also referred to as Dexras-1:
was the fifth most up-regulated gene at TD20 (fold-change 26.66), and was 
the twentieth most up-regulated gene at TD05 (fold-change 6.48). Dexras-1 is 
one of many signal transduction proteins involved in the G-protein-coupled 
receptor signalling pathway. G-protein-coupled receptors (GPCRs) are 
transmembrane receptors that sense molecules and activate the transduction
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of signalling pathways leading to cellular responses, i.e. the transcription of 
other proteins or factors and inflammation (Lodish et al., 1995). GPCRs are 
believed to be involved in the mediation of the release of stored mucin from 
secretory granules. Dextras-1 has been linked to the inhibition of the ERK 
mitogen-activated protein (MAP) kinase signalling cascade, which is involved 
in a range of activities that involve proliferation, differentiation and survival 
(Graham et al., 2002). Over-expression of Dextras-1 in A549 cells was linked 
to a slowing of cell growth and an increase in cells undergoing apoptosis 
(Vaidyanathan et al., 2004). Up-regulation of RASD1 or Dextras-1 in the in- 
house NHBE in-house model, by the commercial polymer, suggests 
inflammation, mucin secretion, and the inactivation of a number of 
metabolic activities leading to apoptosis in a number of cells.
5.5.3.4.2 T o p  25 D o w n -r eg u la ted  G en es  Lists
There were 15 times greater number of genes down-regulated at TD20 when 
compared to TD05. A total of 79 genes were down-regulated by the TD05 
treatment and 1,186 genes down-regulated by the TD20 treatment. When 
comparing the composition of the individual genes from the TD05 and TD20, of 
the “Top 25” most down-regulated genes, there were a total of 3 genes which 
appeared on both lists. When comparing the lists of the “Top 25” down-regulated 
genes to those which had been up-regulated, there were a greater number of 
categories or functional groups. In terms of the p-values, the TD05 p-values were 
much larger, i.e. the changes were considered less significant than those of the 
TD20 treatment list. The TD20 treatment also had a higher number of genes 
down-regulated, suggesting a shut-down of cellular processes in response to a 
higher or more toxic dose of the polymer.
The most significantly down-regulated category of genes, at both the TD05 and 
the TD20 treatments, involved binding, at 36% and 32%, respectively. There were 
metal, protein and calcium ion-binding genes. It is known that secretory products 
of goblet cells, such as lactoferrin and transferrin, bind to iron to deprive bacteria 
of necessary growth factors, as well as for antioxidant formation, as a means of 
protection (Thompson et al., 1995). In the normal healthy lung, iron binding by 
molecules like transferrin plays an important antioxidant role, in that it inhibits 
iron-dependent lipid peroxidation (Pacht and Davis, 1988). Lipid peroxidation is
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an irreversible reaction, and in membrane lipids results in loss of fluidity, 
increased permeability to ions, and eventual cell rupture with release of numerous 
toxic cellular and lysosomal products (Pacht and Davis, 1988). The down- 
regulation of iron fixation may be considered a mechanism of damage inflicted by 
the resin polymer treatment. The TD20 treatment elicited less down-regulation of 
the binding, with 36% of genes for TD05 and 32% of genes at TD20. An example 
of a binding gene was ERp27, the most down-regulated gene in the TD05 
treatment list, (fold-change 0.15); a protein which binds to calreticulin (Alanen et 
al., 2006).
Stress response genes comprised 28% of the genes for TD05 and for TD20, 20% 
of the genes. Transport and signal transduction genes constituted 20% of the 
genes at TD05 and 16% of the genes at TD20 polymer doses. There was more 
down-regulation of cell-adhesion genes, (4% at TD05 and 12% at TD20) and 
growth and proliferation genes (4% at TD05 and 12% at TD20), at the TD20 
versus the TD05 dose, denoting a greater breakdown of the cell culture 
morphology (i.e. tight junctions), and a slow down in any growth or development.
5.5.3.4.2.1 T o p  25 D o w n -r eg u la te d  G e n e s  a t  TD05
The Top 25 down-regulated genes for the TD05 polymer target dose included the 
following:
•  Endoplasmic Reticulum Protein 27kDa (ERP27): was the most down- 
regulated gene at TD05 (fold-change 0.15). ERP27  binds to calreticulin, which 
in turn, binds to calcium ions. The calcium ion acts as a second messenger 
molecule, just as cyclic adenosine monophasphate (cAMP) and cyclic 
guanosine monophosphate (cGMP), which may signal downstream 
transcription. Down-regulation of calcium ion binding in the in-house 
NHBE model by the commercial polymer indicates a termination of 
cellular activities.
•  Keratin 4 (KERT4): was the second most down-regulated gene at the TD05 
treatment (fold-change 0.19). Keratins are cytoskeletal proteins that form 
filamentous structures, which provide cOlls and tissues with their structural 
integrity. Keratins form the building blocks of cell adhesion structures and 
intercellular junctions (e.g., desmosomes and hemidesmosomes, Presland
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and Jurevic, 2002). Down-regulation of keratin 4 has been linked to squamous 
and oral squamous carcinomas, as well as later stages of cell differentiation 
(Contag et al., 2004, Ohkura et al., 2005, Wanner et al., 1996). Down 
regulation of keratin-4 in the in-house NHBE model by the commercial 
polymer implies structural abnormality in the form of DNA or 
intercellular junction damage.
• Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1 and 
ISG56): was the third most down-regulated gene at TD05. IFIT1 is in the 
human viral stress inducible gene family, and has been found to be induced 
by interferon and double stranded RNA or a variety of viruses. IFIT1 can 
inhibit protein synthesis by binding to certain factors to form complexes 
(elF3c) (Terenzi et al., 2006, Ye et al., 2006). Down-regulation of IFIT1 in 
the in-house NHBE model by the commercial polymer represents an 
alteration in signalling and a protective response similar to that induced 
by viruses.
• SEC14L2, also known as Transporter Associated Antigen Processing 2 
(TAP2): was the fifth most down-regulated gene at TD05 (fold-change 0.319). 
It is believed to be involved in modulating phophatidylinositol-3-kinase, a 
central enzyme in signal transduction, cell proliferation and apoptosis and the 
transportation of degraded antigen components (Kempa et al., 2003, Kim et 
al., 2007). Lower expression of TAP2 has been linked to respiratory tract 
infections and disorders, monocyte recruitment and lung injury as well as 
cancer (Hanna et al., 2005, Imanishi et al., 2006). Down-regulation of TAP2 
in the in-house NHBE model, by the commercial polymer, may be a 
protective mechanism, however, studies have shown it indicates 
disease-like conditions.
5.5.3.4.2.2 T o p  25 Do w n -r eg u la ted  G e n e s  a t  TD20
The Top 25 down-regulated genes for the TD20 polymer target dose included the
following:
• Rab37 (a member of the RAS oncogene family): was the most down- 
regulated gene at TD20 (fold-change 0.173). Rab proteins are a family of 
GTPases involved in vesicle trafficking (Masuda et al., 2000). Masuda et al.
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found Rab37 to be expressed in mast cells located in the secretory granules, 
and concluded that it played a role in the exocytosis of mast cell granule 
contents and was involved in allergic inflammation (Masuda et al., 2000). 
Down-regulation of Rab37 in the in-house NHBE model by the 
commercial polymers may have an inhibitory effect on vesicle transport 
and concomitant transport of inflammatory mediators.
• Mannosidase Alpha Class 1C member 1 (MAN1C1): was the second most 
down-regulated gene at TD20, (fold-change 0.263). MAN1C1 is an inner 
membrane protein (Hellemans et al., 2004). Down-regulation of loss of 
function of the MANC1C1 gene have been linked to disorders which involve 
increased bone density and skin lesions of patients with fibrotic skin disorders 
(Hellemans et al., 2004). A down-regulation in MAN1C1 in the in-house 
NHBE model by the commercial polymer may be linked to limited 
findings which infer that MAN1C1 down-regulation affects extracellular 
matrix proteins and remodelling.
• V-set domain containing T-cell activation inhibitor 1 (VTCN1), also called 
B7H4: was the third most down-regulated gene at TD20, (fold-change 0.204). 
The B7 family are cell surface protein ligands which bind to receptors on 
lymphocytes to regulate immune responses (Collins et al., 2005). Decreases 
in B7H4 expression have been linked to inflammatory stimuli and activation 
and increases in tumour cell apoptosis (Collins et al., 2005; Salceda et al.,
2005). The down-regulation of B7H4 in the in-house NHBE model by the 
commercial polymer may be induced by inflammatory conditions and 
play a role in the modulation of the immune response and apoptotic 
events.
• Glutathione S-transferase A2 (GSTA2): was the fourth most down-regulated 
gene at TD20 and plays an important role in the breakdown and inactivation of 
toxicants (Xie et al., 2005). GSTA2 protects cells/tissues against oxidative 
stress (Zhao et al., 1999; Yang et al., 2001). Down-regulation of GSTS2 in 
the in-house NHBE model by the commercial polymer represents a 
decrease in antioxidant protection levels leading to oxidative damage.
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•  Cadherin 6, type 2, K-cadherin  (CDH6): was the fifth most down-regulated 
gene at TD20, (fold-change 0.203). Cadherin is a Ca2+-dependent cell-cell 
adhesion molecule that mediates cell-cell binding, and has been linked to cell 
differentiation (Shimoyama et al., 1995; Mbalaviele et al., 1998). Down- 
regulation of cadherin-6 in the NHBE model by the commercial polymer 
represents disrupted cell-cell adhesions, communication and 
differentiation.
5.5.3.4.3 T op  25 U p-r eg u la ted  G en es  L is t s : E piA ir w a y ™
There were 16 genes from the Top 25 most up-regulated list at TD05 that were 
also found on the TD20 list. TD05 and TD20 shared the same top two most up- 
regulated genes, Tumour Necrosis Factor alpha 1P6 (TNFA1P6) and CSF3. 
These response genes are involved in the recruitment of immune cells. At TD20, 
TNFA1P6 increased by 63-fold, and at TD05 it was increased by 36.4-fold. CSF3 
was elevated by 54.27-fold at TD20, and at TD05, it was elevated by 20.75-fold.
The EpiAirway™ Top 25 up-regulated genes included the following:
• TNFA1P6: was the number one most up-regulated gene at both treatments. 
The TNFA1P6 is a multi-functional protein with anti-inflammatory and 
chrondroprotective functions, linked with extra-cellular matrix (ECM) proteins 
in it’s role in tissue remodelling. It’s up-regulation has been linked to a number 
of inflammatory disease states such as asthma and arthritis (Forteza et al., 
2007; Milner and Day, 2003). Up-regulation of TNFA1P6 in the EpiAirway™ 
cell model by the commercial polymer represents anti-inflammatory 
actions that may have been up-regulated after 24 hours exposure to the 
polymer, as a result of earlier increases in pro-inflammatory mediators.
•  CSF3: was the second most up-regulated gene at both TD05 and TD20, and 
plays a role in neutrophil adhesion. The up-regulation of CSF3 has been 
linked to a number of pulmonary diseases or distress reactions and the 
proliferation of squamous cell carcinomas (Emad and Emad, 2007; 
Wiedermann et al., 2003; Gutschalk et al., 2006; Ramachandran et al., 2006). 
The up-regulation of CSF3 in the EpiAirway™ model by the commercial 
polymers may suggest inflammatory mediation or an increased risk of 
cancer.
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5.5.3.4.3.1 T op  25 U p -r eg u la te d  G en es  a t TD 05
The predominance of stress response genes on the list illustrated that the 
EpiAirway™ cell model was responding to the S2219200 polymer, according to 
an ‘external toxin stress’. The third most up-regulated gene at TD05 was IL-17, 
which was up-regulated by 18.46-fold. It is an immune response gene involved in 
neutrophil recruitment, and is known to play a key role in bronchial neutrophil 
influx in experimentally induced allergic reactions in mice (Hellings et al., 2003). 
There was up-regulation of IL-23A, by a fold-change of 7.27, and this may be 
related to the increase in IL-17. The fourth most up-regulated gene was DEFB4 
with a fold-change of 13.19 (see Section 5.4.3.4.1.2). The Top 25 up-regulated 
genes at the TD05 polymer target dose also included the following:
•  IL-20 : appeared on this list, with a fold-change of 11.6 6 , this interleukin was 
not detected on the NHBE treatment lists. Hsing et al., observed that a 
number of tumour cell types expressed IL-20, and in particular, squamous cell 
carcinomas (Hsing et al., 2006). Wang et al. found that IL-20 mRNA was 
elevated in psoriatic skin cells (Wang et al., 2006). Their workers stimulated 
keratinocytes with recombinant IL-20 and determined that this resulted in the 
up-regulation of genes involved in the regulation of proliferation, apoptosis and 
epidermal differentiation, including Tumor necrosis factor alpha-induced 
protein 3 (TNFAIP3), Serpin peptidase inhibitor clade B (ovalbumin), member 
4 (SERPINB4), Chemokine (C-C motif) ligand 20 (CCL20), and a number of 
small proline-rich proteins. Up-regulation of IL-20  in the EpiAirway™ model 
by the polymer treatment may act to modulate the proliferation and 
differentiation of cells in the culture, as well as the progression of 
inflammatory conditions.
• Forkhead box E1 thyroid transcription factor (FOXE1) : was up-regulated 
by 5.6-fold at TD05 and by 7.76-fold at TD20. Up-regulation of the FOXE1 
gene has been linked to basal cell carcinoma of skin in humans and mice 
(Brancaccio et al., 2004). Mutations of the FOXE1 gene have been linked to 
cleft palates and congenital hypothyroidism (Castanet et al., 2002). Up- 
regulation of the FOXE1 gene in the EpiAirway™ cell model by the 
polymer treatment suggests effects particularly to the basal cells and 
development of the tissue.
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• Claudin 14 (CLDN1): was up-regulated by over 6 -fold at TD05 and by 17.39- 
fold at TD20. Claudin 14 is involved in cell-cell adhesions, and acts as an 
integral molecule in maintaining trans-epithelial resistance in cell cultures (Van 
Itallie et al., 2005). The up-regulation of the CLDN14 gene in the 
EpiAirway™ cell model in response to the polymer treatment may 
represent a repair or cell regeneration response that was activated by 
damage inflicted to cell adhesions.
5.5.3.4.3.2 T o p  25 M o s t  U p-r eg u la te d  G e n e s  a t  TD20
The Top 25 up-regulated genes at the TD20 polymer target dose included the
following:
•  C1Q and tumor necrosis related factor 1 (C1QTNF1): was the third most 
up-regulated gene in the EpiAirway™ cell model at TD20, and was number 5 
on the TD05 list. C1QTNF1 is part of the CTRP superfamily. C1QTNF1 has 
been up-regulated in response to LPS in adipose tissue and has been linked 
to the interruption of the activation/aggregation of platelets by collagen (Kim et 
al., 2006; Lasser et al., 2006). Up-regulation of C1QTNF1 in the 
EpiAirway™ cell model in response to the polymer treatment may 
represent an anti-clotting mechanism.
• MAS-reiated GPR member X3 (MRGPRX3): was the fourth most up- 
regulated gene in the EpiAirway™ cell model at TD20, (fold-change 18.35). It 
was also up-regulated at TD05 by 11-fold. It is a G-coupled protein receptor 
that plays a role in sensory signal transduction. Down-regulation of MRGPRX3 
has been linked to increased sensitivity to pain and heat and up-regulation of 
MRGPRX3 has been linked to disturbances in cell differentiation (Grazzini et 
al., 2004; Kaisho et al., 2005). Up-regulation of MRGPRX3 in the 
EpiAirway™ cell model by the polymer treatment, can be equated to 
increases in response-related signal transductions, and may also result 
in disturbance to cell differentiation.
• IL17C: was the fifth most up-regulated gene in the EpiAirway™ cell model at 
TD20 was with a fold-change of 17.89, (see Section 5.4.3.4.1.1), and was the 
third most up-regulated gene at TD05.
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5.5 .3 .4 .4  T op  25  Do w n -r eg u la te d  G e n e s : E piA ir w a y™
The down-regulated gene lists for the EpiAirway™ cell model contained genes 
from a greater number of functional groups. There were 12 genes from the Top 
25 most down-regulated genes at TD05 which were also found on the TD20 list. 
Most of the genes played roles in a number of metabolic activities. The Top 25 
down-regulated genes as a result of polymer dosing for the EpiAirway™ tissue 
included the following:
• Cornulin: was the number one most down-regulated gene in the EpiAirway™ 
cell model at both the TD05 and the TD20 treatment. Comulin derives it’s 
name from the term cornified envelope, or the cornified outermost epidermal 
layer of the skin, which acts as a protective barrier (Contzler et al., 2005). 
Comulin has been identified as a biomarker of late epidermal differentiation 
(Contzler et al., 2005). Over-regulation of comulin has been linked to inhibited 
cell proliferation and down-regulation of comulin has been linked to 
oesophageal cancer and oral squamous carcinoma cells (Xu et al., 2000; Imai 
et al., 2005). Down-regulation of cornuiHn in the EpiAirway™ cell model 
by the polymer treatment suggests abnormal cell differentiation 
occurring as a result of cellular damage.
5.5.3.4.4.1 T o p  25 D o w n -r eg ula ted  g e n e s  a t  TD05
The Top 25 down-regulated genes at the TD05 polymer target dose included the 
following:
• Mai T-cell differentiation protein (MAL): was the second most down- 
regulated gene in the EpiAirway™ cell model at TD05. Down-regulation of 
MAL has been linked to oesophageal squamous cell carcinomas and pre- 
cancerous lesions. (Mimori et al., 2007; Kazemi-Noureini et al., 2004). The 
down-regulation of MAL in the EpiAirway™ cell model by the polymer 
treatment may represent abnormal cell differentiation or a cellular 
response indicative of DNA damage.
• Homeodomain Only Protein (HOPX): was the third most down-regulated 
gene in the EpiAirway™ cell model at TD05 (fold-change 0.223), which was 
also on the Top 25 most down-regulated list at TD20. Down-regulation of the 
HOPX  gene has been linked to eosphageal squamous cell carcinomas,
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hyphopharygeal carcinomas and lung cancer cells (Yamashita et al., 2008; 
Chen et al., 2003; Lemaire et al., 2004). The down-regulation of the HOPX  
gene in the EpiAirway™ cell model by the polymer treatment may 
represent the inhibition of developmental actions.
• Zinc Finger Protein 114 (ZNF14): was the fourth most down-regulated gene 
in the EpiAirway™ cell model at TD05 (fold-change 0.236). There is minimal 
information available on this gene. Its function, according to the NCBI online 
database Gene Entrez (NCBI, Gene Entrez, 2008), is as a DNA binding 
protein involved in the regulation of gene transcription. The down-regulation 
of ZNF114 in the EpiAirway™ cell model by the polymer represents the 
down-regulation of transcriptional activity.
• Visinin-likel (VSNL1): was the fifth most down-regulated gene in the 
EpiAirway cell model at TD05 was with an expression change of 0.223. 
VSNL1 is a calcium binding protein involved in the transduction of calcium- 
dependent cell signals (e.g. modulation of voltage-gated Ca+2 and A-type K+ 
channels) (Dai et al., 2006). VSNL1 has been linked to cell differentiation and 
up-regulation of VSNL1 has been linked to increased sensitivity and cell death 
and down-regulation has been linked to Alzheimer’s disease (Xie et al., 2007, 
Schnurra et al., 2001). The down-regulation of VSNL1 in the EpiAirway™ 
cell model in response to the polymer represents a disruption to calcium 
homeostasis, and subsequent reduced sensitivity to toxin challenges.
5.5.3.4.4.2 T o p  25 D o w n -r eg u la te d  G e n e s  a t  TD20
The Top 25 down-regulated genes at the TD20 polymer target dose included the
following:
• Keratin-4: was the second most down-regulated gene in the EpiAirway™ cell 
model at TD20 (see Section 5.4.3.4.2.1). Keratin-4 down-regulation in the 
EpiAirway™ cell model in response to polymer treatment represents 
consequential DNA or structural damage.
• CYP2C9 (a cytochrome P450 protein): was the third most down-regulated 
gene in the EpiAirway™ cell model at TD20, with an expression change of
0.121. CYP2C9 is an enzyme known to metabolize carcinogens and 
xenobiotics. The up-regulation of CYP2C9 has been linked to vasoprotective
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COX-2 expression and it’s down-regulation has been linked to malignant 
tissue (Garcia-Martin et al., 2002; Chan et al., 2004; Enayetallah et al., 2006; 
Michaelis et al., 2005). The down-regulation of CYP2C9 in the EpiAirway™ 
cell model in response to the polymer treatment may be a pro- 
inflammatory response linked to cell damage.
• Claudin 8 (CLDN8): was the fourth most down-regulated gene in the 
EpiAirway™ cell model at TD20 was with an expression change of 0.127. 
CLDN8 , together with occuldin, form tight junctions (Grone et al., 2007). 
Down-regulation of CLDN8 has been linked to colon cancer, ulcerative colitis 
and Crohn’s disease (Grone et al., 2007; Zeissig et al., 2007; Kim et al.,
2006). The down-regulation of claudin-8 in the EpiAirway™ cell model 
following polymer treatment in the EpiAirway™ tissue may represent 
deterioration of the cell tight junctions or junctional complexes.
• Transcription factor NFE2 nuclear factor (erythroid-derived 2, 45kDa):
was the fifth most down-regulated gene in the EpiAirway™ cell model at TD20 
with an expression change of 0.137. NFE2  has been shown to have a role in 
the later stages of cell differentiation, platelet production and oxidation 
protection (Koury et al., 2002; Labbaye et al., 1995; McCormack et al., 2006). 
The down-regulation of NEF2 in the EpiAirway™ cell model in response 
to polymer treatment may represent a disruption in the wound response 
mechanisms.
5.5 .3 .5  V enn  D iagram s
The Venn diagram analysis showed that 259 genes were altered at TD05 polymer 
dose; where 90% of these were also altered at the TD20 polymer dose. This type 
of analysis closely aligned with the pattern of gene expression determined via line 
graph analysis. Venn diagram analysis did not reveal whether these genes had 
been up- or down-regulated, but did identify that a greater number of unique gene 
alterations had occurred at the TD20 dose when compared to the TD05 dose.
The second Venn analysis involved a comparison of the lists of genes that had 
been altered following one treatment with the S2219200 polymer. One treatment 
referred to the TD05 and TD20 data as a combined set or series. Donor 7F1169 
was shown to have the greatest number of unique genes; 3352. This donor also
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demonstrated the greatest degree of variance following PCA. Donor 7F300 had 
the second greatest number of unique genes; 1330. Similar gene profiles were 
determined between donors 6F4181 and 7F3000, where 72% of the total number 
of genes altered in the former (2122) were also altered in the latter. This finding 
supported their respective PCA, where these two donors were shown to have the 
least variance.
The third Venn analysis compared the list of genes that had been significantly 
altered in EpiAirway™ samples between; (1) Control and TD05 dose; (2) Control 
and TD20 dose and; (3) the TD05 and TD20 dose. The analysis demonstrated 
that at the TD05 treatment, 259 genes were altered, and of these, 90% were 
significantly altered at the TD20 dose. It was also determined that there were 
many unique gene alterations at TD20, which had not been changed at TD05. A 
similar pattern was observed in the in-house NHBE cell model and reinforced the 
gene expression data via the line graph analysis. Sixty nine percent of the genes 
that had been altered at the TD20 dose were unique.
The final Venn analysis compared the Control gene expression profiles of the in- 
house and EpiAirway™ cell cultures. This analysis provided evidence that there 
was similarity within the Control samples between the in-house NHBE and the 
EpiAirway™ cell cultures, with over 90% of genes shared.
5.5 .3 .6  G o :On to lo g y  L ists
5.5.3.6.1 U p-r eg u la ted  O n to lo g ie s : In -h o u s e  NHBE
There was significant overlap between the up-regulated ontologies in the TD05 
and the TD20 polymer treated cell arrays. Nineteen out of the Top 20 up- 
regulated ontologies were the same for both the TD05 and TD20 treatments. 
However, the lists did not have the exact same rankings for these ontologies; with 
the exception of ‘response to pest, pathogen or parasite’, ranked number seven 
for both. The TD05 target dose was denoted by ‘cytokine and chemokine 
mediated signalling pathways’, whereas the TD20 treatment arrays were 
characterised by ‘carboxylic acid metabolism pathways’.
Other Top 10 ontologies included ‘biological response’ (i.e. response to 
wounding, stress, external biotic, chemical stimuli, taxis, etc.), and two of the up-
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regulated ontologies were associated with ‘cell proliferation’. These lists 
suggested that the in-house NHBE cultures were responding to the S2219200 
polymer dosing in much the same way that they would to a ‘wide range of stimuli’,
i.e. in a protective and defensive manner. The number one cellular response 
‘wounding’, suggested that after 24 hours of exposure to the polymer, cellular 
damage was involved and repair mechanisms initiated. This was further 
supported by the appearance of ‘chemotaxis’ on the lists. Chemotaxis or 
migration of cells to a chemical gradient, is a characteristic of wound repair 
(Juhasz eta!., 1993).
5.5.3.6.2 D o w n - reg u la ted  O n t o l o g ie s : In -h o u se  NHBE 
The lists of down-regulated ontologies for the TD05 dose response included a 
number of categories for ‘physiological processes’, especially ‘biosynthesis and 
metabolism’. Glucocortoids (corticosteroids) are vital regulators of glucose 
metabolism (Michal, 1999). These steroid hormones are signalling compounds 
which coordinate a range of physiological activities in the cells of higher 
organisms (Brown, 2007). The steroids move through the cell binding to steroid 
receptors, and migrating into a cell’s nucleus, to act as a transcription activator 
(Brown, 2007). The glucocortoids are known to have a suppressive effect on 
inflammation (inhibiting leucocyte migration, etc.), and as such, their down- 
regulation could contribute to inflammation. For the TD05 down-regulated 
ontologies list, there were two examples of transport (chloride transport and multi­
drug transport). The down-regulation of transport may suggest a reduction in 
intercellular signalling and subsequent metabolic activity.
Four out of the Top 20 down-regulated ontologies for the TD20 polymer treatment 
dealt with ‘blood coagulation’, e.g., haemostasis, coagulation and heparin 
sulphate proteoglycan metabolism. Haemostasis is “the balanced equilibrium 
between coagulation and fibrinolysis” (Michal, 1999). The heparan sulphate 
proteoglycan acts to inhibit blood coagulation. The down-regulation of blood 
coagulation may cause increases in vascular permeability or an inflammatory 
response (Michal, 1999). For the TD20 dose response, ‘cell adhesion’ was the 
most down-regulated, followed by ‘organ development’ and ‘Wnt signalling’. The 
down-regulation of cell adhesion may be linked to an increase in the permeability 
of the tissue in response to the S2219200 polymer; a pro-inflammatory response
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would also involve the breakdown of the integrity of the tissue. Maunders et al. 
also found that NHBE cells exposed to whole cigarette smoke evoked a down- 
regulation of the Wnt signalling pathway after 24 hours of exposure (Maunders et 
al., 2007).
5.5.3 .6 .3  U p-r eg u la ted  O n t o l o g ie s : E piA ir w a y ™
There was a great degree of overlap between the up-regulated ontologies in the 
TD05 and the TD20 treated cell arrays. Nine out of the Top 10 ontologies were 
the same for both the TD05 and TD20 treatments; ten out of the Top 10, for TD05 
and 9 out of the Top 10 for TD20 were related to ‘response’. The response 
categories included response to external stimulus, external biotic stimulus, stress, 
chemical stimulus, biotic stimulus, pest, pathogen or parasite. The number one 
response for both polymer treatments was the response to ‘wounding’. The 
EpiAirway™ tissue was clearly harmed by both the polymer doses, as noted by 
the histopathology (Chapter 4) and the up-regulation of genes involved in 
‘external stress’, in an ‘immunological defence’ response manner. This was 
further reinforced in examination of the Top 25 up-regulated genes lists, which 
revealed the largest functional category of stress response (Section 5.4.3.4).
5.5.3 .6 .4  D o w n -r eg ula ted  O n t o l o g ie s : E piA ir w a y ™
The two lists of Top 10 ontologies for the down-regulated ontologies did not share 
any categories in common; unlike the lists of up-regulated ontologies from TD05 
and TD20 doses. The down-regulation of genes does not necessarily equate to 
the down-regulation of a process; it simply implies that a process has been 
affected by a treatment. The lists of down-regulated ontologies at TD05 included 
a number of categories involving ‘metabolism’ (e.g., glycine, ethanol, and serine 
family amino acid) and ‘catabolism’ (e.g., glycine, amino acid, amine, serine 
family amino acid, L-serine), as well as ‘ethanol oxidation’ and ‘trans-membrane 
receptor activation’. All of these referred to an effect on metabolic activity across 
a range of biological processes. At TD20, there was an effect on metabolism (i.e. 
alkene, leukotriene, aldehyde, hormone, and secondary), as well as genes 
involved in the ‘response to viruses’, ‘wound healing’, ‘transversing start control 
point of the mitotic cell cycle’, ‘electron transport and haemostasis’. The effect on 
metabolism suggested a possible shut down, such as the cell cycle, indicated by 
the down-regulation of ‘transversing start control point of mitotic cell cycle’. The
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wound healing process and haemostasis may have been affected. Haemostasis 
is the stoppage of bleeding by vasoconstriction, platelet adhesion and 
degranulation, i.e. wound healing. Both of these processes encompass the 
actions of many proteins and have clearly been more greatly affected at the 
higher S2219200 polymer dose.
5.6 Conclusions
The RNA quantification and quality analysis demonstrated that despite similar 
handling and growing conditions, the three different NHBE donors RNA samples 
differed in quantity and quality. The commercial EpiAirway™ samples were grown 
under unknown conditions by the manufacturers. The EpiAirway™ cell inserts 
had larger membrane surface areas and appeared to have the greatest amount of 
tissue, which may have accounted for the greater yields of RNA. The RNA from 
donor 7F1169, which was concentrated and pooled due to low quality and yield, 
revealed an acceptable RIN value. When examining the gene expression data in 
the PCA graphs and the homology trees, this donor (7F1169) demonstrated a 
more varied gene expression pattern, when compared to other NHBE donors, 
and the EpiAirway™ samples. The low yield of RNA for this donor may have been 
due to health status (i.e. unhealthy). This donor tissue might have been more 
sensitive to xenobiotic exposures and hence, compromised from the start. The 
source of donor tissue, whether commercial, i.e. EpiAirway™, or sourced as in 
primary cells (e.g., Lonza), affected the nature of the transcriptomic data 
generated, and should be considered carefully, when setting-up research 
projects.
The PCA provided an overall picture of the apparent differences and similarities 
between the global patterns in gene expression. The EpiAirway™ cell cultures did 
have a gene expression which was unique to the in-house NHBE donors, across 
all the conditions (Control, TD05 and TD20). There were visible trends between 
the gene expression patterns of the Control samples versus the TD05 treated 
cells, as well as shifts in the global expressions between the TD05 and the TD20 
treated cells. PCA suggested that these shifts shared a similar pattern in two of 
the three in-house NHBE donors and the EpiAirway™ cells. The homology trees 
demonstrated that the EpiAirway™ and NHBE cell cultures had similar patterns of
i racy Hughes 200
CHAPTER HVir MICROARRAY TECHNOLOGY GENESPRING ANALYSIS
up- and down-regulation, in most of the genes altered, by the TD05 and TD20 
S2219200 polymer treatments.
The examination of altered genes, on an individual basis yielded insight into the 
specific roles of the altered genes. The up-regulated genes were associated with 
a stress response and inflammation related exposure to a xenobiotic (i.e. GCSF3, 
IL-17, DEFB4, Rab37 and ENA-78 all up-regulated in the in-house NHBE 
model,). Many up-regulated genes have been linked to respiratory infections and 
disease (i.e. TAP2 and MCP-1 both up-regulated in the in-house NHBE model 
and TNFA1P6 in the EpiAirway™ model). Some up-regulated genes suggested 
response to cell-junction damage (i.e. CLDN14 in the EpiAirway™ model at 
TD05). The down-regulated genes may have suggested a reduction of metabolic 
activity (i.e. ZNF114  and VSNL1 in the EpiAirway™ model), and they also 
reflected a possible breakdown of cell adhesions (i.e. cadherin-6 in the in-house 
NHBE model and keratin-4 in both the in-house NHBE model and the 
EpiAirway™ model) and the remodelling of damaged cells and tissue, or a wound 
response (i.e. comulin and NEF2 in the EpiAirway™ model). There were also a 
number of genes which suggested links to cancer (i.e. MAL and HOPX  both 
down-regulated at TD05 in the EpiAirway™ model and FOXE1 up-regulated in 
the EpiAirway™ model, and CSF3 up-regulated in both cell models).
The Go:Ontology lists confirmed that the S2219200 polymer treatment had 
induced the tissue to respond in a manner similar to external stimuli stress and 
that damage had occurred in the tissue. The EpiAirway™ and in-house NHBE 
exhibited nearly identical Go:Ontology lists for the up-regulated genes and 
showed differences in the down-regulated Ontology lists. However, both 
demonstrated down-regulation in a wide range of metabolic and developmental 
genes indicative of a demise to normal growth and activity, which will be further 
explored in Chapter 6 , using Metacore™ analysis.
GeneSpring analysis suggests that both the in-house and EpiAirway™ models 
generated insightful data in terms of transcriptomic responses. The GeneSpring 
software provided an illustrated comparison of individual donor data, in the form 
of PCA, Line Graphs and gene trees. Larger sample group data could be 
analyzed using Venn diagrams, to pinpoint genes shared by all donors in injurious
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polymer responses, to target potential ‘biomarkers’ for polymer inflicted damage. 
This information in could be used in conjunction with Go:Ontology lists, as tools to 
characterize damage ‘profiles’ of xenobiotics in risk assessment.
The studies performed by Carthew et al. of the transcriptomic responses to similar 
polymers in rats showed a parallel pattern of response including alterations in 
inflammatory genes or cytokines (Compliment 3) and immune response genes 
(eotaxin), as well as genes involved in tissue remodelling (macrophage 
metaloelastase and plasminogen activator). When a list of 25 genes shown to be 
changed in both of the high doses of the polymers in the rat studies at both 9 and 
2 2  weeks was compared with a list of genes found to be altered at either the 
TD05 or TD20 treatments in the either the EpiAirway™ or in house NHBE cell 
models, 1 1  of the human equivalents of the rat genes were common to the data 
from this study. This suggests that although the studies are not directly 
comparable due to the differences in the timepoints, tissues and array systems 
used the results show commonality. This provides assurance that the in vitro 
system is demonstrating similar activity to in vivo tissues. However, the 
differences between the gene lists may also be representative of the difference in 
response between human and rodent tissue and could highlight the potential 
benefits of using human-derived rather than rodent test systems to model human 
responses.
As was mentioned in section 5.3.8, the NHBE and EpiAirway™ control sample 
gene expression data has not been explored in this chapter. However, this data 
represents a valuable untapped resource with many potential applications. 
Further exploration of the genes found to be expressed in the control samples 
could be compared to existing human in vivo NHBE gene expression data to 
further characterize and validate these models. These expression profiles might 
also be used in the future to aid in the determination of respiratory cell type 
compositions or the identification of biomarkers representative of human tracheo­
bronchial tissue. These types of studies are beyond the scope of this project due 
to limitations of time and resources, however the data generated in this study is 
now available for such analysis when the time and resources permit.
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C h a pter  6 
M ic r o a r r a y  T e c h n o lo g y : 
M e t a c o r e ™ A na lysis
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6.0 Introduction
Metacore™ is the microarray (pathway) analysis tool used to generated the data 
described in this chapter of work. Metacore™ is a commercially available 
computational tool that translated the statistically filtered array data (e.g. polymer 
treatments, Chapter 5) into information about relevant biological pathways and 
cellular processes. Metacore™ is part of the GeneGo Systems Biology and 
Pathway Analysis data mining tool. GeneGo is a bioinformatics product that 
enables users to upload filtered array data for analysis, using a highly currated 
database of mammalian biology and medicinal chemistry (www.genego.com). 
This database is derived from experimentally proven protein-protein, protein- 
DNA, and protein-compound interactions (www.genego.com), using published 
peer-reviewed experimental findings. The program performed integrated and 
comparative analysis of multiple data types, using advanced algorithms derived 
from an in-depth understanding of signalling and metabolic pathways. The use of 
Metacore™ in this component of the research project has permitted a better 
understanding and elucidation of the mechanism of S2219200 polymer action on 
the in-house NHBE and EpiAirway™ cell models (Chapter 5).
6.1 A ims of the C hapter
The aims of this chapter are:
• Lists of the most significantly altered GeneGo maps, process networks and 
diseases, for both the TD05 and the TD20 S2219200 polymer-treated in- 
house and EpiAirway™ NHBE tissue, are compared, to evaluate the biological 
responses of the tissue
• Metacore™ generated diagrams of the two most significantly altered GeneGo 
process networks are presented at an in-depth level of analysis for each target 
dose and NHBE tissue source.
6.2 M ethods
6.2.1 M e ta c o r e ™
The Metacore™ Online Database Program (https://portal.genego.com) was used 
in order to upload gene lists for further analysis. The Data Manager option 
allowed gene lists to be up-loaded for further analysis. Gene lists had to be 
uploaded in Microsoft Excel spreadsheets which contained the Agilent ID
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numbers, corresponding GenBank ID numbers, as well as the specific values for 
fold-change and p-value. The fold-change values must be up-loaded in log 2 
format, to enable the values for down-regulated genes to be translated or 
transformed. In this way, the Metacore™ program is able to distinguish those 
genes on the list that had been down-regulated from those that had been up- 
regulated. Gene lists could be examined individually or numbers of lists could be 
activated and compared with the Compare Experiment option. Lists could be 
further filtered in Metacore™ by choosing a threshold value and a p-value. The 
threshold value of 0 . 0 0 1  was chosen and the p-value of 0 . 0 1  was chosen.
Experiments or gene lists were used to generate data concerning the statistical 
analysis of five separate categories: (1) GeneGo maps, (2) GeneGo processes, 
(3) GeneGo process networks, (4) diseases, and (5) diseases by biomarkers. 
When comparing two or more experiments or gene lists, the data from the 
number of gene lists were compared by many genes within the various 
categories, as being common, shared or unique. This information is depicted as a 
bar graph. The parts of the bar graph, representing each one of these categories, 
could be selected and saved as separate gene lists. Top 10 lists for each one of 
these five categories were generated. The in-house NHBE TD05 and TD20 
polymer-dosed altered gene lists, derived from the data from three donors, were 
used to generate the Top 10 lists for three of the five categories. The Top 2 maps 
of the greatest statistical relevance, for the TD05 and the TD20 altered gene list, 
were selected for further analysis. The same procedures were followed using the 
EpiAirway™ TD05 and TD20 polymer-dosed altered gene lists.
6.3 R e s u lts  I: In -H o u s e  NHBE
The in-house NHBE data was loaded into the Metacore™ online database 
program to explore the significant changes, as they related to biological 
processes (e.g. inflammation) and signalling pathways (e.g. apoptosis), as a 
result of S2219200 polymer treatments (Chapter 5).
6.3.1 M e t a c o r e™ T o p  10 C a te g o r ie s  L is t s : In -house  NHBE
The list of GeneGo maps, (Tables 6.1 and 6.2), represented the most significantly 
altered biological pathways, and were complied with reference to up-regulated 
and down-regulated genes (Chapter 5). The GeneGo process networks, (Tables
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6 . 1  and 6 .2 ) incorporated a number of inter-linking pathways that were 
significantly altered. The lists of diseases (Table 6.1 and 6.2) were related to 
diseases associated with alterations in specific genes. The tables of the Top 10 
most significantly altered maps, process networks and diseases, were followed by 
the maps of the two most significantly altered pathways (Figures 6.2 to 6.5).
6.3.1.1 T o p  10 C a te g o r ie s  L ist  for  TD05: In-ho u se  NHBE
The GeneGo map analysis (Table 6.1) identified immune response pathways as 
being the associated link to significantly altered genes, following the TD05 
polymer treatment. The GeneGo network analysis (Table 6.1) determined that 
inflammation was the principle process category. The disease list (Table 6.1) 
illustrated a range of inflammation driven disorders (e.g. arthritis and 
arteriosclerosis; Table 6.1).
6 .3.1.2 T o p  10 C a te g o r ie s  L ist  fo r  TD20: In-ho u se  NHBE
The GeneGo map analysis for the TD20 polymer treated, significantly altered 
genes suggested that an immune response was governing the pathways (Table 
6.2). The GeneGo network analysis (Table 6.2) revealed tissue damage related 
processes. The disease analysis (Table 6.2) identified health conditions which 
directly related to inflammation (e.g. arthritis and vascular diseases).
6.3.2 T o p  2 G en eG o  M a p s  fo r  TD05 a n d  TD20: In -h o u se  NHBE
The two most statistically relevant maps (or pathways) for the TD05 treatment 
according to Metacore™ analysis were: (1) Immune response-MIF-mediated 
glucocorticoid regulation (figure 6.2), and (2) Cytokine production by Th17 cells in 
CF (Cystic Fibrosis) (figure 6.3). The two most significantly relevant maps (or 
pathways) for the TD20 treatment were: (1) Cell adhesion-ECM remodelling 
(Figure 6.4), and (2) Development-WNT signalling pathway (Figure 6.5).
6.4 Results  II: EpiA ir w a y™
The EpiAirway™ microarray data was loaded into the Metacore™ online 
database program to explore any significant changes related to biological 
processes and signalling pathways, following S2219200 polymer treatments 
(Chapter 5).
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NHBE TD  05 Polymer Dose
Up and Down Regulated Genes
Maps
Category ratio p-value
Immune response MIF-mediated glucocorticoid regulation 9 81 6.89E-08
Cytokine production byTh17 cells in CF 10 118 1.73E-07
Bacterial infections in CF airways 10 142 9.69E-07
Immune response IL1 signaling pathway 9 127 3.21 E-06
Immune response Bacterial infections in normal airways 9 131 4 15E-06
Immune response Histamine H1 receptor signaling in immune response 11 221 8.24E-06
Cytokine production by Th17 cells in C F (Mouse model) 9 151 1.32E-05
Cholesterol Biosynthesis 6 62 2.47E-05
Immune response _Toll-like receptor (TLR) ligands and common TLR signalling 
pathway leading to cell proinflammatory response 8 139 5.09E-05
Immune response MIF in innate immunity response 8 173 2.32E-04
o o  processes networks
Category ratio p-value
Chemotaxis 24 134 1 70E-11
Inflammation Neutrophil activation 29 217 2 08E-10
Inflammation Amphoterin siqnalinq 21 117 3.23E-10
Cell adhesion Platelet-endothelium-leucocyte interactions 25 175 9.86E-10
Inflammation Innate inflammatory response 24 178 7.14E-09
Inflammation IL-10 anti-inflammatory response 16 88 3.76E-08
Inflammation Histamine sianalinq 24 213 2 40E-07
Inflammation MIF siqnaling 17 140 5.42E-06
Inflammation TREM1 signaling 16 139 2.05E-05
Inflammation Protein C signaling 13 103 4.72E-05
Diseases
Category ratio p-value
Arthritis, Rheumatoid 56 484 4.14E-14
Connective Tissue Diseases 86 1020 3.18E-13
Necrosis 54 479 3.78E-13
58 544 4.89E-13
Digestive System Diseases 141 2177 7.54E-13
Patholoqic Processes 141 2187 1.11E-12
61 605 1 30E-12
Lung Diseases 95 1220 1 45E-12
Arteriosclerosis 46 379 2 01E-12
Arthritis 59 580 2.27E-12
Table 6.1 Meta core Top 10 lists for GeneGo maps, Go processes networks and diseases for NHBE TD05 polymer treatment
CHAPTER 
SIX 
M
ICROARRAY 
TECHNOLOGY 
METACORE™
 
ANALYSIS
Tracy 
Hughes 
208
I ■ NHBE TD 20 Polymer Dose
Up and Down Requlated Genes
[Maps
Category ratio p-value
Cell adhesion ECM remodeling 17 175 1 40E-07
Development W NT signaling pathway. Part 2 16 235 3.18E-05
Bacterial infections in CF airways 12 142 3.84E-05
Cytokine production by Th17 cells in CF 10 118 1 63E-04
Glycine, serine, cysteine and threonine metabolism 10 132 4.05E-04
Cell adhesion Chemokines and adhesion 20 446 1.02E-03
Cytokine production by Th17 cells in CF (Mouse model) 10 151 1.15E-03
Immune response MIF-mediated glucocorticoid regulation 7 81 1.37E-03
Immune response _PG E2 signaling in immune response 9 130 1.47E-03
Immune response Bacterial infections in normal airways 9 131 1.55E-03
Go processes networks
Category ratio p-value
Cell adhesion Platelet-endothelium-leucocyte interactions 36 175 9.49E-09
Chemotaxis 30 134 2.25E-08
Cell adhesion_Cell-matrix interactions 36 207 8.13E-07
Signal transduction W NT siqnalinq 31 178 4.68E-06
Proteolysis Connective tissue degradation 24 120 4.99E-06
Signal transduction NOTCH siqnalinq 36 224 5.51 E-06
Proteolysis ECM remodeling 19 85 9.15E-06
Inflammation TREM1 signaling 25 139 2.24E-05
Inflammation Amphoterin siqnaling 22 117 3.42E-05
Development Blood vessel morphogenesis 32 218 1.14E-04
Diseases
Category ratio p-value
Gastrointestinal Diseases 198 1490 1.46E-13
Joint Diseases 102 605 6.84E-13
Diqestive System Diseases 261 2177 7.45E-13
Arthritis 97 580 4.56E-12
Vascular Diseases 171 1273 5.90E-12
Rheumatic Diseases 92 544 9.35E-12
Wbunds and Injuries 109 694 1.09E-11
Carcinoma 235 1950 1 56E-11
Blood Protein Disorders 67 344 1.58E-11
Vascular Hemostatic Disorders 68 352 1.62E-11
Table 6.2 Metacore Top 10 lists GeneGo maps, Go processes networks and diseases for NHBE TD20 polymer treatment
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Figure 6.1 A legend to identify the icons, letters, arrows and pictorial shapes and structures on the 
GeneGo maps. The shapes of the protein icons define their functional roles, such as enzymes, 
transporters, receptors, regulators, etc. The effects arrows between protein icons identify the 
types of interactions, or effects, one protein has upon another. The green arrows between proteins 
represented the potential activation effect one protein might have on the other and the red arrows 
or lines between proteins represent the potential inhibition. The localisation symbols illustrate 
where in the cell proteins are generally located. The ‘mechanisms’ are the letters which represent 
the types of actions one protein may have on the other and are found on the effects lines with the 
arrows.
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glucocorticoids
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Figure 6.2 The image generated in Metacore™ for the map of Immune Response-MIF mediated 
glucocorticoid regulation. This map illustrates the NHBE in-house tissue microarray data. Genes 
up-regulated at TD05 are signified by the red thermometers with the number one and include the 
receptor Intercellular Adhesion Molecule 1 (ICAM1), the receptor ligands Tumor Necrosis Factor 
alpha (TNF-alpha), interleukins IL-6 and IL-8, the binding protein I kappa B (IkB), the 
metalloprotease MMP-1, the enzyme Cyclooxygenase 2 (COX-2) and the transcription factor 
Nuclear Factor kappa B (NFkB). All of these proteins, except for the binding protein IkB, were up- 
regulated at the TD20 treatment, as indicated by the thermometers with the number two.
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Figure 6.3 The image generated in Metacore™ for the map of Cytokine production by Th17 cells 
in CF. This map illustrates the in-house NHBE tissue microarray data. Genes up-regulated at the 
TD05 polymer treatment are signified by the red thermometers with the number one and include 
the receptor ICAM1, the receptor ligands IL-6, IL-23, IL-23A, IL-8, G-CSF, GM-CSF, GCP2, 
transcription factor NF-kB and the binding protein IkB. All of these were also up-regulated at the 
TD20 treatment, signified by the red thermometers with the number two.
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Figure 6.4 The image generated in Metacore™ for the map of Cell adhesion-ECM remodelling. 
This map illustrates the in-house NHBE microarray data. Genes up-regulated at TD05 are 
signified by the red thermometers with the number one and includes the metallopoteases MMP-1, 
16 and 9, the enzyme Urokinase Plasminogen Activator (PLAU), the receptor PLAUR, the 
receptor ligands Heparin Binding-Epidermal Growth Factor (HB-EGF) and IL-8, the binding protein 
moesin, and the ECM protein Laminin-5. Genes down-regulated at TD05 are signified by the blue 
thermometers with the number 1 and include the ECM proteins fibronectin, vesican and 
osteonectin and the binding protein Tissue Inhibitor of Metalloproteinase 3 (TIMP-3). At the TD20 
treatment (illustrated by the number two thermometers), there was up-regulation of the enzyme 
PLAU, the receptor PLAUR, the metalloprotease MMP-1, and the receptor ligands HB-EGF and 
IL-8. At TD20 the down-regulation genes are indicated by the blue thermometers with the number 
two, and include the ECM proteins nidogen, collagen I and IV, vesican, Laminin-5, fibronectin and 
osteonectin, the metalloprotease MMP-12 and the binding protein TIMP-3.
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Figure 6.5 The image generated in Metacore™ for the map of Development -Wnt signalling 
pathway (part 2). This map illustrates the in-house NHBE tissue microarray data. Genes up- 
regulated at TD05 are signified by red thermometers with the number one and include the 
receptor ligand WNT, the receptor Galpha (q)-specific frizzeled G-Coupled Protein Receptor 
(GCPR) and the transcription factor Fos related antigen- 1 (Fra-1). The genes down-regulated at 
TD05 are signified by the blue thermometers with the number one and include the binding protein 
Axin. At the TD20 treatment, the red number two thermometers indicate up-regulation of the Fra-1 
transcription factor and the receptor ligand Vascular Epidermal Growth Factor A (VEGF-A). At the 
TD20 treatment the blue thermometers with the number two indicate down-regulation of the 
receptor ligands WNT, the receptor Galpha(q)-specific frizzled GPCR, the binding proteins 
Frequently Rearranged in Advance T-cell lymphoma 1 (FRAT1), Axin, Ectodermal Neuronal 
Cortx-1 (ENC1) and survivin, the transcription factors Tcf(lef) and Immunoglobulin Transcription 
Factor 2 (ITF2) and the metalloprotease MMP-7.
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6.4.1 M etacore™ Top Ten categories Lists: EpiA irway™
The list of GeneGo maps represented the most significantly altered biological 
pathways, and was comprised of both the up-regulated and down-regulated lists 
(Table 6.3 and 6.4). The GeneGo process networks (Tables 6.3 and 6.4) 
incorporated a number of interlinking pathways that were significantly altered. The 
lists of diseases (Table 6.3 and 6.4) showed those associated with alterations in 
specific genes.
6.4.1.1 T op 10 categories List for TD05: EpiA irway™
The GeneGo map analysis (Table 6.3) was dominated by immune response and 
cytokine and inflammatory mediator production. The processes network analysis 
(Table 6.3) demonstrated inflammatory networks as being the most prevalent.
6.4.1.2 Top 10 categories List for TD20: EpiA irway™
The GeneGo map analysis (Table 6.4) was divided among cell adhesion and 
developmental pathways (i.e. cell-adhesion-ECM remodelling and development- 
Wnt signalling), metabolic (i.e glycine, serine, cysteine and theronine 
metabolism), defensive (i.e. bacterial infections in the CF airways) and immune 
pathways (i.e. immune response-MIF-mediated). The process network analysis 
(Table 6.4), was again divided, this time between cell adhesion, signal 
transduction, proteolysis and inflammation-related networks. The disease 
analysis (Table 6.4) incorporated a number of disorders that involved damage 
and restructuring of tissue.
6.4.2 Top 2 GeneGo Maps for TD05 and TD20: EpiA irway™
The two most statistically relevant pathway maps for the TD05 treatment 
according to Metacore™ analysis were: (1) Immune response -  bacterial 
infections in normal airways (Figure 6 .6 ) and (2) Cytokine production by Th17 
cells in CF (Figure 6.3). The two most significantly relevant maps for the TD20 
treatment were: (1) HETE (hydroxyeicosatetraenoic acids) and HPTE
(hydroperoxy eicosatetraenoic acids or hydroperoxides) biosynthesis and 
metabolism (Figure 6.7) and (2) Cytokine production by Th17 cells in CF (Figure 
6.3).
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EpiAirway TD 05 Polymer Dose
Up and Down Regulated Genes
Maps
Category ratio p-value
Immune response Bacterial infections in normal airways 13 131 5.35E-06
Cytokine production by Th17 cells in CF 12 118 9.50E-06
Bacterial infections in CF airways 13 142 1 29E-05
HETE and HPETE biosynthesis and metabolism 7 50 9.17E-05
Prostaglandin 1 biosynthesis and metabolism 6 42 2.61 E-04
Immune response MIF-mediated glucocorticoid regulation 8 81 3.53E-04
Immune response J L 1 signaling pathway 10 127 4.32E-04
Cytokine production by Th17 cells in CF (Mouse model) 11 151 4.43E-04
Immune response _Signaling pathway mediated by IL-6 and IL-1
9 107 5.12E-04
Immune response _Toll-like receptor (TLR) ligands and common TLR  
signalling pathway leading to cell proinflammatory response 10 139 8.75E-04
Go processes networks
Category ratio p-value
Inflammation Innate inflammatory response 27 178 3.89E-06
Inflammation Protein C signaling__ 18 103 2.39E-05
Inflammation Amphoterin signaling 19 117 4.15E-05
Cell adhesion Platelet-endothelium-leucocyte interactions 24 175 7.35E-05
Inflammation IL-10 anti-inflammatory response 15 88 1.53E-04
Inflammation TREM1 signaling 19 139 4.30E-04
lnflammation_MIF signaling 19 140 4.71 E-04
Cell cycle G1-S Interleukin regulation 17 123 7.51 E-04
Inflammation Neutrophil activation 25 217 8.18E-04
Development Blood vessel morphogenesis 25 218 8.76E-04
Diseases
Category ratio p-value
Sepsis 31 127 7.95E-10
Shock, Septic 13 27 9.12E-09
Lung Diseases, Obstructive 50 311 3.69E-08
Hypersensitivity, Immediate 51 323 4.90E-08
Shock 13 31 7.17E-08
Asthma 42 245 7 69E-08
Respiratory Hypersensitivity 42 246 8.66E-08
Respiratory T ract Diseases 143 1338 1.13E-07
Lung Diseases 133 1220 1.16E-07
Necrosis 66 479 1.16E-07
Table 6.3 Metacore Top 10 lists GeneGo maps, Go processes networks and diseases for the EpiAirway TD05 polymer treatment
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EpiAirway TD  20 Polymer Dose
Up and Down Regulated Genes
Maps
Category ratio p-value
HETE and HPETE biosynthesis and metabolism 8 17 6.03E-04
Cytokine production by Th17 cells in CF 12 35 9.22E-04
Development Beta-adrenergic receptors signaling via cAMP 12 39 2.66E-03
Cholesterol Biosynthesis 8 21 3.15E-03
Cell adhesion ECM remodeling 14 50 3.24E-03
Inhibitory action of Lipoxins on neutrophil migration 11 37 5.33E-03
Prostaglandin 1 biosynthesis and metabolism 6 14 5.36E-03
Signal transduction PKA signaling 8 23 6.01 E-03
Apoptosis and survival_DNA-damage-induced apoptosis 6 15 7.98E-03
Apoptosis and survival Beta-2 adrenergic receptor anti-apoptotic action 6 15 7.98E-03
Go processes networks
Category ratio p-value
Cell adhesion Platelet-endothelium-leucocyte interactions 36 175 5.95E-07
Inflammation Interferon signaling 22 110 1.47 E-04
Inflammation Protein C signaling 21 103 1.55E-04
Inflammation Innate inflammatory response 30 178 2.65E-04
Blood coagulation 18 85 2.77 E-04
Inflammation Amphoterin signaling 22 117 3.69E-04
Muscle contraction 26 150 4.30E-04
Chemotaxis 24 134 4.33E-04
Reproduction Spermatogenesis, motility and copulation 35 229 5.81 E-04
Development Blood vessel morphogenesis 33 218 9.82E-04
Diseases
Category ratio p-value
Sepsis 38 127 3.50E-09
Bronchial Diseases 63 273 4.18E-09
Lung Diseases, Obstructive 68 311 1.06E-08
Hypersensitivity 80 404 5.74E-08
Asthma 55 245 1.13E-07
Hypersensitivity, Immediate 67 323 1.20E-07
Respiratory Hypersensitivity 55 246 1.31E-07
Shock, Septic 14 27 1.66E-07
Vascular Headaches 23 68 3.95E-07
Headache Disorders 23 68 3.95E-07
Table 6.4 Metacore Top 10 lists for GeneGo maps, Go processes networks and disease for EpiAirway TD20 polymer treatment
CHAPTER 
SIX 
M
ICROARRAY 
TECHNOLOGY 
METACORE™
 
ANALYSIS
CHAPTER SIX: MICROARRAY TECHNOLOGY: METACORE™ ANALYSIS
In normal airways CFTR regulates secretion of chloride and fluid 
hydration followed by mucociliary clearance of bacterial Infection
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Figure 6.6 The image generated in Metacore™ for the map of Immune response- 
bacterial infection in normal airways. This map illustrates the EpiAirway™ tissue 
microarray data. Genes up-regulated at the TD05 treatment are signified by the red 
thermometers with the number one and include the transcription factor NF-kB, the 
receptor ligands IL-6, IL-8, Beta-defensin 2  and IL-1(3, the receptors Interferon gamma 
(IFN  gam m a) and the Toll-like R ecep to r 2 (TL2), the enzymes Janus Family Tyrosine 
Kinase 1(JAK1) and Interleukin 1 R eceptor Associates Kinases 1/2 (IRAK1/2). Down- 
regulated genes are signified by the blue thermometers and include the transcription 
factor Signal Transduction A ctivator 1 (STA T1), the enzyme Nuclear Factor kappa B 
Induced Kinase (NIK) and the Toll-like R ecep to r 4 (TL4).
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Figure 6.7 The image generated in Metacore™ for the map of Hydoxyeicosatetraenoic Acids 
(HETE) and Hydroperoxy eicosatetraenoic Acids or Hydroperoxides (HPETE) biosynthesis and 
metabolism. This map illustrates the EpiAirway™ tissue microarray data. Genes up-regulated at 
the TD05 polymer treatment are signified by the red thermometers with the number one, and 
include the enzymes Arachidonate 15-Lipoxygenase type B (ALOX15B), and COX-2. The genes 
down-regulated at the TD05 polymer treatment are signified by the blue thermometers with the 
number one, and include the enzymes CYP4F2, CYP4F8 and Epoxide Hydrolase(HYEP). The 
genes up-regulated at the TD20 polymer treatment are signified by the red thermometer with the 
number two, and include the enzymes ALOX15B and COX-2. The genes down-regulated at the 
TD20 polymer treatment are signified by the blue thermometer with the number two, and include 
enzymes CYP4F2, CYP4F8, HYEP and EPHX2.
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6.5 D isc u ssio n
The current use of microarray technology has expanded, as have the number of 
methods employed to analyze the information generated by array scanners or 
gene expression data. GeneSpring is just one tool with a number of approaches 
to both the statistical analysis and the visualization of microarray gene expression 
data. A number of software products are similar to GeneSpring, in normalizing 
and filtering array data, for examples the University of Pittsburgh Gene 
Expression Data Analysis Suite or GEDA (GEDA, 
http;//bioinformatics.upmc.edu/GE2/GEDA.html) (Ptitsyn et a i, 2008). As more 
researchers gather gene expression data, more public databases have been 
developed where such information can be deposited and shared (Ptitsyn et a i, 
2008).
Another tool, such as the National Institutes of Health and National Cancer 
Institute funded, Gene Set Enrichment Analysis (GSEA) tool allows users to 
compare multiple array data sets. Users can look for statistically significant 
differences, as well as analyze and interpret these differences 
(www.broad.mit.edu/gsea). Another method referred to as SAFE or the Significant 
Analysis of Function and Expression method, examines microarray expression 
data by comparing the gene expression data from two experimental conditions 
(Barry et al., 2005). The SAFE method compares expression data groups of 
related genes or genes within the same functional categories. A number of 
methods of statistical analysis are used to statistically rank the alterations of 
groups, and to eliminate the possibility of false discovery (Barry et a i, 2005). The 
SAFE method compares biologically relevant processes also referred to as 
pathway and ontological analysis.
GeneGo uses parametric tests to express gene data, such as p-values. These 
are used in combination with error rate control statistical tests, i.e. the Benjamin- 
Hochberg FDR (False Discovery Rate) analysis, to estimate the significance or 
the over-representation of particular biological pathways. Metacore™ has gone 
beyond GeneSpring, by examining changes in gene expression patterns in terms 
of detailed categories of biological processes and exploring the significant 
expressions of particular cell signalling pathways and networks. Metacore™ 
allows the user to derive parallels between array gene expression profiles and
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patterns of gene alterations documented for disease conditions and disease 
biomarkers. It also permits researchers to investigate “the mechanisms behind 
the development of adverse effects, commonly referred to as “predictive” and 
“mechanistic” toxicogenomics”. (Shi et a i, 2008). Probing more deeply into the 
ways that the genes may be involved in pathways or processes may help to 
uncover the biological mechanism of a compound’s toxicity. Metcore™ also 
contains diagrams of the networks and pathways that can be examined, and 
illustrates specific gene alterations (up-and down-regulation) within the pathway 
or network. Products similar to Metacore™ include Ingenuity Pathway Analysis, 
and even some free tools (DAVID [Database for Annotation, Visualization and 
Integrated Discovery]), GoTree and GoStat. The Metacore™ program was 
selected because of its extensive database capabilities. Other researchers have 
used the GeneGo database to explore possible genomic biomarkers for 
xenobiotic nephrotoxicity (Shi et al., 2008); the comparison of inflammatory 
responses in mice lung tissue to combinations of inhaled toxins (Meng et ai,
2006), and the comparison of solid and metastic tumour tissue (Ptitsyn et al., 
2008).
6.5.1 M e t a c o r e ™ : T o p  10 C a t e g o r ie s  L is t s : In -h o u se  N H B E R esu lts
The up- and down-regulation of genes can have vastly different effects on a 
pathway, depending on the roles the genes or proteins play. A binding protein 
may act to inhibit the actions of a transcription factor. The up-regulation of the 
binding protein may in fact have an inhibitory effect on a pathway as a result. 
Therefore signalling pathways, networks and diseases altered by the polymer 
treatment may have combinations of both up- and down-regulated changes in 
gene expression. In order to examine which pathways, networks and diseases 
were associated to the genes on our altered lists, both the up- and down- 
regulated genes were included.
6 .5.1.1 T o p  10 M e t a c o r e ™ c a t a g o r ie s  a t  TD05: In-house  NHBE
6.5.1.1.1 M aps
The TD05 polymer treatment Top 10 maps were dominated by immune response 
pathways (six out of the ten). The number two map was for cytokine production 
by Th17 cells in CF. This same map in the mouse model appeared at number 7. 
The third map related to CF disease and bacterial infection in CF airways. CF is
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a disease which involves both exaggerated inflammatory conditions and lack of 
clearance of mucins, and results in patients suffering from repeated bacterial 
infections. Cholesterol biosynthesis was the 8 th most altered pathway and could 
be related to inflammation; many inflammatory mediators are synthesized from 
cholesterol, the building block of membranes. These response pathways 
represent an innate protective and inflammatory response.
6.5 .1 .1 .2  NETWORKS
The Top 10 GeneGo processes networks at TD05 identified ‘inflammation’ ( 8  out 
of the 10) to be the principle network processes. ‘Chemotaxis’ was the number 
one network altered, suggesting that there was migration of cells, and in the case 
of the S2219200 polymer treatments, indicative of tissue repair. The alteration in 
cell adhesion and platelet interaction networks reflect a change in the cell 
culture morphological organization.
6 .5 .1 .1 .3  D iseases
The Top 10 diseases involved a number of tissue types not related directly to the 
lung, but links were clearly associated by the levels of inflammatory gene 
alteration and tissue restructuring. The appearance of Inflammatory disease, 
with resultant tissue damage/remodelling, was further supported by 
necrotic and pathological processes.
6 .5.1.2 T o p  10 M e t a c o r e ™ c a t a g o r ie s  a t  TD20: In -h o u s e  NHBE
6.5.1.2.1 Ma ps
The Top 10 pathway maps at the TD20 dose was ’Cell adhesion-ECM 
remodelling’, which may have been indicative of a restructuring of NHBE cell 
tissue culture. The second most significant map was ‘Development-Wnt signalling 
pathway’, which may have inferred changes in the cell culture development. The 
pathways which involved immunity and cytokine production, as with the 
TD05 treatment, also reflected changes in metabolism and cell adhesions.
6.5.1.2.2 NETWORKS
In the category of GeneGo processes networks, ‘cell adhesions’ and ‘chemotaxis’ 
were affected. There were a number of networks that involved ‘signal 
transduction’ and ‘proteolysis’ (i.e. tissue degradation). The principle networks
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appeared to be focused on remodelling and alterations in metabolic and 
developmental activity rather than immune/inflammatory (e.g. TD05).
6.5 .1 .2 .3  D isea ses
Diseases highlighted a range of non-specific tissue types involved in conditions 
under which tissue was damaged, remodelled and repaired. A shift from a 
predominantly immune response (i.e. TD05 treatment) to that of repair and 
alterations of structural integrity occurred.
6.5.2 T o p  2 G e n eG o  M a p s  f o r  TD05 a n d  TD20: In -h o u se  NHBE
At TD05, the two most significantly altered pathways were classified as ‘Immune 
response MIF-mediated glucocortoid regulation’ and ‘Cytokine production by 
Th17 cells in CF’. Both of the top two maps at TD05 also appeared on the top ten 
list for TD20 treatment. At the TD20 dose, the two most significantly altered 
pathways were classified as the ‘Cell-adhesion-ECM remodelling’ map, and the 
‘Development-Wnt signalling pathway’ map.
6.5.2.1 Im m u n e  Re s p o n s e -M IF  m e d ia te d  G lu c o c o r to id  r eg ulatio n
The MIF (macrophage migration inhibitory factor)-mediated immune response 
pathway is one which begins with the binding of the receptor ligand MIF onto the 
CD74 surface receptor. This results in the transcription of numerous receptor 
ligands and enzymes (Section 6 .5.1.2.1.1) by a number of transcription factors 
(e.g. ETS1, c-Jun, c-Fos and N F -kB). CD74 activated the ERK (MAP1/3) kinase, 
with resultant cascade involving the ERK (MAP1/3) kinase phosphorylation of the 
transcription factors. In parallel to the activities of ERK(MAP1/3), the IKK kinase 
can also act to phosphorylate the IkB binding factor that binds to NF-kB, and can 
have an inhibitory action on its transcription. N F -kB, along with the other 
transcription factors, activates the transcription of a number of enzymes and 
receptors. On the map, (figure 6.2) ETS1 was up-regulated, at both the TD05 and 
TD20 dose, as well as I-kB and NF-kB. The latter was shown to result in the up- 
regulation in the receptor ligands TNF-a, IL-6 and IL-8, the receptor ICAM-1, the 
metalloprotease MMP-1 and the enzyme COX-2. Glucocortoids are very potent 
anti-inflammatory factors that inhibit the activities of factors such as N F-kB. They 
bind with the receptor GCR-alpha, which in turn binds to and inhibits the actions 
of N F-kB and ETS1 and the receptor ligand IL-6 . MIF has been shown to up-
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regulate the activities of chemokines in human aortic endothelial cells to promote 
the recruitment of monocytes and T-cells (Bernhagen et al., 2007).
6.5.2.1.1 U p-r eg u la tio n  o f  R ela ted  S u bsid ia ry  C o m po n en ts  
The following genes were also highlighted as being up-regulated during the 
‘Immune response MIF-mediated glucocortoid regulation’ pathway map. 
Collectively these genes, as related subsidiary components, suggest reaction 
pathways to the polymer treatments as being driven by inflammation, immune 
response and tissue remodelling.
• IL-6: known to play a key role in the ‘inflammatory’ response and 
pulmonary disease-like symptoms (Janeway and Travers, 1997; Yu et al., 
2002; Cuzzocrea, etai., 1999; Escotte etai., 2003)
• TNF-a: a ‘stress response’ gene, which in the airways, plays a role in 
persistent inflammation and/or the development of pulmonary fibrosis 
(Janeway and Travers, 1997; Piguet etai., 1989; Juhasz etai., 1993)
• MMP-1: a metalloprotease involved in the degradation of ECM proteins 
and ‘tissue remodelling’, and is linked to pulmonary emphysema and 
fibrosis (Morimoto etai., 1997; Rosas etai., 2008; Mercer et al., 2004)
• 1C AM-1: a chemokine linked to ‘immune responses’ which contribute to 
fibrotic lung damage in animals and humans (Jane and Travers, 1997; 
Schmal etai., 1998; Chu etai., 1995; Hallahan etai., 2002)
• COX-2: an ‘inflammatory mediator’ involved in the metabolism of a 
number of factors which play a number of roles in inflammation, possibly 
leading to tissue damage, as well as cancer (Tang et al., 2002; Mascaux, 
et al., 2005,)
• IL-8: a chemokine linked to influxes in inflammatory PMN cells, possibly 
leading to ‘damage in tissue’ and found to be increased in pulmonary 
disease conditions (Kurdowska et al., 1999:Coulter et al., 2000)
6 .5.2.2 C yto k in e  p r o d u c tio n  b y T h 17 cells  in CF
The NHBE model responded to the polymer treatment by displaying activity 
similar to that found in CF. The GeneGo map illustrated the communications 
between airway epithelial cells, Th17 (Helper T cells) cells, T-cells and 
macrophages cells in the airways of CF patients. The NF-kB up-regulation
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resulted in the transcription of a number of factors not observed in the Immune- 
response-MIF mediated map, and included GCP-2, IL-23 and IL-23A.
6.5.2.2.1 U p-r e g u la tio n  o f  R ela ted  S u b sid ia r y  C o m po n e n ts  
The following genes were also highlighted as being up-regulated during the 
‘Cytokine production by Th17 cells in CF’ reaction pathways. Collectively these 
genes may also be reflective of a defensive immune response with tissue 
specificity (i.e. respiratory).
•  GCP: a receptor ligand and chemokine linked to ‘inflamed respiratory 
tissue’ ‘lung cell cancers’ and ‘tissue damage’ development (Van Damme 
etai., 1997; Sachse etai., 2006; Zhu etai., 2006)
•  IL-23: a ‘defensive stress response’ gene, which in vivo would result in 
increases in immune cells and other inflammatory cytokines (Dubin and 
Kolls, 2007; Ivanov etai., 2007; Happel etai., 2005).
6 .5 .2 .3  C ell A d h e s io n -E C M  R e m o d e llin g
Cell adhesion-ECM remodelling was the most significantly altered pathway at the 
TD20 dose. ECM proteins play an important role both in the development and the 
maintenance of the adult lung. During lung development the ECM protein, elastin, 
lays down fibrils as part of the structural groundwork for the lung epithelial 
branching morphology. This ‘branching morphogenesis’ also involves key 
interactions between cell substrate adhesion molecules, the underlying ECM and 
intercellular adhesion molecules (McGowan, 1992). In the developed lung, ECM 
proteins (e.g. proteoglycans, elastin, and collagen), provide structural stability 
(rigidity), as well as the needed flexibility. ECM proteins also play a role in the 
repair from damage and provide the building blocks in fibrosis (McGowan 1992). 
As a result of injury or prolonged inflammatory conditions, such as asthma, airway 
remodelling can result. It is defined as the presence of persistent changes to 
normal airway structure involving changes in the composition, organisation and 
function of structural cells, as well as enhanced turnover of extra-cellular matrix 
components (Lloyd and Robinson, 2007). The Cell-adhesion-ECM remodelling 
map exhibited both up- and down-regulation of ECM proteins, as well as MMP 
(McGuire et al., 2003).
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6.5.2.3.1 U p -r e g u la tio n  of  R ela ted  S u bsid ia ry  C o m po n en ts
The following genes were also highlighted as being up-regulated during the Cell 
adhesion-ECM remodelling reaction pathways. Collectively these genes 
appeared to be linked to tissue remodelling following wounding.
•  MMP-1, 9 a n d  6: metalloproteinases known to play an important role in 
‘epithelial tissue injury’, ‘remodelling’ and ‘repair’ (McGuire et al., 2003; 
Ratjen et al., 2002)
• HB-EGF: linked to ‘wounded tissue repair’ and to ‘cancer cell survival’ or 
‘apoptotic resistance’ (Mathey etai., 2008; Wang etai., 2007)
•  Urokinase-type Plasminogen activator: produces enzymes involved in a 
‘defensive response’ leading to ‘tissue remodelling’ (Hildebrand et al., 
2008; Matinez et al., 2007)
• Laminin-5: an essential basement membrane protein found to be up- 
regulated in ‘damaged skin tissue’ (Klees et al., 2007; Schneider et. al.,
2007)
•  Moesin: transmembrane protein linked to ‘signal transmission’ and the 
formation of ‘fibrotic tissue’ (Golpon et al., 2004; loncheva et al., 2004).
6 .5.2.3.2 Do w n -r eg u la tio n  o f  R e la ted  S u b s id ia r y  C o m p o n e n ts
The following genes were also highlighted as being down-regulated during the 
Cell adhesion-ECM remodelling reaction pathways. Collectively these genes may 
also be indicative of tissue remodelling akin to fibrosis.
• MMP-7 and MMP-12: metalloproteinases related to and up-regulated 
during ‘wounding’ and ‘fibrotic tissue’. MMP-12 has been specifically 
linked to ‘emphysema and COPD progression’ (McGuire et al., 2003; Zuo 
et al., 2002; Babusyte etai., 2007; Joos etai., 2002)
•  TIMP-3: metalloproteinase inhibitor, the down-regulation of which would 
be indicative of ‘initiating fibrosis’ (Zuo et al., 2002; Watelet etai., 2004).
•  ECM Proteins: Collagen IV  and I, fibronectin and Laminin -  4 ( at TD05) 
and collagen I and IV, versican, nidogen, fibronectin and Laminin-4 (at 
TD20). The down-regulation of numerous ECM proteins may be indicative 
of ‘restructuring’ of the in-house NHBE tissue, particularly at the higher 
TD20 dose (Juhasz etai., 1993; Mizuno etai., 2005).
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6 .5.2.4 D e v e l o p m e n t  - W n t  S ig nalling  Pa th w a y  (par t  2)
Wnt signalling was found to be the second most significantly altered pathway at 
the TD20 polymer dose treatment. Wnt signals are involved in a wide range of 
cellular activities including cell adhesion, changes in cell polarity and 
differentiation (Nusse, 2005). A number of conditions or diseases including 
cancer and degenerative diseases have been associated with malfunctions in 
Wnt signalling. Wnt signalling regulates stem cell proliferation and renewal 
(Nusse, 2005). Wnt signalling involves the binding of a Wnt protein to a cysteine- 
rich domain of a transmembrane molecule. It has three different branches: (1) (3- 
catenin pathway, activates target genes inside the nucleus of the cell; (2 ) planar 
cell polarity pathway, involves jun N-terminal kinase (JNK) and cytoskeletal 
rearrangements and; (3) W nt/Ca+2 pathway leads to the release of intracellular 
calcium (Huelsken and Behrens, 2002). In the S2219200 polymer treatments of 
the NHBE cells, the p-catenin pathway was most affected and as a result, there 
was both up- and down-regulation of a number of the resulting products in this 
pathway (i.e. Fra-1, VEGF-A, Survivin, ITF2).
6 .5.2.4.1 U p-r eg u la tio n  o f  R e la ted  S u b s id ia r y  C o m p o n e n ts
The following genes were also highlighted as being up-regulated during the 
Development-Wnt signalling reaction pathways. Collectively these genes seem to 
be associated with cellular responses to carcinogenesis and survival.
•  FRA-1: an activator protein associated to ‘cancer progression’ and cellular 
responses to cigarette smoke, suggesting a ‘protective’ and ‘anti-apoptotic’ 
response (Adiseshaiah et al., 2007; Song et al., 2006; Andreokas et al.,
2008)
•  VEGF: up-regulation has been linked to ‘cell survival’ in tumour cells and in 
response to viral infection, indicative of an ‘anti-apoptotic response’ (Li et al., 
2008; Watelet et al., 2004)
6.5.2.4.2 D o w n -r eg u la tio n  o f  R e la ted  S u b s id ia r y  C o m po n en ts
The following genes were also highlighted as being down-regulated during the 
Development-Wnt signalling pathway reaction pathways. Collectively these genes 
seem to be focused on cell survival during cancer via pro-apoptotic mechanisms.
• FRAT1 a n d  AXIN: binding proteins. Axin is a scaffold protein, the mutations of 
which have been linked to ‘cancer’ cells (Shimizu et al., 2002). Axin plays an
Tracy Hughes 226
CHAPTER SIX MICROARRAY 'f ECHNOLOGY ME TAGORE rM ANALYSIS
important role in ‘moderating P-catenin’ levels and the ‘Wnt signalling’ 
pathway, the down-regulation of which has been shown in the EpiAirway™ 
model, in response to cigarette smoke. This results in being ‘suppressive of 
proliferation’ and contributes to ‘apoptosis’ (Maunders et al., 2007)
•  Survivin: decreases during cell differentiation and increased expression in 
malignant cancer cells suggests a ‘pro-apoptotic’ effect (Hu et al., 2008; Jin et 
al., 2007; Ikeguchi and Kaibara, 2002).
•  ENC-1: p53 tumour suppressive protein linked to ‘oxidative stress’ in cancer 
cells, via a ‘pro-apoptoticeffect’ (Hammarsund etai., 2004; Seng etai., 2007).
6.5.3 M etaco re™ Top  10 categories L is ts : EpiA ir w a y™
6.5.3.1 T o p  10 M e ta c o r e™ c atag o r ies  a t TD 05: E piA ir w a y ™
6.5.3.1 .1 Ma ps
For the EpiAirway™ TD05 treatment in the maps category, all of the Top 10 were 
related to immune response (i.e. immune response-bacterial infections in normal
airways, immune response-MIF mediated glucocorticoid regulation, immune
response-IL-1 signalling pathway), cytokine production (i.e. cytokine production 
by Th17 cells in CF) and the production of inflammatory mediators (i.e HETE and 
HPTETE biosynthesis and metabolism, prostaglandin 1 biosynthesis and 
metabolism). The most affected pathways were inflammatory and protective 
immune responses.
6 .5 .3 .1 .2  NETWORKS
In the processes networks category for the EpiAirway™ tissue at TD05, 7 out of 
the 10 networks related to inflammation, one to the ‘cell cycle’ (cell-cycle-G1-S 
Interleukin regulation) and another to the ‘development of blood vessels or blood 
vessel morphogenesis’. The most altered networks were those of an 
inflammatory response.
6 .5 .3 .1 .3  D iseases
In the disease category at TD05 for the EpiAirway™, five diseases involved a 
respiratory or lung-related link. The top disease at both TD05 and TD20 was 
Sepsis; a condition that occurs when the immune system is overwhelmed by a 
bacterial infection. Septic shock can result from sepsis and is characterized by a 
dangerously low blood pressure and low blood flow. An example of such a
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condition is acute respiratory distress (ARD). ‘Lung disease, obstructive’ was 
number 3 for the TD05 and TD20 treatments. ‘Hypersensitivty’, ‘asthma’ and 
‘respiratory hypersensitivity’ appeared on both lists; all three conditions develop 
following an exaggerated immune response (e.g. polymer treatment). At TD05, 
the tenth disease condition was necrosis, suggesting that cell death related genes 
have been activated. The altered disease-related genes suggested a 
hypersensitive response.
6 .5 .3 .2  T o p  10 M e ta c o r e  c atag o r ies  a t TD20: E piA ir w a y ™
6.5.3.2.1 Maps
For the TD20 S2219200 polymer treatment, the GeneGo ‘maps’ list included 
cytokine and inflammatory mediator production pathways, (e.g. Cytokine 
production by Th17 Cells in CF, HETE and HPETE biosynthesis and 
metabolism), Cell adhesion and ECM remodelling pathways, and a pathway for 
apoptosis and survival (Apoptosis and Survival-DNA-Damage-lnduced 
Apoptosis). Number three on the Top 10 list for TD20 was Development-Beta- 
Andrenergic Receptors Signalling via cAMP which are G-coupled protein surface 
receptors. There are a number of types of beta receptors and their actions are 
dependent on the type of tissue in which they were found. Some beta receptors 
respond to stimulants, such as epinephrine and norepinephrine, and transmit 
signals through the release of the secondary signalling molecule, cAMP, resulting 
in vasodilation or vasoconstriction. Beta receptors are also involved in smooth 
muscle contractions, the breakdown of lipids and the inhibition of mast cell 
histamine production. Beta-andrenergic receptor blockers have been used in the 
treatment of obstructive pulmonary disease (Bohm et al., 1991). Beta agonists 
have been found to improve the clearance of edema in rats by stimulating Na+ 
channels in alveolar epithelia cells (Saldias et al., 2000). Mutlu et al. found that 
these receptors accelerated the clearance of excess airspace fluid when working 
in connection with the CF membrane conductase regulator (Mutlu et al., 2005). 
The HETE and HPETE biosynthesis and metabolism pathway was also linked to 
(the 6 th listed pathway), Inhibitory action of lipoxins on neutrophils migration. 
Lipoxins are products of arachidonic metabolism (via the LOX pathway) like 
HETE and HPETE (Zeldin, 2001). The alterations to maps or signalling 
pathways implied both an inflammatory response, as well one which 
involved apoptosis and remodelling.
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6 .5.3.2.2 NETWORKS
At the TD20 polymer treatment in the EpiAirway™ tissue, Blood Coagulation, 
Muscle Contraction, Chemotaxis, Reproduction-Spermatogeneis, Motility and 
Copulation were found; none of which was observed on the TD05 list. Network 
categories were linked to a general response to wounding.
6 .5 .3 .2 .3  D is e a s e s
Most of the diseases listed for the TD20 polymer treatment of the EpiAirway™ 
tissue were found on the TD05 treatment list, and involved a ‘hypersensitive 
response’. On the TD20 treatment list, the final two conditions were ‘vascular 
headaches’ and ‘headache disorders’, which may be associated with 
vasoconstriction-related genes being altered, as well as the activation or 
alteration of genes linked to sensory or neuron cell activity. Gene alterations 
were linked to diseases characterized by an exaggerated immune response.
6.5.4 M e t a c o r e ™ T o p  2 G e n e G o  M a p s  fo r  TD05 a n d  TD20: E piA ir w a y ™
At TD05, the two most significantly altered pathways or maps were ‘Immune 
response-bacterial infections in normal airways’ and ‘Cytokine production by Th17 
cells in CF’, for the EpiAirway™ tissue. Of these two maps, the latter also 
appeared as number two on the TD20 treatment list. At the TD20 polymer 
treatment, the two most significantly altered pathways were ‘HETE and HPETE 
biosynthesis and metabolism’ at number one and ‘Cytokine production by Th17 
cells in CF’, at number two, for the EpiAirway™ tissue.
6.5.4.1 Im m u n e  R e s p o n s e  -  Ba c te r ia l  In f e c t io n s  in N o r m a l  A ir w a ys
The IFN-gamma receptor was up-regulated at both the TD05 and TD20 
treatments and the Toll-like Receptor 5 (TLR5), was down-regulated at both the 
S2219200 polymer doses. Down-stream, the IRAK 1/2 kinase was up-regulated 
at both the polymer treatments and the NF-KB-induced kinase (NIK) enzyme was 
down-regulated at both the polymer treatments. There were a number of 
differences detected in this pathway between the TD05 and the TD20 polymer 
treatments. Toll-like receptor 2 (TLR2) was up-regulated at the TD20 treatment 
only. Janus-family tyrosine kinase (JAK1), was up-regulated in expression at the 
TD05 treatment only. The JAK1 kinase phosphorylates signal transduction 
activator 1 (STAT1), which was down-regulated at the TD20 treatment, but not
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significantly altered at the TD05. As a result of the up-regulation of NF-kB, there 
was up-regulation of the ‘Immune Response’ Beta-Defensin 2 Molecule for both 
the polymer treatments. However, the inflammatory mediator IL-8 was only shown 
to be up-regulated significantly at the TD20 treatment.
6.5.4.1.1 U p -r e g u l a tio n  o f  S u b sid ia r y  C o m po n e n ts
The following genes were also highlighted as being up-regulated during the 
‘Immune response -  bacterial infections in normal airways’ reaction pathways. 
Collectively these genes suggest a defensive mode protection via immune 
response.
•  INF-y: a multipurpose activator involved in ‘macrophage activation’, ‘viral 
protection’ and activation of the ‘JAK1 pathway’. It suggested an immune 
protective response involved in ‘survival and proliferation’ (Janeway and 
Travers, 1997; Huang e ta i ,  2005; Shi e ta i ,  2007)
•  TLR2: a receptor known to recognize and bind to gram positive bacteria, 
associated with bacterial exposure and ‘innate immune response’ (Zhang et 
at, 2005)
•  IL1-p: an inflammatory mediator linked to the activation of the NF-kB 
transcription factor and cytokine production, fibrosis in infected rat lung, 
bacterial resistance and mucous secretion (Torre et a i, 1994; Samuel et al., 
2008; Tu and Lai, 2006; Marshall e ta i ,  2008).
6.5.4.1.2 Do w n -r e g u la tio n  o f  S u b s id ia r y  C o m p o n e n t s
The following genes were also highlighted as being down-regulated during the 
‘Immune response -  bacterial infections in normal airways’ reaction pathways. 
Collectively these genes infer a reduced immune response.
•  NIK: linked to pathways involved in ‘cell proliferation and differentiation’, 
‘development survival’, and ‘NF-kB activation’ (Nadiminty et at, 2007; Yang 
e ta i ,  2005)
6 .5.4.2 C y to k in e  p ro d u c tio n  b y T h 1 7  c ells  in CF
The Metacore™ map for the EpiAirway™ samples (data has shown) for the 
‘Cytokine production by Th17 cells in CF’, revealed the same results observed in 
the in-house model (Section 6 .5.1.2.2). The map showed a very similar pattern of 
predominantly up-regulated genes. A few differences between the EpiAirway™
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and in-house NHBE samples were detected. There was no significant up- 
regulation, at either the TD05 or the TD20 treatments, for the following genes in 
the EpiAirway™ samples: 1-kB binding protein and the receptor ligands GCP-2 
and /L-6 . The receptor ligand IL-8 had shown up-regulation for both the TD05 and 
TD20 treatments in the in-house NHBE samples, and only showed up-regulation 
at the TD20 treatment in the EpiAirway™ samples. The receptor ligand GM-CSF 
exhibited up-regulation for both the TD05 and TD20 doses for the in-house 
samples and only showed up-regulation at the TD05 treatment for the 
EpiAirway™ samples. The Toll-like receptor 4 (TLR4) was down-regulated in the 
in-house model and did not demonstrate significant change in the 
EpiAirway™model.
6 .5.4.2.1 U p -r e g u l a tio n  o f  S u b s id ia r y  C o m p o n e n ts
The following genes were also highlighted as being up-regulated during the 
‘Cytokine production by Th17 cells in CF’ reaction pathways. Collectively these 
genes deem an inflammatory response.
•  GRO-1: a chemokine linked to chronic nasal inflammation (Rudack e t al., 
2003; Rudack et. al., 2007)
6 .5.4.3 HETE AND HPETE BIOSYNTHESIS AND METABOLISM
HPETE and HETE are produced by the actions of the enzymes which metabolize 
arachidonic acid. Arachidonic acid metabolites have a variety of important 
functions in the lung (Jacobs and Zeldin, 2001). Eicosanoids are a group of 
hormones which are derived from the fatty acid arachidonic acid and have been 
implicated as mediators in tissue inflammation (Zubay et al., 1995). There were 
three main pathways by which arachidonic acid is metabolized, the 
cyclooxygenase (COX) or prostag la ndin-H synthase (PGHS) pathway, the 
lipoxygenase (LOX) pathway and the cytochrome P450-dependent epoxygenase 
pathway (CYP-450) (Tang et al., 2002). All three of these pathways were 
observed in the Metacore™ map of ‘HETE and HPETE Biosynthesis and 
Metabolism’.
6 .5.4.3.1 T he  P450 Pa th w a y
Cytochrome P450 is involved in drug detoxification and steroid biosynthesis by 
hydroxylation (Becket et al., 2006). In the cytochrome P450 arachidonic acid
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pathway, arachodonic acid is metabolized by a number of different cytochromes 
to HETEs and cis-epoxyeicosatrienoic acids or EETs (Jacobs and Zeldin, 2001). 
In a review of research concerning the HETE and EETs in the lung, Jacobs and 
Zeldin hypothesized that P-450-derived arachidonate metabolites in the lungs 
have a number of potential functions that involve hypoxic pulmonary 
vasoconstriction, regulation of bronchomotor tone, control of composition of 
airway lining fluid and limitation of pulmonary inflammation (Jacobs and Zeldin, 
2001). If the products of the CYP4F8 enzyme have an immunosuppressive effect, 
then down-regulation of CYP4F8  may have the opposite effect, meaning an 
immune response to activate immune cells to defend the lung. The down- 
regulation of CYP4F8  indicates a defence response.
6 .5 .4 .3 .2  E p o x y h y d r o l a s e  e n z y m e s
Epoxide hydrolase enzymes play a role in the metabolism of toxicants and clinical 
drugs (Fretlan and Omiecinski, 2000). Node et al. found that different forms of 
EETs and Dihydroxyeicosatrienoic Acid (DHET) had inhibitory effects on TNF-a 
induction of VCAM-1 and on mononuclear cell adhesion in human endothelial 
cells (Node et al., 1999). Down-regulation of EPHX2 suggests a pro- 
inflammatory response.
6 .5.4.3.3 T h e  LOX Pa t h w a y
The LOX pathway gives rise to a number of hydroxyperoxy and hydroxyl (HETE) 
fatty acids and leukotrienes, as well as Lipoxins (Tang et al., 2002; Zeldin, 2001). 
In the HETE and HPETE biosynthesis map, the ALOX15B gene was shown to 
have been up-regulated at both the TD05 and the TD20 treatments. LOX15 
metabolizes aracidonic acid to 15-S-hydroxyeicosatetraeonic acid (15-S-HETE) 
(Subbarayan et al., 2005). Moreover, expression of 15-LOX-2 in normal cells was 
inversely related to cell cycle progression and it was concluded that 15-LOX-2 
was acting as an endogenous negative cell cycle regulator (Tang et al., 2002). 
Marom et al., revealed that HETE production increased mucus release, 
particularly in instances of anaphylaxis, to conclude that “leukotrienes were potent 
secretagogues which contribute to mucus secretion accompanying allergic airway 
diseases” (Marom et al., 1983). Up-regulation of LOX15B, indicates an up- 
regulation of mucin section, as well as an inhibition of cell cycle 
progression.
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6 .5.4.3.4 T h e  COX Pa th w a y
The role of COX-2  up-regulation was described in Section 6.5.1.2.1.5. Up- 
regulation of COX-2 could either cause injury via inflammation or indicates 
cancerous progression in the tissue.
6.6 C o n c lu s io n s
6.6.1 M e ta c o re ™  C a te g o r y  L is ts
The Metacore™ Top 10 category lists for the TD05 and TD20 treatment 
suggested contrasting biological responses. The TD05 treatment resulted in 
alteration predominantly in the processes of inflammation and immune response. 
The TD20 treatment consequences included alterations in immune response 
pathways, with more significant alterations made in ECM remodelling and 
developmental pathways, indicating a wound response and tissue repair. There 
were a number of parallels between the Metacore™ generated array analysis of 
the in-house NHBE and the EpiAirway™ samples. For both cell cultures, the 
Metacore™ map lists suggested ‘protective and inflammatory responses’ at 
TD05, with diseases indicative of ‘overwhelmed and hypersensitive inflammatory 
systems’. For the TD20 target doses, in-house and EpiAirway™ tissue culture 
models showed a shift from predominantly ‘immune and inflammatory networks 
and diseases’ to ‘remodelling, wounding and repair networks and diseases’.
6.6.2 M etacore™ G eneGo Maps
The overlap in the Top 2 most significantly altered maps, between the in-house 
NHBE and EpiAirway™ NHBE model samples at the TD05 polymer treatment, 
suggested that a similar overall response was taking place in the two tissues. The 
altered genes and pathways at the TD05 treatment in the in-house NHBE cultures 
were mainly linked with ‘inflammation, defence and pulmonary disease-like 
conditions’. The altered genes and pathways (within the Top 2 maps) at the TD05 
treatment for the EpiAirway™ tissues were predominantly linked to ‘inflammation, 
survival and proliferation’. The altered genes and pathways (within the Top 2 
maps) at the TD20 treatment for the in-house NHBE cultures were principally 
linked to ‘remodelling, defence, pro-apoptosis and wounding’, whereas the genes 
and pathways at the TD20 treatment for the EpiAirway™ tissues were chiefly 
linked to ‘cell cycle inhibition, defence, and inflammation’. The results of map
gene and pathway comparisons of just these Top 2 maps alone, imply that the
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EpiAirway™ tissue was undergoing less remodelling or damage at the TD20 
treatment. However, three of the Top 5 maps on the Top 10 list were the same for 
the two tissue types, with ‘Cell adhesion-ECM remodelling’ at number five for 
EpiAirway™ samples and ‘apoptosis related pathways’ at number nine and ten. 
Overall, this implies that the EpiAirway™ tissue had also experienced tissue 
remodelling and wounding at the TD20 S2219200 polymer treatment.
6.6.3 F in a l  C o n c l u s io n s
In conclusion, the Metacore™ microarray mining tool data suggested that the in- 
house NHBE tissue presented a viable or comparable alternative to the 
EpiAirway™ model. Both of these models, when treated with commercial resin 
polymer S2219200, a representative xenobiotic, generated comparable gene 
expression alterations. Many of these types of gene alterations have been found 
in compromised or diseased, in vivo, respiratory tissue.
i Tc-cv Huone?
C hapter  7 
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7.0 O v e rv ie w
The overall objective of this project was to optimize and to characterize both the 
phenotypic and genotypic responses of the NHBE primary cell model; to assess 
it’s comparability to human tissue (particularly the bronchial epithelium in vivo); 
and it’s viability, as part of a battery of in vitro tests designed to replace inhalation 
toxicology testing in vivo.
An essential research objective was to use conventional toxicological techniques 
to establish the target dosage of polymers required to alter the viability of the 
culture by sub-toxic levels. Two dosages were chosen, a lower TD05 dose, in 
order to characterize a possible ‘protective or reversible response’, and a higher 
TD20 dose, to observe a more ‘injurious and damaging response’. The aim was 
to determine and to compare the affected mechanisms and pathways of stress 
imposed by the polymers. Light and electron microscopy were employed to 
examine concomitant changes in the gross and the intercellular morphology. 
Transcriptomic analysis tools were applied to microarray data to examine and to 
compare the observed changes at a molecular level. The application of online 
database tools allowed the probing of gene expression profiles. These were used 
to uncover biological pathways and biochemical networks which characterized the 
different dosage responses.
The first hypothesis of this study was that ‘the NHBE primary cell model provided 
biological tissues and responses representative of those observed in vivo’. In 
order to support this hypothesis, the establishment of an NHBE primary culture 
was tissue engineered to represent a robust, fully-differentiated, 3D, bronchial, 
epithelial tissue. A protocol was established which successfully resulted in a 
differentiated culture that exhibited a functional mucociliary morphology with 
evidence of tight junction formation, as found in vivo. These cultures were derived 
from normal (i.e. not cancerous), primary, human cells which had not been 
transfected with viral genes. The resulting tissue was more reflective of in vivo 
tissue then other airway models currently in use. These models have been 
derived from tumors or transfected tissue (i.e. A549 or BEAS-2B cells). 
Morphological characterization of the NHBE culture morphogenesis (passage 3, 
ALI) at key points during cultural development revealed that the optimum 
representation of the bronchial epithelium in vivo was between days 24 and 33.
By day 24, many of the cells had a columnar morphology and were arranged in a 
pseudostratified layer. Ciliogenesis was completed by day 24 (i.e. no further 
growth in cilia length). Specific staining for protein components of mucus 
confirmed its presence during days 24-33. Thus, by the use of general 
morphological criteria and specific staining, the major cell types of the airway 
epithelium (e.g. basal, goblet and ciliated) could be observed after 3 weeks in 
culture. Taken together, these findings demonstrate similarities in cellular turnover 
rates, between this culture system and the airway epithelium. The transformation 
from a proliferative, squamous cell layer into a pseudostratified, ciliated epithelium 
that had many of the properties of the in vivo airway epithelium was achieved.
The second hypothesis to be confirmed was that this model could be used to 
observe and to compare the toxicological effects of a number of polymers in a 
dose-dependent manner, and examine if these observed responses would 
correlate with known effects in vivo. The toxicological effects were first examined 
by conventional biochemical and histopathological means. The experiments 
illustrated that the four polymers investigated had clearly distinguishable 
toxicological profiles. Three of the four polymers showed a similar pattern of 
response, with an initial increase in viability and trans-epithelial resistance at low 
dose levels, (compared to control). The specimens exhibited subsequent dose- 
dependant decrease in viability with increased dose levels. This counter-intuitive 
pattern of response has been observed in the EpiAirway™ tissue following 
application of a number of known respiratory toxicants (e.g. tobacco smoke 
components - Balharry et al., 2008). This was believed to be a hormetic response, 
demonstrating a sub-toxic protective mechanism which is comparable with what 
occurs in vivo (Balharry et al., 2008). Hormesis is believed to be common to a 
variety of tissues and organisms (Calabrese, 2004), and despite some hesitance 
in the scientific community to accept this as a viable toxicological response, there 
is growing evidence that this is an essential human response to xenobiotics.
The third hypothesis of this study was that ‘transcriptomic techniques could be 
used to compare the gene expression profiles’ in the response of the NHBE 
model at sub-lethal doses of a polymer. These techniques provided insight into 
the specific mechanisms, or the biological pathways of lung damage inflicted by 
this exposure. These microarray analyses give new insight into the genetics of
airway epithelial tissue responses to poorly soluble materials (e.g. polymers). 
They also provide a catalogue of gene expression that will be a valuable resource 
for scientists interested in airway biology, pathology and toxicology.
7.2 C o n c lu s io n s
The use of the NHBE primary cell model and the application of a combined 
approach provided relevant morphological and transcriptomic information about 
the potential human response from an exposure to sub-lethal levels of polymers. 
The TD05 dose initiated a ‘protective and inflammatory response’ in the NHBE 
model, whereas the TD20 dose resulted in a more ‘injurious response, involving 
tissue remodeling’, as summarized in figure 7.1.
Key deductions from optimization and characterization experiments:
•  A strict cell culturing protocol, using specific quality assured growth medium 
and supplements, splitting reagents and insert membranes is required.
•  NHBE cells are viable for a limited number of passages (3), after which they 
are unable to establish differentiated cultures.
•  NHBE cultures were comparable to their in vivo counterpart, both at the gross 
and ultrastructural morphology levels.
•  Mature ALI cultures demonstrated evidence of mucus secretion and tight 
junction formation.
•  Characterization of cultural morphogenesis demonstrated that the cultures 
maintained a steady level of maturity, most reflective of human tissue in vivo, 
between days 24 and 33.
Key deductions from conventional toxicology:
•  Conventional biochemical analysis of the comparative toxicologic potential of 
the four polymers showed that one polymer in particular, S221880, had the 
highest toxicity.
•  This data, and the subsequent hierarchy of toxicologic potential for the 
remaining three polymers, correlated with the known toxicity profiles in vivo 
(Dr L Merolla, personal communication).
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Figure 7.1 Summary of the response of the NHBE cells at the TD05 and TD20 polymer dose 
treatments. Histopathology data was gathered using TEM and SEM. Transcriptomic data was 
acquired using GeneSpring and Metacore™. Red arrows represent up-regulation and blue arrows 
represent down-regulation.
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•  Further validation using a much wider set of known chemicals is required for 
complete certainty, but at this point we can assert that NHBE cultures can be 
used to rank the toxicologic potential of chemicals in a manner 
representative of in vivo systems (based on parallel polymer toxicity ranking 
data).
Key deductions from TD05 polymer treatment histopathology:
•  TEM observations revealed that NHBE cultures exhibited ultrastructural 
alterations characterized by regional hypertrophy or focal damage. Many 
classical pulmonary toxins (cigarette smoke, cadmium, zinc chloride, etc.) 
cause similar in vivo damage characterized by focal lesions.
•  SEM imaging of NHBE cell surfaces revealed smaller numbers of ciliated cells 
when compared to control samples; cilia have been ‘lost1 as a result of 
polymer treatment. Loss of cilia or cilia dysfunction has been associated with 
early or first responses to toxin exposure in respiratory epithelium and 
respiratory disease.
Key deductions from TD20 polym er treatm ent histopathology
• TEM imaging of cellular fine structure demonstrated evidence of cellular 
degradation, especially in the supra-basal region. The breakdown of cellular 
structure, along with evidence of chromatin condensation, suggests necrotic 
reactions. These observations were reflective of acute, toxin-related injury.
•  SEM observations demonstrated that the NHBE cells were ‘sloughing-off the 
insert/cellular surfaces. This type of degradation to the NHBE organizational 
structure correlated with the types of changes that occur to respiratory tissue 
during infections and disease conditions. These findings illustrated that the 
higher dose of polymer induced an acute epithelial injury, with morphologically 
relevant and evident changes, that could be associated with transient 
functional detriment in mucociliary tissue and general respiratory health in 
humans and animals (in vivo).
Key deductions from transcriptom ics
• This was the first study to profile the whole genome response to commercial 
polymers in mucociliary cultures of human bronchial epithelial cells grown at 
ALI. The experimental design of three independent experiments of three cell
donors (and a commercial NHBE model [EpiAirway™]) generated a data set 
suitable for robust statistical analysis. Bioinformatics tools enabled the 
characterization of responsive genes into categories followed by pathway 
analysis. Many of the direct effects of the polymer treatments were consistent 
with previous reports of in vivo toxicity of related polymers (Carthew et al., 
2006).
•  The majority of altered genes were found to have in vivo links to human airway 
epithelial tissues under distressed and diseased conditions. The principal 
pathways of disease were identified as an exaggerated immune response 
characterized by tissue remodeling or wounding, as observed in numerous 
respiratory disorders (in humans and in vivo). Pathway analysis using the 
Metacore™ program gave a contrasting picture of the two toxicological doses; 
the TD05 dose revealed a protective inflammatory response and at the TD20 
exposure, responses included airway injury, wounding and remodeling.
•  GeneSpring was most useful in illustrating comparative analysis of numerous 
samples in terms of overall gene expression and gene alterations. 
GeneSpring generated ontology lists gave an overall comparison of sample 
responses, in terms of evidence of pathways represented.
•  Metacore™ provided a more in depth analysis of the interactions of over­
represented genes within the altered biological pathways and might be a more 
useful tool in drug design or the selection of therapies for conditions resulting 
from the polymer or xenobiotics exposures.
Key deductions comparing NHBE and EpiAirway™ responses
•  EpiAirway™ tissue gene expression profiles differed from the in-house NHBE 
tissue in their controls. However, they showed similar transcriptomic 
responses to polymer exposures. GeneSpring illustrated parallel patterns of 
up- and down-regulation of gene expressions in response to the TD05 and 
TD20 polymer treatments, across all three NHBE donors and the EpiAirway™ 
samples. This suggests comparable responses to polymer treatments.
•  Although the responses of the in-house NHBE and EpiAirway™ were simliar 
in terms of pathways, they did differ in terms of the magnitudes or fold- 
changes in individual gene expressions.
•  PCA revealed that all three NHBE donors shared similar global gene 
expression for control and treated samples. These were separated from or
had greater variance when compared to the EpiAirway™ tissue global gene 
expression for both control and treated samples. This data indicates that the 
different growing conditions and/or age of the tissue may be a determining 
factor in the starting global gene expression.
•  In terms of morphological and transcriptional reactions to the pulmonary 
toxins, the models appeared comparable. TEM and SEM analysis illustrated 
greater damage or structural remodeling at the higher dose in the 
EpiAirway™, indicating the in-house NHBE may be more robust.
•  The benefits of tissue engineering an in-house model versus procurement of a 
commercial model became self evident. The in-house model enabled usage of 
cells in the preferred experimental window of 24 to 33 days. Therefore both 
acute and chronic exposures are possible. With the commercial model, the 
cultures arrived to the end users at the late stages of viability; these aged cell 
cultures may explain the few instances of differential biological responses 
detected.
•  In a cost comparison, the production of the in-house inserts was significantly 
less expensive. It is now possible to generate up to 400 inserts of cells from 1 
cyrovial of NHBE cells (Lonza). The EpiAirway™ cell inserts from MatTek 
were sold as sets of 24 or 48 inserts at approximately triple the cost of the in- 
house system. Although the NHBE system is more labour-intensive for the 
end user, the benefits demonstrated in terms of culture viability, usability and 
flexibility offer sufficient added value to recommend it as the optimal test 
system.
7.3 F uture  W o rk
7.3.1 C e l l  c u ltu r in g  and  x e n o b io tic  t re a tm e n t  techniques
Some researchers have co-cultured the NHBE cells with fibroblast cells, in order 
to explore the interactions between these cell types. They then explored how the 
presence of the fibroblast cells might affect the responses of the primary NHBE in 
culture (Malavia et al., 2008). These same researchers explored the response of 
the NHBE cultures to treatment with IL-13, both the immediate response and the 
response following a recovery from the treatment. They were trying to determine 
whether the immediate response was reversible or could change, given time to 
recover. This group found that the NHBE cultures exhibited ‘plasticity’ and an 
ability to return to a baseline. One possible extension to this project is to expose
the NHBE cultures to the TD05 and TD20 dosages of polymer. The cultures could 
then be given time to recover. This might present a more accurate account if the 
changes observed at the TD05 and TD20 exposure, could be regenerated or 
recovered given time.
7.3.2 CO-CULTURES
The NHBE primary cell cultures have been co-cultured with fibroblasts (Malavia et 
al., 2008; Wang et al., 2007; Darveau et al., 2008). Both NHBE and A549 cells
have also been co-cultured with T cells and macrophages respectively. (Darveau
et al., 2008; Goodrum and Poulson-Dunlap, 2002). Further extensions of this 
project might include such co-culturing techniques, in order to more fully evaluate 
the responses of the NHBE cells to polymer exposures. Such co-culturing 
techniques might provide a broader perspective of the potential responses of 
these cells in vivo.
7.3.3 T r a n s c r ip to m ic  a n a ly s is
A great number of techniques and software applications have been developed to 
analyze the data generated by microarray scanners. This project has employed a 
number of these programs including GeneSpring and Metacore™. Some 
research groups have used a variety of analysis programs to confirm or to 
reinforce that the conclusions drawn using one database or software package, 
was consistent when the same data had been reanalyzed using an alternative 
product. In addition to multiple transcriptomic analyses, other experimental 
techniques could have been used to confirm the microarray data. One example is 
quantitative polymerase chain reaction (Q-PCR). This technique would confirm 
the presence and up- and/or down-regulation, of selected highly expressed 
genes. Another technique would include the use of Western blotting and antibody 
detection to examine treated (e.g. polymer) tissue, to determine if those highly 
expressed genes were, in fact, translated into the production of higher levels of 
the protein. This could be performed at the 24 hour time frame, as well as other 
time periods.
7.4  O ver all  C o n c lu sio n  a n d  R ecom m endations
There is a growing need in respiratory toxicology to address the move towards 
the three Rs -  the reduction, refinement and replacement of animal-based
toxicology test systems. The NHBE model should be viewed as one method for 
studying human disease/toxicology. It cannot be viewed in isolation nor 
extrapolated directly to the clinical setting. The model optimized, characterized 
and utilized in this project did not study the complex interactions between NHBE 
cells and other physiological components of the human respiratory response, 
such a fibroblasts, dendritic cells, macrophages etc. However, it did offer a 
complex, 3D, fully-differentiated tool which was reflective of the human bronchial 
epithelium; a primary target of inhaled xenobiotoics. Moreover, it offered clearer 
reproducible transcriptomic data than could be acquired in in vivo tissue. Finally, it 
offered the potential for longer term culture of primary tissues in vitro, which is a 
major benefit. It has great potential for future applications in respiratory 
applications in toxicology. Gaining knowledge of the responses of cells within this 
vital region of the human respiratory tract is of great value. This model of the 
human airway epithelium demonstrated a useful means of comparing the 
potential toxicities of any number of inhalation hazards.
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Appendix 1. Recipe for Bronchial Epithelial Growth Medium (BEGM).
For every 10ml of BEBM (Bronchial Epithelial Basal Medium) the following 
growth supplements were added in the following quantities:
VOLUME SUPPLEMENT
40 pi Bovine pituitary extract (BPE)
1 0  pi Insulin (ISN)
1 0  pi Hydrocortisone (HC)
1 0  pi Transferrin
1 0  pi Tridothronin (T3)
1 0  pi Epinephrine
1 0  pi Epidermal Growth Factor(EGF)
1 0  pi Gentamicin/amphitericin
1 0  pi Retinoic Acid (R.A)
Appendix 2. Recipe for Air-Liquid Interface (ALI) Growth Solution.
VOLUME SUPPLEMENT
1 0  ml BEBM
80 pi Bovine pituitary extract
2 0  pl Hydrocortisone (HC)
2 0  pl Insulin (ISN)
2 0  pl Transferrin
2 0  pl Tridothronin (T3)
2 0  pl Epinephrine
2 0  pl Epidermal Growth Factor(EGF)
2 0  pl Gentamicin/amphitericin
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Appendix 3. Formulation for 55% neutralized polymer S2219200
Ingredient % Active % in Formulation Final %
Methyl Aminopropanol 95 0.96 .91
High Molecular 
Weight -  HC Polymer
40 12.50 5
Water 100 94.13 94.13
_ _ . . . .
Appendix 4. Formulation for 55% neutralized polymer S221880
Ingredient % Active % in Formulation Final %
Methyl Aminopropanol 95 1.91 1.81
Low Molecular Weight 
-  HC Polymer
40 25 10
Water 100 88.19 88.19
Appendix 5. Formulation for 24% neutralized polymer S2218600
Ingredient % Active % in Formulation Final %
Methyl Aminopropanol 95 1.21 1.14
Diisopropanolamine 98 1.84 1.80
Polymer 40 60 30
Alcohol 100 2.2 2.2
Water 100 64.86 64.86
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Appendix 6. A diagram of the microchannels inside the Nano-chip which 
carry the RNA samples through the gel to the laser detector. The circles 
represent the wells into which the samples are loaded.
Appendix 7. The Lab-Chip primer station. The Lab-chip has been loaded into 
place and a sample is being loaded into one of the wells in the Lab-chip. The 
syringe on the top of the station can be seen. When the top of the station is 
closed the syringe is used to apply the force needed to distribute the loaded 
gel-dye mix throughout the Lab-chip, prior to the loading of samples.
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Appendix 8. The cDNA or (Reverse Transcription) Master Mix recipe used 
was as follows:
Component Per Reaction
5X First Strand Buffer 4 pl
.1 M DTT 2 pl
10mM dNTP mix 1 pl
MMLV-RT 1 pl
RNaseOut 0.5 pl
Total Volume 8.5 pl
-
Appendix 9. The Transcription Master Mix Recipe used was as follows:
Component Per Reaction
Nuclease-free water 15.3 pl
4X Transcription Buffer 20 pl
0.1 M DTT 6 pl
NTP mix 8 pl
50% PEG 6.4 pl
RNaseOut 0.5 pl
Inorganic pyrophosphatase 0.6 pl
T7 RNA Polymerase 0.8 pl
Cyanine 3-CTP 2.4 pl
Appendix 10. To this cRNA and nuclease free water hybridization solution 
components were added to each tube in the following volumes:
Component Volume (pl) per microarray
cRNA (2 pg) + nuclease-free water 30 pl
Nuclease-free water 11.8 pl
10X Blocking Agent 11 pl
25X Fragmentation Buffer 2.2 pl
Total Volume 55 pl
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THUMBSCREW
CHAMBER COVER
TWEEZERS
CHAMBER BASE
Appendix 11. The individual parts that comprise the SurHyb chamber, the 
chamber base, inside which the gasket and array slide sit, the chamber cover 
which fits on top of the sandwiched slides and the clamp assembly which 
holds together the chamber and slides.
Appendix 12. The SureHyb chamber assembled with the chamber base, 
cover, clamp and sandwiched slides in place.
Appendix 13. Hydridzation oven/rotisserie. On the left, the SureHyb assembly 
and rotisserie. On the right the hybidization oven/rotisserie.
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Appendix 14. One representative example of page one, of the three page QC
document, generated by the Agilent scanner using the feature extraction
software (GE1_v5_95_Feb07), for one particular array.
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Appendix 15. One representative example of page two, of the three page QC
document, generated by the Agilent scanner using the feature extraction
software (GE1_v5_95_Feb07), for one particular array.
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Appendix 16. One representative example of page three, of the three page
QC document, generated by Agilent scanner using the feature extraction
software (GE1_v5_95_Feb07), for one particular array.
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Appendix 17. Poster presented at the 1Cfh International Inhalation Symposia, 
Hannover, Germany, June 2006.
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Development of In Vitro Normal Human Bronchial Epithelia for 
k Toxicological Applications
Tracy Hughes1. Leona Greenwell2 & Kelly B6ruB61
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Background: Traditionally inhalation toxicology has been studied using the NOEL/NOAEL (No Observed Effect Level/No Adverse 
Effect Level) strategy, using animal models. Recent legislation (The 7m amendment of the EU Cosmetics Directive) has specified 
that by the year 2013 there cannot be any animal testing performed on new cosmetic ingredients intended for sale in the European 
Market. This project involves the examination of the NHBE in vitro cell model as a viable alternative to animal testing.
Project Aims:
lUtplMtory EpitMium 1. Development/Optimization of NHBE Cell Culture
2. Identification of Genomic Biomarkers
3. Identification of Proteomic Biomarkers
4. Link Genomic and Proteomic Data Analysis
Methods:
1 NHBE Cells (undifferentiated) derived from heart-lung transplants 
(Cambrex - Clonetics™)
2. Cells grown in Corning CoStar® Transwell® Clear Inserts
3. Characterisation of model:
* TEER Trans-epithelial resistance (viability of tight junctions)
Light Microscopy: Top View
CellTiter-Blue™ Viability assays
MUC Gene Expression Analysis
□2.RNA R.
Extraction
(j
-*■ Gel Extraction
lii
Pa«Mg« 1- in T75 Passage 2 -  In T175
Light Microscopy : Histology (H &E Staining)
Passage 3 -  in inserts
Day 1 -  in Insert
Electron Microscopy:
Oay S -  in inesrt Day 15 -  in insert
Day 12 Day 18 Da» 21
Confocal Microscopy: (LIVE/DEAD® fluorescence cell viability assay)
Ligation
DMA - p '7 Sequencing 
@ V v j y purification I
Transformation ■— — *   ♦CACATCCACCCTTCCAAC
MUC 5B Gene Confirmed via cloning and sequencing
Control Cultures 25mM Nicotine Treated 50mM Nicotine Treated 
cultures cultures
Progress: Year One
Establishment and characterization of 3-D, fully differentiated cell cultures that formed tight junctions, secreted mucin, had active cilia and 
responded to stimuli.
Future Work:
• MUC Gene Quantification - Q -  PCR for MUC2, MUC5B and MUC5AC over 36 day life span.
• Solute permeability assay - To confirm TEER readings
• ELLA -  enzyme linked lectin assay - To more accurately measure mucin secretion.
• SEM - To more accurately view cilia and microvili.
• Xenobiotic Challenge to model and assessment of changes.
ProteoPlex™ Cytokine Microassay
■■ ■###•••••■
--
Genomics of lung injury/repair
:: ?•??:::: 
--
80.000 g .n « /ch ,u
n>2;9»«CL J
Proteomics (identify biomarkers of injury/repair)
I% 4
20 SCSPA>£ Msit V«L«
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Appendix 18. Poster presented at the In Vitro\ In Vitro Toxicology Society 
Winter Meeting, GlaxoSmithKline R&D, Hertfordshire, UK November 2006
Background: Traditionally Inhalation toxicology has been studied using the NOEUNOAEL (No Observed Effect Level/No Adverse Effect Level) 
strategy, using animal models. Recent legislation (The 7th amendment of the EU Cosmetics Directive) has specified that by the year 2013 there 
cannot be any repeat-dose animal testing performed on new cosmetic ingredients Intend ed for sale in the European Market. This project Involves 
the examination of the NHBE in vitro cell model as a viable alternative for specific endpoints of animal testing for inhalation toxicology.
Methods:
1.NHBE Cells (undifferentiated) derived from donors post-mortem. 
(Cambrex - Clonetics™)
2. Cells grown In Coming CoStar® Transwell® Clear Inserts
Cardiff
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Light Microscopy : Histology (H &E Staining)
3.Characterisation of model:
TEER: Trans-eplthellal resistance (viability of tight Junctions) Electron Microscopy:
Scanning Electron Microscopy:
Bradford Assays (protein)
MTT Viability Assay (metabolism)
MUC Gene Expression Analysis
Confocal Microscopy: (LIVE/DEAD® fluorescence cell viability assay)
Future Work:
•Solute permeability assay • To confirm TEER readings
• Xenobiotic challenge to model and assessment of changes to genomics and proteomics of cellular tissue.
ProteoPlex™ Cytokine Microassay Genomics of lung injury/repair Proteomics (identify biomarkers of injury/repair)
U
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Appendix 19. Poster presented at NC3Rs Parliamentary Event, Westminster, 
London ,UK February 2007
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Why Use a Rat Lung?
Tracy Hughes, Zoe Prytherch, Dominique Balharry, Keith Sexton 
Lata Koshy, Timothy Jones and Kelly BeruBe
Introduction: Recent legislation has accentuated the importance of developing alternative toxicology 
testing methods which avoid the use of animals, particularly for lung toxicity. The focus of this study is to 
develop an in vitro, sensitive, human-based, cellular lung model to identify signals of damage and repair 
inflicted by inhaled particles. Our human tissue equivalent lung model avoids the use of animals and 
represents an absolute replacement technique for toxicology.
Replacing
animals
with
alternatives
R1 Benefits:
? Avoids 
Animal 
Use
? Absolute 
Replacement
? Repeat 
Toxicity 
Testing
? High 
Sample 
Numbers
? Cost 
Effective
? Human 
Endpoint 
Data
Conventional Toxicology
Instillation of 
Tast Particles
Acute/Chronic
Exposure
Euthanise
Rat
Lung
Lavage
Lavage:
© •  •  
•  •o
Analyse 
Cells &
Proteins
Identify Rat 
Lung 
Biomarkers of 
Injury & Repair
Cells & 
Proteins
Extrapolate to  
H um an Lung  
R esponse
Replacement Toxicology
Air-Liquid
Interface
Apical
Region
E *  O #  != ■ *
Lung Tissue Lung Tissue Cell Culture 
Excision Maceration
Human Donors: Autopsy, Heart & Lung 
Transplants: Male, Fem ale, Children:
Normal, Asthm atic, COPO
TranswelP
NHBEInsert
Microporous Basal
Membrane R egion
Norm al Human Bronchial Epithelial 
(NHBE) Cells Culture:
Ciliated
Cell
Goblet
Cell 3> | ’St •  |
Conduct
Toxicology
Mucous 
Over-'Sep ration
1 f a  Cilia j 
I *1 Loss :
Expose Cells: 
Acute/Chronic
: Goblet Cell
: Multiplicatio
Death
Cytokine Basal Cell Loss I 
Release Multiplication Junction
R2efining
tests to 
minimise 
suffering M
Intratracheal Instillation:
«r
A s
® Invasive Technique _____ , m
® Anaesthetics Required V e rs u A
® Animals Sacrificed ' JL
® Expensive: Low Sample Numbers
® Non-human Endpoint Data
R3educing
numbers 
of animals 
used
1. Sham Control Group (No Treatment)
2. Positive Control Group 1 (Progressive Damage)
3. Positive Control Group 2 (Regressive Damage)
4. Negative Control Group (No Damage)
5. Treatment Control Group (Unknown Effect)
Intratracheal Instillation:
®  Acute Exposures (1 week) = 210 Rats 
®  Chronic Exposures (2 yrs) ■ 3,300
Human Tissue Equivalents: 
? N = 0 R ats!
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